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Abstract 
The potato cyst nematode Globodera pallida costs the UK potato industry over £50 
million per annum. In order to invade a host-plant, the infective J2 stage must hatch 
from eggs within the soil and migrate towards the root system. 
Orthologues of Caenorhabditis elegans genes involved in neurotransmission were 
identified in the G. pallida and G. rostochiensis genome assemblies. The complement 
of cys-loop ligand-gated ion channel genes was distinct compared to C. elegans and 
other parasitic nematodes. Orthologues of genes encoding subunits which comprise 
the C. elegans levamisole-sensitive nicotinic acetylcholine receptor (cel-lev-1, cel-lev-8, 
cel-unc-29, cel-unc-63 and cel-unc-38) were searched for, and cel-lev-1 and cel-lev-8 
orthologues were absent in both Globodera spp. Two orthologues were identified for 
cel-unc-29 and cel-unc-38. This suggested that the composition of the G. pallida 
L-nAChR may differ. 
The use of C. elegans as a heterologous system to study the expression pattern of       
G. pallida nAChR genes was explored. GFP-expressing lines were created using 
promoter regions of gpa-acr-2 and gpa-unc-63. Expression was observed in the ventral 
nerve cord and nerve ring for pgpa-acr-2. Expression of pgpa-unc-63 was variable, but 
was found in the head and tail region and along the ventral side of the body. 
The impact of this distinct complement of cys-loop subunits on anthelmintic sensitivity 
was demonstrated by the increased resistance of both G. pallida and G. rostochiensis 
J2s to levamisole. The EC50 of G. pallida and G. rostochiensis was 19.7 mM and 5.6 mM 
respectively, compared to the EC50 of 9 µM for C. elegans, representing a 500 – 2000 
fold increase in levamisole resistance. This increased resistance to levamisole was 
associated with an orthologue of cel-unc-38 identified in G. pallida, gpa-unc-38.1. 
Rescue of C. elegans unc-38(x20) mutants with gpa-unc-38.1 restores normal 
movement suggesting a functional reconstitution of the L-nAChR, but full sensitivity to 
levamisole is not restored. Gpa-unc-38.1 was expressed with the remaining four 
subunits from C. elegans in Xenopus oocytes to produce a chimeric receptor. The EC50 
of the response to acetylcholine and levamisole of the chimeric receptor and the 
native receptor was comparable and had similar opening responses to different 
agonists. 
Chimeric genes were created to analyse key motifs in gpa-unc-38.1 that may affect 
receptor function and levamisole sensitivity. Gpa-unc-38.1 was necessary for structural 
reformation of the receptor, but not acetylcholine binding. Removal or addition of a 
loop B glutamate residue, previously associated with levamisole sensitivity of 
Cel-UNC-38, did not affect levamisole sensitivity of Cel-UNC-38 or Gpa-UNC-38.1. An 
amino acid change (I>M) in TM2 of Cel-UNC-38 increased levamisole sensitivity and 
basal thrashing rate. The reciprocal change (M>I) in Gpa-UNC-38.1 comprised basal 
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thrashing rescue. The basis of increased levamisole resistance of gpa-unc-38.1 was not 
identified, as all gpa-unc-38.1 chimeric genes retained a higher resistance to 
levamisole than cel-unc-38. This works reveals that the nAChRs of plant-parasitic 
nematodes have distinct pharmacological characteristics. 
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1. General Introduction 
Nematodes are roundworms, characterised by their bilateral symmetry and 
unsegmented body. The phylum Nematoda is large and includes members with diverse 
morphologies, life-styles, and habitats. More than 23,000 individual species of 
nematodes have been described (Blaxter 2011), yet it is estimated that the total 
number of nematode species may be over a million with a large number of these 
unidentified species present in marine environments (Lambshead and Boucher 2003). 
The longest known species of nematode Placenta gigantissima parasitises the placenta 
of sperm whales, and can grow to a length of over 8 metres (Gubanov 1951) while the 
smallest is a marine nematode only 0.08 mm long (Groombridge 1992). Free-living 
species can feed on bacteria, fungi or other nematodes in the soil and parasitic species 
are able to parasitise plants, animals or insects. They may inhabit terrestrial or aquatic 
environments and be able to endure freezing (Wharton and Block 1993), desiccation 
(Freckman, Mankau and Ferris 1975) or long periods of starvation (Golden and Riddle 
1984).  
 Nematode evolution and phylogeny 1.1
Nematodes are an ancient class of organism. Due to their soft bodies, the age of the 
nematode phylum is not easy to determine as fossil records are not common. 
Nevertheless, there is some fossil evidence that dates nematodes as being present 470 
million years ago (Baliński, Sun and Dzik 2013) and they are believed to have first 
appeared during the “Cambrian Explosion” that occurred 600-550 million years ago. 
Understanding the phylogenetic relationship amongst nematodes to each other is 
complex, although as increasing amounts of DNA sequencing data have been made 
available in the last few years, multiple phylogenetic relationships have been drawn 
(Blaxter et al. 1998; Holterman et al. 2006; van Megen et al. 2009).  
These phylogenetic trees support three main subdivisions of the phylum Nematoda, 
the Enoplia, Dorylaimida and Chromadorea (Figure 1-1). In the most recent 
phylogenetic trees (Holterman et al. 2006; van Megen et al. 2009) full-length SSU rDNA 
sequences from nematodes throughout the phylum were used to generate a 
phylogenetic tree which hypothesises the further division of these subdivisions into 12 
clades.  
The Enoplia consist of clade 1, and are predicted to be the most basal of the clades 
(Holterman et al. 2006). Many members of this clade are marine nematodes, although 
some freshwater nematodes are found here. There are a few examples of ectoparasitic 
plant-parasitic nematode species. The Dorylaimida comprise clade 2 and contain 
freshwater and terrestrial nematodes. Some ectoparasitic plant-parasitic nematodes 
are present in this clade such as the Xiphinema and Longidorus genera (van Megen et 
al. 2009). The Chromadorea consist of clades 3-12. Clades 3-7 contain predominantly  
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Figure 1-1: Cladogram of inferred relationships in the phylum Nematoda 
Relationships derived from Holterman et al. (2006) and van Megen et al. (2009). Subdivisions 
of the phylum Nematoda are indicated at the side. The main feeding strategy within clades is 
indicated by the icons and key. Main orders in each clade are listed. An image of the feeding 
apparatus of a representative plant-parasitic nematode is shown for each clade where they are 
present. Image from Jones et al. (2013).  
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marine nematodes. Clades 9 and 10 contain mainly bacteria feeding nematodes. The 
Rhabditomorpha, of which the bacterivore Caenorhabditis elegans is a member, is in 
Clade 9. Some animal parasitic nematodes such as Haemonchus contortus (9) and 
Strongyloides ratti (10) are present in these clades. Clade 8 contains animal parasites 
such as Ascaris suum and Loa loa.  
Clade 12 contains the majority of plant-parasitic nematodes. The order Tylenchida is in 
Clade 12 which contains the sedentary endoparasitic root-knot and cyst nematode 
species. Migratory endoparasites are found in multiple clades. Clade 10 contains the 
Bursaphelenchus species. Clade 12 contains the Pratylenchus and Radopholus species 
which attack the root and Ditylenchus dipsaci which attacks stem and bulb tissues. The 
semi-endoparasitic nematode Rotylenchulus reniformis belongs to clade 12.  
There is evidence that plant-parasitism has evolved multiple times due to the presence 
of plant-parasites in multiple clades and may have evolved from ancient fungivorous 
nematodes. Fungivorous nematodes are only found in the clades which contain 
plant-parasitic nematodes and in some clades (i.e. 12) it has been demonstrated that 
fungivorous nematodes are basal to the plant-parasitic nematodes (Holterman et al. 
2006). 
 Plant-parasitic nematodes 1.2
Plant-parasitic nematodes are obligate parasites that infect a wide range of plants 
(Nicol et al. 2011). They are among the most damaging pathogens of crops worldwide 
and are estimated to have an annual economic impact of over $125 billion dollars 
globally (Chitwood 2003). 
All plant-parasitic nematodes share the common feature of a stylet, which is a hollow 
needle-like mouthpart. The stylet is involved in a range of behaviours such as exploring 
the surface of the root preceding invasion, puncturing of plant cells and the uptake of 
nutrients. 
Among the plant-parasitic nematodes, there are three main methods of infecting 
plants. These are ectoparasitism, semi-endoparasitism and endoparasitism.  
1.2.1 Ectoparasites 
1.2.1.1 Migratory  
Migratory ectoparasites do not enter the root and remain in the soil throughout their 
life-cycle. They travel along the root surface and feed from cells available from the root 
surface using the stylet. The length of the stylet affects how deep into the root-tissue 
the nematode is able to feed. Those with short stylets (15-30 µm long), such as 
members of the Genus Tylenchorhynchus feed on cells which are close to the surface 
such as epidermal cells and root hair cells. Those with longer stylets, such as members 
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of the family Longidoridae feed at the root tips from cells deeper within the tissue. 
They feed from single cells by puncturing them with their stylet, but do not establish 
permanent feeding sites. 
1.2.1.2 Sedentary 
Sedentary ectoparasites may feed for several days from a single root cell (cortical or 
epidermal). The nematode Criconemella xenoplax is able to feed on a single cortical 
cell for up to 8 days (Hussey, Mims and Westcott III 1992).  
1.2.2 Semi-endoparasites 
Rotylenchulus reniformis nematodes are sedentary semi-endoparasites, which infect 
over 350 plant species. The females penetrate the root and initiate a feeding site from 
cells in the endodermis or pericycle, although 2/3 of the body remains outside the 
root. Males of the species are not parasitic, do not feed and remain in the soil 
(Robinson et al. 1997). 
1.2.3 Endoparasites 
1.2.3.1 Migratory 
Migratory endoparasites enter the root, but do not set up permanent feeding sites. 
They migrate inter- and intra- cellularly through root-cells feeding and reproducing. 
Damage caused to the host includes mechanical damage, caused by feeding and 
migration and the inducement of galling within the root tissue. Three nematode 
families adopt this feeding strategy. Those in the Pratylenchidae attack below-ground 
tissues and include the burrowing nematode Radopholus similis which infects over 250 
plant species in 16 families and Pratylenchus penetrans which can reproduce on over 
350 hosts. The two other families Anguinidae and Aphelenchoididae attack the 
above-ground areas of the plants. In the Aphelenchoididae is the pinewood nematode, 
Bursaphelenchus xylophilus, which infects the vascular system of the plant leading to 
blocked xylem vessels and to pine-wilt disease. Bursaphelenchus species associate with 
beetle hosts, which spread infective juveniles to new trees and provide feeding 
wounds that facilitate nematode entry (Perry and Moens 2013; Jones et al. 2013). The 
stem and bulb nematodes belong to the family Anguinidae. Ditylenchus dipsaci has a 
wide host range and is a pest on important food crops such as garlic, onion and broad 
bean as well as ornamental crops such as tulips and narcissus. They enter the plant 
through stomata or other wounds and feed from parenchyma cells (Duncan and 
Moens 2013). 
1.2.3.2 Sedentary 
Nematodes that adopt this feeding strategy are among the most widespread and 
damaging. These set up long-term (weeks) feeding structures in their host plant, and 
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induce physiological and genetic changes to produce this specialised feeding structure. 
They fall into two main categories characterised by either the galling of the roots 
caused by cell proliferation (root-knot nematodes) or visible cysts on the roots caused 
by the eruption of gravid adult females through the root tissue (cyst nematodes). 
Root-knot nematodes and cyst nematodes are further differentiated by method of 
root invasion and the type of feeding structure that is induced.  
 Root-knot nematodes 1.3
1.3.1 Agricultural impact and host range 
Root-knot nematodes are members of the genus Meloidogyne and belong to the order 
Tylenchida. They are generally able to infect a wide-range of host species (Trudgill 
1997) successfully, although some species have narrower host ranges such as M. naasi 
which parasitises grasses and cereals. Most are able to parasitise a wide range of 
monocotyledonous and dicotyledonous plants. The most economically important 
species have wide host ranges and are M. arenaria, M. incognita, M. javanica and   
M. hapla. These four species are able to reproduce on important agricultural crops 
such as rice, wheat, tomato and tobacco. However, between the species there are 
differences in host range. M. arenaria and M. hapla reproduce well on groundnut, 
while M. incognita does not. M. incognita is able to parasitise cotton whereas the 
other three species cannot, and M. javanica is unable to reproduce on pepper while 
the other species can. The four species are all able to reproduce on tomato (Sasser 
1980; Moens, Perry and Starr 2009).  
The effect of root-knot nematode infection in the field can be very damaging. Damage 
to the root system leads to plants which have reduced shoot growth, wilting and 
reduction in plant yields. Changes to the root architecture also impact the ability of 
nutrient uptake, contributing to reduced yields.  
1.3.2 Life-cycle of root-knot nematodes 
1.3.2.1 Pre-invasion 
The eggs of Meloidogyne species are enclosed in a gelatinous matrix known as an egg 
mass that protects them from the soil environment. Hatching of the eggs is triggered 
generally by temperature-related cues, rather than by specific host-derived cues 
(Goodell and Ferris 1989), although root diffusate can also stimulate hatching.                
M. chitwoodi J2s hatch in a temperature-dependent manner early in the plant growing 
season, while unhatched J2s in egg masses at the end of the growing season may be 
stimulated to hatch by diffusate from host roots (Wesemael, Perry and Moens 2006).  
The infective J2 stages, once hatched, are attracted to plant roots and accumulate 
behind the root cap in the region of cell elongation. General attractants such as CO2 
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and amino acids are generated by a growing root and form a gradient in the soil which 
may act as cues for J2s to follow. CO2 has been demonstrated to be an attractant for 
M. incognita and M. javanica (Rasmann et al. 2012) and a pH between 4.5 and 5.4 has 
also been shown to act as an attractant (Wang, Bruening and Williamson 2009). This 
chemotaxis towards host roots has been shown to be sufficient for J2s of M. incognita 
and M. graminicola to reach host roots by the most efficient method when separated 
from host-roots by a maze-system. There was also evidence for host-specific cues 
acting on the J2s as movement towards a host plant was greater than movement 
towards a non-host plant (Reynolds et al. 2011).  
1.3.2.2 Invasion and induction of giant cells 
Following contact with the root, J2s search for an invasion site. This behaviour is 
characterised by the rubbing of lips over the epidermal cell surface and the gentle 
exploratory thrusting of the stylet. At the region of cell elongation, the J2s penetrate 
the root with a combination of mechanical disruption provided by the thrusting of the 
stylet and the secretion of cell wall-degrading enzymes to rupture the cell walls. On 
successful invasion, the nematodes travel intercellularly towards the root-tip until they 
reach the apex of the meristematic zone and then turn round and migrate back 
towards differentiating tissue. Here, the nematodes stop moving and initiate 
formation of their feeding site (Wyss, Grundler and Munch 1992).  
The J2 starts feeding from several cells by inserting the stylet, inducing formation of 
the giant cells. These are specialised feeding structures for root-knot nematodes, and 
their formation is essential for the J2 to successfully complete its life-cycle. They are 
initially established from cells of the phloem or parenchyma and each J2 induces and 
feeds from between 2 – 12 cells. The giant cells are multinucleated as a result of 
multiple rounds of endomitosis without cytokinesis. The J2 feeds from these cells by 
withdrawing the cell contents through the stylet and feeding tube.  
Secretions from the nematode, injected into the cell through the stylet contain 
effector proteins which contribute to this reprogramming of the plant cells to produce 
giant cells. Some candidate effectors have been identified, which allow successful 
invasion by co-opting cellular processes. Some affect hormone balances within the cell, 
such as a chorismate mutase, which may act to suppress auxin formation (Doyle and 
Lambert 2003). Some are localised to the nucleus of giant cells (Jaouannet et al. 2012), 
or have canonical nuclear localisation signals which predict targeting to the nucleus 
(Huang et al. 2003), although the targets of many of these effectors are not known. 
The targets of some have been identified, such as the effector 16D10 which interacts 
with the root protein SCARECROW which causes root cell proliferation (Huang et al. 
2006). These effectors are synthesised in the oesophageal glands of the root knot 
nematode. Three moults occur in order to reach maturation. During this process the 
nematode swells and after the final moult the females become pear-shaped and 
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secrete a gelatinous matrix in which they lay eggs. Male root-knot nematodes follow a 
different developmental path and become vermiform after the final moult. 
1.3.2.3 Root-knot nematode reproduction 
The Meloidogyne genus has three different modes of reproduction. There are 
amphimictic species like M. pinis and M. carolinensis in which male worms fertilise 
females, and the oocyte undergoes meiosis. This method of reproduction is 
uncommon in the Meloidogyne genus. Some species such as M. chitwoodi and most 
populations of M. hapla reproduce by facultative meiotic parthenogenesis in which, if 
males are present, amphimictic reproduction occurs. In the absence of males, the pro 
nucleus and polar body of the oocyte fuse and the embryo develops. Most species of 
Meloidogyne reproduce by obligate mitotic parthenogenesis and these include the 
most economically damaging root-knot nematodes M. incognita, M. arenaria,    
M. javanica and some populations of M. hapla. Although males are present in these 
species, they play no role in reproduction and their number is affected by 
environmental state. 
The parthenogenic nature of many Meloidogyne species may be a result of 
hybridization between two ancient RKN genomes resulting in polyploidisation. This 
results in a high background of genetic diversity within Meloidogyne species, which is 
thought to account for the broad host-range of many Meloidogyne species as it can 
provide variability in order to overcome plant defences. In contrast, the amphimictic 
species have narrower host ranges (Castagnone-Sereno 2006; Castagnone-Sereno 
2002; Chitwood and Perry 2009). 
 Cyst nematodes 1.4
1.4.1 Agricultural impact and host range 
The most economically damaging cyst nematodes belong to the genera Heterodera 
and Globodera. Cyst nematodes typically have a narrower host range than 
Meloidogyne species and each species can only reproduce on a small range of crops. 
Globodera pallida and G. rostochiensis can reproduce on potato, tomato and eggplant 
whilst wheat, barley, oat and maize are hosts for H. avenae and filipjevi. H. glycines 
reproduces on soybean and other legume varieties, although it can also reproduce on 
other non-leguminous weeds. H. schachtii has a wide host range for a cyst nematode, 
and is able to infect plants such as broccoli, chickpea and spinach (Turner and Subbotin 
2013). 
Despite the reduced host-range of cyst nematode species, many important crops have 
a cyst nematode species which is able to infect them. The economic loss associated 
with cyst nematode infection is high. 9% of potato crop yield losses worldwide have 
been estimated to be due to potato cyst nematodes (Perry and Moens 2013). The 
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potato cyst nematode, G. pallida, causes yield losses of over £50 million per annum to 
the UK potato industry. Potato cyst nematode has been found in 65% of potato 
growing fields in the UK, of which 67% of the nematodes were G. pallida (Minnis et al. 
2002) and the remaining G. rostochiensis.  
1.4.2 Life-cycle of cyst nematodes 
1.4.2.1 Pre-invasion 
As cyst nematodes tend to have a more limited host-range, their hatching is triggered 
by specific host-derived cues. This hatching response to host-derived cues varies 
between cyst nematode species. While G. pallida and G. rostochiensis are dependent 
on host-derived cues for hatching, H. schachtii with a wider host range hatches well in 
the absence of host-derived cues. Globodera pallida in particular requires 
root-exudates of potato to induce a hatching response (Den Nijs and Lock 1992). While 
host-derived cues are required for hatching, temperature also affects hatching. Two 
potato cyst nematode species G. pallida and G. rostochiensis have different optimal 
hatching temperatures (16°C and 20°C) (Turner and Subbotin 2013). 
The eggshell of cyst nematode J2s protects against environmental conditions. Within 
the eggshell, the J1 undergoes the first moult to a J2. In its quiescent state, the J2 is 
partially dehydrated and metabolically inactive. In response to hatching cues, the 
permeability of the eggshell changes to allows rehydration of the J2, which becomes 
metabolically active. The J2s uses the stylet to perforate the eggshell until a slit is 
produced through which it exits the egg.  
Host-derived cues may also be attractants for cyst nematodes as diffusate from 
host-roots tends to attract infective J2s (Reynolds et al. 2011). Specific compounds 
which have been highlighted include δ-aminobutyric acid and L-glutamic acid for           
G. pallida, and α-aminobutyric and L-glutamic acid for G. rostochiensis (Rasmann et al. 
2012).  
1.4.2.2 Invasion and induction of syncytia formation 
The J2s initiate root invasion near to the tips of the roots. The stylet is used to rupture 
the epithelial cell walls by thrusting. The J2 enters the cortical cells and migrates 
intracellularly towards the vascular cylinder. During this intracellular migration, the 
stylet is used to rupture cell walls and aid the J2’s movement through the cells of the 
root.  
Upon reaching the vascular cylinder, the J2 selects a cell to initiate formation of the 
feeding site by piercing it with the stylet. The stylet may be withdrawn and a new cell 
selected several times, before a suitable cell is found (Wyss and Zunke 1986; Wyss and 
Grundler 1992). The syncytium is formed from enlarged root cells caused by the 
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breakdown of cell walls between neighbouring cells and has a dense granular 
cytoplasm. Endoreduplication leads to increased number of nuclei and there is an 
increase in the number of ribosomes and mitochondria. The J2 feeds from this cell by 
withdrawing the cell contents through the stylet and a specialised feeding tube 
structure that forms at the stylet tip.  
Nematode effectors are injected into the cell via this stylet that trigger a plethora of 
changes in gene expression which facilitate syncytium formation. A Cellulose Binding 
Protein (CBP) identified in H. schachtii interacts with a cell wall modifying enzyme 
pectin methylesterase and is involved in the restructuring of cell wall architecture 
(Hewezi et al. 2008). Host genes such as expansins (Wieczorek et al. 2006) and 
endo-β-1,4-glucanases are also found to be upregulated in syncytia, and are required 
for successful infection and expansion of the cells (Karczmarek et al. 2008). Effectors 
also act to suppress host defences. The Hs4F01 gene of H. schachtii interacts with an 
Arabidopsis oxygenase, which has been shown to be involved in pathogen 
susceptibility previously (Patel et al. 2010). A chorismate mutase gene identified in        
G. pallida may also have a role in reducing plant defence response, or in altering auxin 
levels (Jones et al. 2003). More putative effectors have been identified in cyst 
nematodes such as G. pallida, although the function of most is not yet known. They 
can be observed by GFP fusions accumulating in the nucleus and cytoplasm (Thorpe et 
al. 2014).  
The J2 feeds from the syncytial cell for approximately 7 days before moulting to a J3. 
This is the last stage at which the male cyst nematode will feed, although the female 
continues to feed. After the final moult to J4 stage, the female nematode enlarges and 
the posterior end erupts from the root. The vermiform adult male develops within the 
J4 cuticle, before emerging from the root (Turner and Subbotin 2013; Lilley, Atkinson 
and Urwin 2005). 
1.4.2.3 Reproduction 
Cyst nematodes reproduce amphimictically. Sex determination occurs towards the end 
of the J2 stage and there is evidence that this is dependent on aspects of the status of 
the syncytium such as nutrient availability. More females develop under 
environmentally favourable conditions (Grundler, Betka and Wyss 1991), while a high 
proportion of males develop under conditions such as high infestation levels (Trudgill 
1967). The adult male locates the female on the root, likely by responding to sex 
pheromones (Riga et al. 1996) in order for fertilization to occur. After fertilisation, the 
female nematode becomes gravid and polyphenol oxidases tan the cuticle to produce 
the cyst, which contains the fertilised eggs (Awan and Hominick 1982).  
The life-cycle of a cyst nematode is summarised in Figure 1-2. 
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Figure 1-2: Life cycle of a cyst nematode 
The life cycle of a cyst nematode such as G. pallida. a) Eggs hatch from the soil as migratory J2 
stages. Hatching is triggered by sensing of host-derived cues under favourable conditions. b) 
The J2 enters the root and migrates intracellularly towards the vascular cylinder. A cell is 
selected for initiation of the feeding site. Sex is determined towards the end of the J2 stage. c) 
The J2 moults to the J3 stage. The syncytium is induced and the nematode feeds and begins to 
swell. d) The final moult to the J4 stage occurs. The ovaries of the female develop. e) Eggs 
develop within the female body wall, tanning by phenol oxidases occur to produce the 
toughened cyst. f) Male worms develop as a vermiform inside the J4 cuticle. g) Adult male 
worms leave the root and fertilise eggs within the females. Adapted from Lilley, Atkinson and 
Urwin (2005). 
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 The need for novel methods of control 1.5
1.5.1 Current social methods 
Nematode infection in fields is often overlooked as symptoms of infection can be 
similar to those of abiotic stresses such as drought. As a result, nematode infection is 
frequently not controlled as it is not identified.  
Crop rotation can be used to control nematodes. However, for cyst nematodes such as 
G. pallida long crop rotation periods are required in order to reduce cyst nematode 
populations due to the highly protective cyst (Kerry, Barker and Evans 2002). Decline 
rates of G. pallida in the field are <30% per year resulting in a recommended rotation 
time of between 8 and 14 years (Trudgill et al. 2003). Although the eggs of 
Meloidogyne species do not have a toughened protective coating, crop rotations for 
control of Meloidogyne species requires the growth of host-species that Meloidogyne 
cannot proliferate on. As most Meloidogyne species have a wide-host range, selection 
of suitable crops for crop rotations can be difficult. Crop rotation also entails an 
economic cost, as often less profitable crops are used. Use of trap crops to control 
Meloidogyne species is being investigated. In this model, plants which induce 
Meloidogyne hatching and invasion, but are unsuitable hosts in which to complete the 
nematode life cycle are used (Melakeberhan et al. 2006). 
1.5.2 Nematicide use is reduced 
Nematicides have been used in the past to control nematodes, but many relied upon 
nematicides are now becoming phased out due to environmental concerns. Fumigants 
are used to treat the soil by mixing nematicidal compounds into the air spaces 
between the soil particles. The fumigant methyl bromide is no longer used in most 
countries due to its classification as an ozone depleting compound (Ristaino and 
Thomas 1997). The carbamate Aldicarb targeted chemoreception, but has been 
banned due to its effect in off-target organisms. The producer of Aldicarb, BayerCrop 
Sciences, plans to end distribution by the end of 2017.  
New research in the areas of control focuses on novel manufactured nematicides such 
as fluensulfone (Kearn et al. 2014) and monepantel (Rufener et al. 2010) and 
nematicides derived from biological sources like garlic extracts (Danquah et al. 2011). 
However, it has been estimated that unless a nematicide is able to reduce the 
population of nematodes in a field by over 90%, a sufficient number will remain for the 
population levels to rebound to problematic levels (Trudgill et al. 2003).  
1.5.3 Use of resistant crops 
Crops resistant to nematode infection have also been produced using traditional 
breeding techniques. The Mi-1 gene of tomato (introgressed from a wild tomato 
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relative) confers resistance to the root-knot nematodes M. incognita, M. arenaria and 
M. javanica (Vos et al. 1998). Some commercial cultivars of potato which carry the H1 
resistance gene are fully resistant against G. rostochiensis (Bakker et al. 2004). The 
Hero gene confers high resistance of tomato to G. rostochiensis and partial resistance 
to G. pallida (Ernst et al. 2002).  
Development and breeding of resistant lines is time-consuming and expensive. 
Resistance genes which are effective in one host-plant, may not be effective in another 
making the use of identified resistance genes more limited. For example, transgenic 
potato lines expressing the tomato Hero gene were not resistant to potato cyst 
nematodes (Sobczak et al. 2005). Additionally, resistance genes are often over-come in 
time due to high-selection pressures on the parasite. Growth of potato cultivars 
resistant to G. rostochiensis has additionally had the unintended side-effect of 
increasing G. pallida populations due to reduced competition (Minnis et al. 2002). 
Genetic engineering of resistance is also part of ongoing research, although there is 
still considerable resistance against GM crops, particularly in Europe. However, it is 
critical that new avenues for nematode control are continually being investigated.  
 Caenorhabditis elegans 1.6
C. elegans is a free-living bacterivore found in soil environments. Wild populations of  
C. elegans have been found associated with composting material (Dolgin, Felix and 
Cutter 2008). The C. elegans worm is translucent and as an adult ~1 mm in length. The 
life-cycle (Figure 1-3) is fast and the nematode develops from egg to sexually mature 
adult in three days, although adults can live for several weeks (Brenner 1974). Before 
reaching maturity, there are four larval stages and four moults that occur in the 
life-cycle. Under unfavourable environmental conditions such as starvation or 
overcrowding the worm may enter a dauer stage after the second moult. These are 
developmentally arrested, and metabolically less active stages which can survive for 
weeks until conditions become favourable for continued development (Cassada and 
Russell 1975).  
The adult hermaphrodite contains 959 somatic cells; the lineage of each has been 
studied in detail. Thousands of worms can easily be propagated within a week on agar 
plates seeded by E. coli as an individual self-fertilising hermaphrodite can lay over 300 
eggs (Brenner 1974). There are two C. elegans sexes, although males in the population 
are rare (under 0.1%) (Ward and Carrel 1979).  
1.6.1 Food-searching behaviours of C. elegans 
C. elegans has distinct behaviours in the way it responds to and seeks food. As a simple 
model, a C. elegans worm on a lawn of bacteria will primarily adopt dwelling 
behaviours, where it will move slowly and remain in a restricted area. It may  
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Figure 1-3: Life-cycle of the C. elegans hermaphrodite at 22 °C 
Diagram shows the different life-stages of C. elegans and duration of the life-stage at 22 °C. 
The conditions under which L1 larval arrest and dauer formation can be induced are shown in 
red. Development of the reproductive system is shown in blue, the pharynx in green and the 
intestine in purple. Length of the worm at each stage is given in µm. Diagram from Altun and 
Hall (2005) 
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sometimes switch to roaming behaviours, where it will move more quickly over the 
lawn. If the worm is moved from a bacterial lawn to a plate without bacteria, the 
behaviour changes to rapid movement punctuated with turns mediated either by 
reversals followed by a directional change or omega turns (Croll 1975). This behaviour 
is known as Area Restricted Search (ARS). During the 30 minutes following the worm 
being moved from food, the number of reversals steadily decreases and the behaviour 
changes to a dispersal based behaviour. On encountering a new food source, the worm 
will slow its speed in a behaviour known as enhanced slowing. These changes in 
response to food serve to help C. elegans locate food sources in an environment where 
food is likely to be disrupted in discrete units (e.g. bacterial colonies around rotting 
fruit). In the presence of bacteria, behaviours which may lead to leaving the food are 
suppressed. If the food runs out, the local area is searched first and then the worm 
leaves to find new bacterial sources (Bargmann 2006).  
1.6.2 The use of C. elegans as a model organism 
C. elegans was the first multicellular organism for which the full genome was 
sequenced (Consortium 1998) and this is now completed to a high degree of 
confidence (Chen et al. 2005a). Although more genomes of plant-parasitic and other 
parasitic nematodes have been sequenced and published (Opperman et al. 2008; 
Cotton et al. 2014; Abad et al. 2008; Laing et al. 2013; Jex et al. 2011; Ghedin et al. 
2007) in the last few years, C. elegans is still considered an excellent model on which to 
base research of other nematode species.  
C. elegans was popularised as a model organism by Sydney Brenner in the 1960s. Initial 
study of the worm employed forward genetics and induced mutations by ethyl 
methanesulphonate (EMS) in order to characterise aberrant phenotypes, such as those 
which caused deviations in locomotion (Brenner 1974). Developments in RNAi 
technology employed reverse genetics to target specific genes, and analyse the 
phenotype caused by disruption of gene function (Fire et al. 1998). 
Microinjection allows transformation of C. elegans by injection of DNA into the gonads 
of a young hermaphrodite. The injected DNA forms large extrachromosomal arrays 
which can become stably inherited. A selectable marker e.g. rol-6 or gfp allows positive 
selection of transformants (Mello et al. 1991). Microparticle bombardment has also 
been developed to create transgenic lines of C. elegans. Plasmid DNA is coated onto 
gold beads, and bombarded into large populations of C. elegans to generate lines in 
which the transforming DNA has been integrated into the genome (Praitis et al. 2001). 
In recent years, CRISPR-Cas9 technology has allowed specific targeting of genomic 
sequence to create insertions, mutations or deletions in the genomic copies of specific 
genes (Friedland et al. 2013). As C. elegans populations are predominantly 
self-fertilising hermaphrodites which can produce 300-350 offspring per day, the 
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maintenance and propagation of mutant strains is very simple, as they can be 
generated from a single worm. 
The C. elegans community is large and collaborative and many resources have been 
made available online. The full genome sequence is publicly available on Wormbase. 
The genome is 100 Mb in size and contains over 19,000 predicted genes collated with 
associated data that is available on Wormbase. The ORFeome project provides 
validated predicted gene models, and integrates it with the C. elegans genome 
sequence and provides open reading frames of C. elegans genes in vectors to facilitate 
expression in bacteria (Chen et al. 2004). Studies on the effect of RNAi on more than 
86% of C. elegans genes have been done systematically and the results have been 
integrated onto the Wormbase database (Kamath et al. 2003). Microarray data is also 
available, detailing changes in gene expression of C. elegans in response to different 
growth conditions, developmental stages and in different mutants (Kim et al. 2001b). 
Additionally SAGE (Serial Analysis of Gene Expression) has also yielded information 
about changes in gene expression over different life-stages and in different conditions 
(Jones et al. 2001). High-throughput yeast-two-hybrid screen has also yielded 
information about protein-protein interactions in C. elegans, and an interactome for 
many proteins is available (Li et al. 2004). The expression patterns of many C. elegans 
genes are available online, generated from a promoterome which used the expression 
pattern of GFP driven by promoters of interest to highlight where particular genes are 
expressed (Dupuy et al. 2004). This is all available, organised by gene name on the 
Wormbase site with links to the supporting literature. 
The Caenorhabditis genetics centre (CGC) produces and distributes mutant strains to                    
C. elegans researchers. Over 3,000 mutant strains of C. elegans are available to 
academic institutes free of charge, or for a small fee to industrial institutes.  
The physical features of C. elegans and the amount of genetic resources, databases 
and research papers has made C. elegans a very popular model organism. It has been 
used in biomedical studies to investigate human diseases, despite the very wide 
evolutionary gap between the nematode worm and human biology. Despite this, the 
worm still has many features that are shared in the mammalian body such as muscle, 
intestine, reproductive system, glands and a nervous system. It has found uses as a 
model for anticancer drugs (Hara and Han 1995) and in the development of treatments 
for depression (Dempsey et al. 2005), among many other examples in the 
pharmaceutical world (Kaletta and Hengartner 2006). Much of the information and 
techniques used to produce the C. elegans genome sequence were subsequently used 
to aid the human genome project (Blaxter 2011). 
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1.6.2.1 C. elegans as a model for plant-parasitic nematodes 
C. elegans can be maintained in the laboratory environment using simple materials 
and techniques. For these reasons, C. elegans is an attractive model for plant-parasitic 
nematodes. In contrast, plant-parasitic nematodes are obligate parasites which require 
their host-species to complete their life-cycle. The life-cycles are comparatively long 
(4-5 weeks) and require the time to grow the host plants and the space in which to 
keep them. There have been no reported instances of the production of transgenic 
lines of plant-parasitic nematodes, although there has been some success at creating 
transformants for some other parasitic nematodes (Li et al. 2006; Grant et al. 2006). 
However, the time and space required to generate and maintain such mutant lines 
would make such a task unfeasible. The molecular techniques available for 
plant-parasitic nematodes are more limited than those for C. elegans. RNAi has been 
used to knockdown target genes in some plant-parasitic nematode species (Urwin, 
Lilley and Atkinson 2002; Chen et al. 2005b) and in some animal-parasitic species 
(Aboobaker and Blaxter 2003), however this effect is transient.  
Despite the different life-styles of C. elegans and parasitic nematodes, they are likely 
to have broadly the same body structure, development, reproduction and responses to 
stimuli. In comparisons between the nervous system of A. suum and C. elegans the 
structure of the nervous system has been shown to be very similar despite the 
hypothesised species divergence time of 500 million years (Jorgensen 2005; White et 
al. 1986). All nematodes have the requirement to sense and migrate towards food 
sources or hosts, and the molecular mechanisms underpinning these behaviours are 
likely to be shared. The dauer larval stage of C. elegans and the infective juvenile 
stages of parasitic nematodes had been thought to be functionally homologous as 
both are long-lived, non-aging and non-feeding. However, metabolism in C. elegans 
dauer larvae and soybean cyst nematodes H. glycines J2s has been shown to be 
dissimilar. Additionally only 22% of dauer-enriched genes are conserved in H. glycines, 
and only 41% of these are expressed at the same analogous time point as in the dauers 
(Elling et al. 2007). Furthermore, an orthologue of daf-7 in the parasitic nematode 
Parastrongyloides trichosuri, a gene that controls entry into dauer development in   
C. elegans, was unable to rescue daf-7 C. elegans mutants. It seems likely that the 
parasitic infective stages are either not functionally identical to the C. elegans dauers, 
or evolutionary distance has changed many pathways (Crook, Grant and Grant 2010).  
C. elegans can be used as a model for plant-parasitic nematodes in two main ways. 
Information obtained from C. elegans may be applied directly to plant-parasitic 
nematodes or it may be used as an expression system in which the gene from the 
parasite is expressed and its function probed. 
The mode of action of many of the anthelmintic drugs has been elucidated in               
C. elegans before the parasite which they target. The molecular targets of ivermectin 
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(Dent et al. 2000), levamisole (Lewis et al. 1980) and monepantel (Kaminsky et al. 
2008) along with many others were first characterised in C. elegans. It has also been 
used as a method of high-throughput screen for potential anthelmintic drugs (Taylor et 
al. 2013; Katiki et al. 2011). The roles of certain families of proteins have been 
characterised first in C. elegans and from this, their role in parasitic nematodes 
inferred. For example, a cathepsin L protease was demonstrated to be essential for 
embryonic development of C. elegans (Hashmi et al. 2002) and this role was shown to 
be functionally conserved in the parasite H. contortus (Britton and Murray 2002). 
C. elegans may also be used as an expression system in which to express genes from 
parasitic species in order to investigate their function. By expressing homologues of    
C. elegans genes identified in a parasitic nematode, the function of the parasitic gene 
can be determined if it is able to rescue the equivalent mutant strain of C. elegans 
(Glendinning et al. 2011). This allows the likely role of genes from parasites to be 
studied further, such as the characterisation of the tub-1 gene encoding β-tubulin from 
H. contortus and its role in benzimidazole resistance (Kwa et al. 1995). It has also been 
used in vaccine develop against parasites such as H. contortus in order to express        
H. contortus derived antigens (Roberts et al. 2013). Expression patterns of genes from 
parasitic nematodes can also be analysed by the generation of promoter:GFP or LacZ 
fusions from the parasitic nematode, which are then transformed into C. elegans. The 
promoter region of an acetylcholinesterase gene, gpa-ace-2 from G. pallida has been 
used to drive GFP expression in C. elegans in specific neurons. Gpa-ace-2 was also able 
to rescue the C. elegans acetylcholinesterase mutants (Costa et al. 2009). The 
promoter region of a GAPDH gene from G. rostochiensis has been used to drive GFP 
expression in the body wall muscle of C. elegans. (Qin et al. 1998) The expression 
pattern of GFP is likely to be similar to where the gene is expressed in the parasite. 
The new era of genome sequencing is beginning to provide more completed genome 
sequences for parasitic nematode species. The 959 Nematode Genomes project aims 
to collate all the ongoing genome sequencing work on nematodes (Kumar, Schiffer and 
Blaxter 2012). A similar resource also exists for nematode transcriptome data 
(Elsworth, Wasmuth and Blaxter 2011). Including C. elegans, 21 genomes have been 
recently sequenced and of these 16 are parasitic nematode genomes (Rödelsperger, 
Streit and Sommer 2013). This increase allows for a new field of comparative genomics 
highlighting aspects of parasitic nematodes. 
C. elegans as the organism in which functions have been ascribed to most genes, has a 
fundamental role in this. Comparisons of newly sequenced parasitic genomes can 
allow orthologues between the species to be identified, and can highlight expansions 
or reductions in gene families which may be indicative of the switch to a parasitic 
lifestyle. Parasitic genomes can also be compared to each other to determine which, if 
any, are the core genes for parasitism (Sommer and Streit 2011). This has also 
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highlighted the role of Horizontal Gene Transfer in nematodes, which may have had 
implications on the evolution of parasitism (Dieterich and Sommer 2009). 
1.6.3 Aspects of the neurobiology of C. elegans 
The adult hermaphrodite C. elegans contains 302 neurons and over 7000 synapses. 
The nervous system makes up roughly one third of the animal (White et al. 1986). 
These neurons are separated into two distinct and independent systems; the larger 
somatic system that consists of the 282 neurons in the body of the worm and the 
smaller pharyngeal system of 20 neurons that controls the pharynx. The two networks 
are connected by a pair of RIP interneurons allowing signalling between the two 
neuronal systems. The neurons of C. elegans can be functionally grouped into 4 
categories: motor neurons that connect onto muscular tissue, sensory neurons that 
mostly have ciliated ends for sensing, interneurons which receive signals and pass on 
signals to other neurons and polymodal neurons that have more than one function. 
The synapses connecting the neurons are primarily chemical and signal via the use of 
neurotransmitters. Additionally, gap junctions that mediate electrical signalling 
between cells are found between muscle cells and between neurons (White et al. 
1986).  
The neurotransmitters used at the chemical synapses are acetylcholine, 
γ-Aminobutyric acid (GABA), glutamate, dopamine, serotonin, tyramine, octopamine, 
and neuropeptides. They are involved in all aspects of C. elegans neurobiology 
controlling locomotion, food-seeking behaviours, pharyngeal pumping and egg-laying. 
The annotation of neurotransmitter roles has been achieved through investigation of 
the behavioural changes of mutants in which synthesis or perception of the 
neurotransmitters has been decreased. Application of exogenous neurotransmitter 
and the change in behavioural responses has also been used to elucidate their role. 
Through methods like these the involvement of neurotransmitters in particular 
behaviours can be elucidated. 
1.6.3.1 Musculature and locomotion 
The body wall muscle of C. elegans is obliquely striated, as is all nematode muscle 
studied so far. In contrast, vertebrate muscle is cross striated. 95 rhomboid-shaped 
body wall muscle cells line the body wall muscle of the adult hermaphrodite. 75 motor 
neurons innervate the body wall muscles, leading to the sinusoidal locomotion pattern 
observed on solid media. Sinusoidal locomotion is controlled by cholinergic B- type 
(forward locomotion) and A- type (backward locomotion) as well as GABAnergic D-type 
neurons. Rhythmic co-ordination between contractions of body wall muscle on one 
side of the body, accompanied by relaxation on the other side drives this sinusoidal 
movement. In forward locomotion, alternating excitation of dorsal and ventral muscle  
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Figure 1-4: Generation of sinusoidal locomotion in C. elegans 
a) Basic principal of sinusoidal locomotion in C. elegans. Contraction on one side of the worm is 
induced by acetylcholine and relaxation on the other side of the worm is induced by GABA.  
b) Neurons that control this behaviour. In forward locomotion (red), DB and VB neurons trigger 
acetylcholine receptors in the body wall muscle, and trigger GABA release from DD and VD 
neurons on the alternate side of the wall triggering a GABA receptor. In backward locomotion 
(blue), DA and VA neurons trigger acetylcholine receptors and DD and VD neurons.  
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is mediated by the DB and VB neurons respectively, which then elicit relaxation on the 
opposite side of the worm via the VD or DD neuron. Contraction of the body wall 
muscle is mediated by two acetylcholine receptors (contraction), and a GABA receptor 
(relaxation) at the neuromuscular junction (Richmond and Jorgensen 1999) (Figure 
1-4).  
1.6.3.2 Acetylcholine 
Acetylcholine is the major excitatory neurotransmitter acting at neuromuscular 
junctions. 120 of the 302 neurons in the hermaphrodite nervous system are cholinergic 
and they are primarily motor neurons. It has roles in feeding, egg-laying and 
locomotion. The mechanism of acetylcholine release from the synapse is shown in 
Figure 1-5. Acetylcholine is loaded into vesicles by a synaptic vesicle acetylcholine 
transporter UNC-17 (Alfonso et al. 1993). The vesicles then dock with the cell 
membrane and are primed for Ca2+ dependent fusion. On fusion with the membrane, 
acetylcholine is released into the synaptic cleft and activates acetylcholine receptors 
on the post-synaptic membrane. Continued activation is prevented by the action of 
acetylcholinesterase that breaks down acetylcholine and removes it from the synaptic 
cleft. The resulting choline is then taken up again to the presynaptic cleft by a choline 
transporter CHO-1 (Okuda et al. 2000). CHA-1 resynthesises acetylcholine by the 
acetylation of choline (Rand and Russell 1985). Mutants in cha-1 and unc-17, which are 
impaired in acetylcholine synthesis, are uncoordinated in movement, as acetylcholine 
is required for generation of smooth body movement. Pharyngeal pumping is also 
slowed as the MC neuron that stimulates pharyngeal pumping is activated by 
acetylcholine. Null mutants of cha-1 and unc-17 are lethal (Alfonso et al. 1993).  
The largest class of acetylcholine receptors in C. elegans are the nicotinic acetylcholine 
receptors (nAChRs). These are cys-loop receptors which will be discussed in more 
detail in 1.7. In addition to these, there are also G-protein coupled receptors, 
expressed primarily in the head and pharyngeal muscle.  
1.6.3.3 GABA 
GABA in C. elegans is an inhibitory neurotransmitter and primarily acts at the 
neuromuscular synapses to affect the body movements which mediate locomotion 
and head movements during foraging (Mclntire et al. 1993). UNC-25 is a glutamic acid 
decarboxylase and essential for GABA synthesis. Mutations in unc-25 abolish GABA 
transmission. The animals shrink in size, and their movements are uncoordinated e.g. 
display exaggerated head movements during foraging (McIntire, Jorgensen and Horvitz 
1993). Unc-47 encodes a transporter which loads GABA into vesicles in the presynaptic 
neuron (McIntire et al. 1997). GABA is cleared from the synaptic cleft by active 
transport mediated by GABA transporter SNF-11 (Jiang et al. 2005). 
21 
 
 
Figure 1-5: Schematic of mechanism of acetylcholine release 
a) Acetylcholine is loaded into vesicles by UNC-17. b) Vesicles dock at the presynaptic 
membrane. c) Vesicles fuse with the membrane and acetylcholine is released into the synaptic 
cleft and activates acetylcholine receptors on the post-synaptic membrane. d) Removal of 
acetylcholine from the synaptic cleft by breakdown catalysed by acetylcholinesterase. e) 
Uptake of choline by choline transporter CHO-1. f) Synthesis of acetylcholine by CHA-1. 
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There are two classes of GABA receptors. The GABAA receptors belong to the cys-loop 
family. The unc-49 gene encodes three different subunits of the GABAA receptor via 
alternate splicing. An additional receptor, EXP-1 has also been identified which 
provides an excitatory role for GABA during defecation (Schuske, Beg and Jorgensen 
2004). The GABAB receptor is a GPCR that is a heterodimer of two subunits. 
1.6.3.4 Glutamate  
Glutamate mediates rapid excitatory synaptic signalling and is involved in locomotion, 
the perception of the environment and feeding activity (Hills, Brockie and Maricq 
2004). Mutants of eat-4, a vesicular glutamate transporter which mediates release of 
glutamate into the synapse, are deficient in glutaminergic signalling, and are abnormal 
in the pharyngeal pumping responsible for feeding (Lee et al. 1999). 
The primary receptors for glutamate are the ionotropic glutamate receptors (iGluRs), a 
class of heteromeric ligand-gated ion channels. At least 10 genes encoding subunits of 
iGluRs exist in C. elegans (Brockie and Maricq 2002). The subunit encoded by glr-1 
appears to be involved in many aspects of nematode biology as mutants for this gene 
do not demonstrate the typical backing away response to nose touch (Hart, Sims and 
Kaplan 1995). Glr-1 and glr-2 also appear to be involved in the onset of area-restricted 
search, which increases turning rate after an encounter with food to remain in an area 
where more food is likely to be encountered (Hills, Brockie and Maricq 2004). 
In addition to the iGluRs, there is a small family of glutamate-gated chloride channels 
which appear to be unique to invertebrates and were first identified by their sensitivity 
to the anthelmintic paralysing drug ivermectin.  
1.6.3.5 Serotonin  
Serotonin modulates behaviour in response to food and egg laying (Sawin, 
Ranganathan and Horvitz 2000). Serotonin signalling is involved in the enhanced 
slowing response that food deprived animals demonstrate when encountering a 
bacterial lawn. Pharyngeal pumping is triggered and increased by serotonin and egg 
laying is promoted. Bas-1 and cat-4, both involved in serotonin biosynthesis, 
demonstrate that serotonin is important in this enhanced slowing response as 
mutations in these genes abolish this response (Sawin, Ranganathan and Horvitz 
2000). Tph-1 encodes a tryptophan hydroxylase that catalyses a rate limiting step in 
serotonin biosynthesis. Mutants in this gene do not accumulate serotonin and are not 
able to respond to the presence of food (Sze et al. 2000). 
Four receptors for serotonin have been identified: MOD-1 is a serotonin gated chloride 
channel, and SER-1, SER-4 and SER-7 are G-protein coupled receptors. Mutants in ser-7 
show various differing responses to food such as irregular pharyngeal pumping 
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(Hobson et al. 2006). MOD-5 is the reuptake transporter which clears serotonin from 
the synaptic cleft after release (Ranganathan et al. 2001). 
1.6.3.6 Dopamine  
In C. elegans, dopamine is involved in modulating locomotion in response to 
environmental cues, and learning particularly in food-seeking behaviours (Hills, Brockie 
and Maricq 2004; Sawin, Ranganathan and Horvitz 2000). Dopamine is proposed to 
have a role in slowing in the presence of food. It has a role in the area-restricted search 
behaviour, which is triggered by encountering food and keeps worms in an area where 
it is likely to encounter food again by increasing the number of high-angled turns. 
Mutations in cat-2, which encodes a tyrosine hydroxylase that synthesises dopamine, 
are deficient in this behaviour. Application of exogenous dopamine was also shown to 
be sufficient to increase the number of high-angled turns (Hills, Brockie and Maricq 
2004). Additionally, dopamine is involved in the basal slowing response when a worm 
encounters food and slows its locomotion rate. Mutations in cat-2 completely 
abolished this basal slowing response. The application of exogenous dopamine is 
sufficient to restore this response in cat-2 mutants (Sawin, Ranganathan and Horvitz 
2000). Dat-1, the reuptake transporter for dopamine, is necessary for thrashing 
behaviour in liquid (McDonald et al. 2007).  
Four dopamine receptors have been identified in C. elegans (DOP1-DOP4) and are 
G-protein coupled receptors (Chase, Pepper and Koelle 2004; Suo, Sasagawa and 
Ishiura 2002; Suo, Sasagawa and Ishiura 2003). 
1.6.3.7 Octopamine  
Octopamine has a limited role in C. elegans neurobiology and is possibly involved in 
signalling starvation and low-food situations. Starvation triggers changes in gene 
expression such as the activation of CREB, cAMP response element-binding protein. 
CREB induces gene expression from genes containing a cAMP responsive element. The 
starvation-triggered induction of CREB expression was demonstrated to be dependent 
on SER-3, an octopamine receptor and TBH-1, a putative dopamine β-hydroxylate, 
which converts tyramine to octopamine (Suo, Kimura and Van Tol 2006). It has also 
been shown to be necessary to trigger the loss of body fat in C. elegans (Noble, 
Stieglitz and Srinivasan 2013). SER-6, OCTR-1 and SER-3 have been proposed to form 
octopamine receptors (Mills et al. 2012).  
1.6.3.8 Tyramine 
Tyramine is only present in low abundance in C. elegans. There is evidence that it may 
also have a role in signalling starvation. Application of exogenous tyramine inhibits 
pharyngeal pumping, which may be a food-deprivation response (Alkema et al. 2005). 
A gene encoding a receptor SER-2, has been identified (Rex and Komuniecki 2002). 
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1.6.3.9 Neuropeptides  
Neuropeptides are short sequences of amino acids (4-20 amino acids in length) that 
either act directly at the synapse, or modulate synaptic activity in co-ordination with 
other neurotransmitters. Over 250 neuropeptides have been detected in C. elegans 
and there is evidence to show that they are involved in all aspects of C. elegans 
neurobiology. Over 113 genes in C. elegans are known to encode neuropeptides which 
give rise to the 250 neuropeptides detected by posttranslational modification (Li 
2005). 
Proneuropeptides are packed into dense core vesicles in the endoplasmic reticulum 
and kinesins are required for the vesicles’ movement and neuropeptide release. 
Processing of the proneuropeptides occurs within these dense core vesicles to produce 
mature neuropeptides (Jacob and Kaplan 2003). Four propeptide convertases are 
involved in this process KPC-1, EGL-3, KPC-3 and KPC-4 (Thacker and Rose 2000). Fewer 
different mature neuropeptides were detected by mass-spectrometry in C. elegans 
egl-3 mutants than in the wild-type N2 (Husson et al. 2006), showing the role of these 
propeptide convertases in production of these neuropeptides. Behavioural effects of 
mutations in egl-3 include defects in egg-laying and impaired response to external 
stimuli (Kass et al. 2001). 
The sheer number of different individual neuropeptides and the possibility of overlap 
in function make individual functions difficult to ascribe although some roles are 
beginning to be assigned. For example, flp-1 appears to be involved in locomotion. 
Mutants in flp-1 demonstrate hyperactivity and a more exaggerated waveform during 
movement (Nelson, Rosoff and Li 1998). 
 Cys-loop receptors 1.7
The cys-loop ligand-gated ion channels (cys-loop LGICs) are found in both vertebrates 
and invertebrates. They are likely to have evolved from an ancient bacterial 
counterpart, which may have acted in a chemosensory capacity (Tasneem et al. 2004). 
C. elegans has the largest known superfamily of cys-loop LGIC subunits in which over 
102 members of this family have been identified and are involved in 
neurotransmission. 
Cys-loop LGICs fall broadly into two categories - those which are cation permeable 
such as the serotonin and nicotinic acetylcholine receptors (nAChRs) and 
anion-permeable such as those gated by GABA and glutamate. There is also a class of 
cys-loop LGIC gated by acetylcholine which are cation selective. Some classes of 
cys-loop receptors seem to be unique to invertebrates such as those gated by 
glutamate and serotonin. Many of the putative cys-loop LGICs identified in C. elegans 
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have not yet been characterised, such as those belonging to the ggr-1 group and the 
ggr-3 group.  
Cys-loop LGICs comprise five subunits forming a pentameric ring around a central 
channel pore. The receptors may be homomeric (consist of the same repeated 
subunit) or heteromeric (contain up to five different subunits). Different 
stoichiometries and combinations of subunits in heteromeric receptors can yield 
differing pharmacological properties and differing channel properties. This leads to a 
high diversity of potential receptors. 
Each subunit consists of three main domains, the extracellular domain, the 
transmembrane domain and the intracellular domain. The extracellular domain 
contains the cys-loop after which the class of proteins is named. This is two cysteine 
residues forming a disulphide bond, and separated by 13 amino acids. The extracellular 
domain also contains various loops, which are involved in forming the ligand binding 
pocket. When arranged in the pentameric structure, the ligand binding site is between 
the interfaces of two subunits. In a homomeric receptor, there will be five identical 
ligand-binding subunits. In a heteromeric receptor, there will be fewer ligand binding 
sites as not all subunits will have ligand binding residues. A minimum of two ligand 
binding sites is believed to be required for efficient opening of the receptor (Rayes et 
al. 2009). The transmembrane domain consists of four membrane spanning α-helices. 
The second of these transmembrane helices is involved in lining the channel pore. The 
amino acid residues that face the channel pore affect ion selectivity and channel 
opening times. The third and fourth transmembrane domains are important for 
structural reasons. The intracellular M3-M4 loop is thought to be involved in the 
assembly of the receptor, targeting and trafficking and may also contain 
phosphorylation targets that may alter channel properties (Thompson, Lester and 
Lummis 2010). 
On the binding of two ligands to the ligand binding domain, the extracellular domain 
moves and this movement is transduced to the second transmembrane region. 
Movement of this second transmembrane domain opens the channel. 
1.7.1 Cys-loop receptors and anthelmintic drugs 
The nAChRs and glutamate-gated chloride channels have attracted the most interest, 
as they are common targets for anthelmintic drugs (Jones and Sattelle 2008). 
GABA-gated cys-loop receptors have also been the target for new anthelmintic drugs, 
such as piperazine. As glutamate-gated chloride channels are unique to invertebrates, 
and the family of nAChRs is much larger in nematodes, they have been a common 
target for design of anthelmintic drugs.  
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Figure 1-6: Schematic of cys-loop receptor subunit structure 
a) The basic structure of a cys-loop receptor. The N-terminal extracellular domain contains the 
cys-loop and ligand binding loops. Four membrane spanning regions are present. The 
intracellular domain between M3 and M4 is the longest internal loop. b) X-ray structure of 
assembled cys-loop receptor (glutamate-gated chloride channel) arranged in a pentameric 
structure. Coloured units represent the cys-loop receptor subunits. Grey subunits represent 
fab fragment used to stabilise structure for X-ray crystallography. Diagram from Hibbs and 
Gouaux (2011). 
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The glutamate-gated chloride channels are the targets of the anthelmintic ivermectin. 
Discovered in the 1970s, it has been used extensively since to treat human-infecting 
and animal-infecting nematodes, as well as other parasites such as mites and ticks. In 
C. elegans ivermectin targets body-wall muscle, but causes paralysis of the pharynx 
more potently. Genes encoding subunits of the glutamate-gated chloride channels in 
C. elegans are glc-1, glc-2, glc-3, avr-14, avr-15 and a putative channel glc-4.  
Avr-14 and avr-15 can each be alternatively spliced to produce two different subunit 
configurations. Due to this range of different subunits it is not yet established what 
configuration of subunits each glutamate-gated chloride channel exists in, and how 
many multiple forms of the receptor there may be (Yates, Portillo and Wolstenholme 
2003). Co-expression of glc-1 and glc-2 in Xenopus oocytes yields a functional 
ivermectin sensitive-channel (Cully et al. 1994), although as glc-2 expression appears 
to be restricted to the pharynx (Laughton, Lunt and Wolstenholme 1997) this 
association may not occur as a native glutamate-gated channel.  
There is evidence that the subunits contribute different amounts of ivermectin 
sensitivity. The subunits glc-1, avr-14 and avr-15 are associated with susceptibility to 
ivermectin. A mutation in just one of these is not sufficient to cause ivermectin 
resistance - all three must be mutated before full resistance is achieved (Dent et al. 
2000). Avr-15 is expressed in the pharynx and is required for the regulation of 
pharyngeal pumping and for the sensitivity of the pharyngeal muscle to ivermectin 
(Dent, Davis and Avery 1997). Ivermectin was also found to bind to and activate GLC-3 
when expressed in Xenopus oocytes (Horoszok et al. 2001) and this subunit may also 
play a role in forming ivermectin sensitive glutamate-gated chloride channels. 
The nicotinic acetylcholine receptors present in the body-wall muscle are targets for 
anthelmintic drugs. Levamisole is a widely used anthelmintic, particularly used in 
veterinary applications to treat farm animals for nematode infection. ACR-16 forms a 
homomeric cys-loop receptor sensitive to nicotine, but insensitive to levamisole 
(Touroutine et al. 2005). The levamisole-sensitive nicotinic acetylcholine receptor of  
C. elegans is the main excitatory receptor at the neuromuscular junction and is 
comprised of the subunits LEV-1, LEV-8, UNC-29, UNC-38 and UNC-63 (Boulin et al. 
2008; Lewis et al. 1980). Binding of levamisole to this receptor induces paralysis of the 
worm. A newly identified anthelmintic monepantel targets ACR-23, also present in the 
body-wall muscle (Rufener et al. 2013). Other nicotinic acetylcholine receptors are 
expressed in the neurons of C. elegans, such as the neuronal receptor comprised of 
UNC-63, UNC-29, ACR-12, ACR-2 and ACR-3 (Jospin et al. 2009). 
 Known aspects of neurobiology in plant-parasitic nematodes 1.8
In comparison to C. elegans, little is currently known about the neurobiology of 
plant-parasitic nematodes. 
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Studies in which exogenous neurotransmitters have been applied to the J2s of            
M. hapla and H. glycines have revealed there to be likely receptors for the biogenic 
amines in plant-parasitic nematodes as they are observed to affect nematode 
behaviours such as locomotion and stylet thrusting (Masler 2008; Masler 2007). 
Acetylcholine is likely to have a role, due to the effect that acetylcholinesterase 
inhibitors have on plant-parasitic nematodes. Application of acetylcholinesterase 
inhibitors initially increases body movement, and then causes a cessation of activity 
indicating that acetylcholine is building up at the neuromuscular junction, leading 
ultimately to paralysis (Wright, Birtle and Roberts 1984). Genes encoding 
acetylcholinesterases have been cloned from M. incognita and G. pallida (Costa et al. 
2009; Laffaire et al. 2003). The roles of glutamate and GABA remain less well 
characterised (Holden-Dye and Walker 2011). 
The neuropeptides are the best studied aspects of the neurobiology of plant-parasitic 
nematodes. They have roles in locomotion and are expressed in pharyngeal neurons 
and nerves surrounding the sensory apparatus, indicating a role in host-seeking 
behaviours (Kimber et al. 2001). Five flp genes so far have been cloned from G. pallida 
(Kimber and Fleming 2005) and 19 flp and 21 nlp genes have been identified from   
M. incognita (Abad et al. 2008). In situ hybridisation experiments in G. pallida allowed 
the expression patterns of these flp genes to be examined, in order to elucidate their 
role. Gpflp-6 was expressed in the circumpharyngeal and perianal ring, although the 
interneurons identified were involved in many processes making a role difficult to 
ascribe. Gpflp-12 is expressed in neurons innervating the muscles in the body wall, and 
is likely to have a role in locomotion. Gpflp-14 is expressed in motor neurons around 
the head of G. pallida, and in nerves which receive input from the amphids. This 
suggests that Gpflp-14 may have a role in responding to environmental cues and may 
be involved in host-seeking behaviour. Gpflp-1 is expressed in the motor neurons in 
the retrovesicular ganglion, suggesting a role in the coordination of movement (Kimber 
and Fleming 2005). In M. incognita and M. minor, five genes encoding FLPS were 
identified using RACE PCR, designated miflp-1, miflp-7, miflp-12, mmflp-12 and 
miflp-14. A combination of immunoreactivity and in situ hybridisation showed 
expression of these flp genes in the circumpharyngeal nerve ring, pharyngeal nerves 
and ventral nerve cord. These locations imply a role in locomotion and responding to 
sensory cues (Johnston et al. 2010) 
The genome sequences of M. incognita and M. hapla have allowed comparison to   
C. elegans, identifying potential receptors for acetylcholine, serotonin and potential 
GPCR (Abad et al. 2008; Opperman et al. 2008). In M. hapla and M. incognita, 147 and 
108 genes for GPCRs have been identified respectively. 
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The receptors that are targets for anthelmintic drugs (e.g. levamisole and ivermectin) 
have not yet been studied in detail in plant-parasitic nematodes and little is known 
about them. 
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Objective 
The overall objective of this work is to nvestigate aspects of the neurobiology of 
Globodera pallida that may reveal potential selective targets for control of the potato 
cyst nematode. Analysis of cys-loop receptors involved in neurotransmission and 
associated mechanisms of sensitivity and resistance to anthelmintics will be facilitated 
by the wealth of data and resources available for Caenorhabditis elegans compared to 
plant parasitic nematodes. The complement of genes encoding cys-loop receptors in 
Globodera spp. will be defined and functional studies will provide insight into their 
roles in mediating observed behaviours and sensitivity to anthelmintics. 
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2. General Materials and Methods  
 Maintenance of nematodes  2.1
2.1.1 Maintenance of Globodera pallida populations 
Globodera pallida (Pa 2/3) population Lindley was originally obtained from the James 
Hutton Institute. Nematodes were cultured on susceptible potato plants (Solanum 
tuberosum cv. Desiree) in a glasshouse growing in an equal mix of sand/loam. Cysts 
were stored in dry soil at 4°C. 
2.1.2 Collection of cysts from infected soil 
Cysts of G. pallida were extracted from the soil using the Fenwick canning method 
(Fenwick 1940). Briefly, infected soil was washed through a wide mesh sieve into a 
Fenwick can. Dense soil debris settled to the bottom, while the lighter cysts floated 
and were washed through a column of three different meshes (500 µm, 150 µm and 63 
µm). Cysts were collected in the 150 µm mesh sieve, and washed into a fast flow filter 
paper (Whatman, UK) in a funnel with the end sealed. The mixture was allowed to 
stand for a few minutes then the water was released, leaving the cysts stranded in a 
ring around the top of the filter paper. The cysts were then collected using fine 
tweezers into a microcentrifuge tube containing water under a (stereo-binocular 
microscope). 
2.1.3 Hatching of cysts for collection of J2s 
Cysts were prepared for hatching by a bleaching method (Heungens et al. 1996) using 
a modified 20 ml syringe with the end cut off and replaced by a 30 µm nylon mesh. 
Cysts were put in the syringe, and washed in 5 ml of 100 % ethanol for 30 seconds. The 
cysts were then treated with 10 ml 1% hypochlorite solution for 12 minutes or until 
sufficient numbers of the cysts had lightened in colour and broken open to release 
eggs. The cysts were then washed in 5 ml of autoclaved tap water five times before the 
disrupted cysts and eggs were transferred to a ring with 30 µm mesh at the bottom, 
and placed in 10 ml of sterile tap water in a hatching jar. The eggs were then left to 
hatch at 20°C in darkness for three days before J2s were collected from the liquid 
outside the mesh on the fourth day. Collections of J2s were continued daily over five 
days, replacing the water taken each time. The collected J2s were stored at 10°C in 
water if not used immediately. 
 C. elegans strains 2.2
2.2.1 N2 
Genotype: C. elegans wild-type; var. Bristol wild-type isolate. Available from the 
Caenorhabditis Genetics Centre (https://www.cbs.umn.edu/research/resources/cgc) 
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2.2.2 ZZ20  
Genotype: unc-38(x20) I – deletion in third exon of unc-38 gene. Phenotype: 
uncoordinated movement and levamisole resistance. Available from the 
Caenorhabditis Genetics Centre (https://www.cbs.umn.edu/research/resources/cgc) 
2.2.3 DP38  
Genotype: unc-119 (ed3) – mutagenised by EMS. Phenotype: uncoordinated, dauer 
defective. Available from the Caenorhabditis Genetics Centre 
(https://www.cbs.umn.edu/research/resources/cgc) 
2.2.4 Maintenance of C. elegans populations 
All C. elegans strains were maintained on NGM-lite media plates seeded with 
Escherichia coli (strain: OP50) at 20°C in the dark. 10 worms were transferred onto 
fresh plates approximately every 3-5 days to maintain a healthy population. 
2.2.5 Production of NGM-lite media plates 
1 L of NGM media contained 1.5 g NaCl, 4 g Peptone, 3 g KH2PO4, 0.5 g K2HPO4 and 20 
g Agar. This was autoclaved, allowed to cool, and then cholesterol added to a final 
concentration of 8 µg/ml. Nystatin was added to a final concentration of 10 µg/ml. 10 
ml of media was poured into 5 cm petri dishes and allowed to set. 50 µl of an 
overnight culture of E. coli (strain: OP50) was spread onto each plate and allowed to 
grow for two days at 20°C. For some experiments, which required a faster growing 
strain, E. coli (strain: HB101) was used.  
2.2.6 Cleaning contaminated C. elegans stocks 
If necessary due to bacterial or fungal infection of C. elegans stocks, a bleaching 
method was used to sterilise the affected lines. Contaminated plates containing gravid 
adults were washed with 4 ml sterile water into 15 ml polypropylene tubes. 0.5 ml 5 M 
NaOH and 0.5 ml bleach (10 % sodium hypochlorite) was added. The tube was shaken 
vigorously every 2 minutes for 10 minutes to dissolve adult carcasses and release eggs. 
The tube was centrifuged for 30 seconds at 1300 x g. Liquid was aspirated to 0.1 ml 
and sterile water added to 5 ml. The tube was centrifuged again, and aspirated to 0.1 
ml. The cleaned pellet of eggs was pipetted onto the edge of a clean NGM-lite plate 
with E. coli OP50 lawn. The plate was checked for healthy hatched larvae after 24 
hours, which were moved to fresh NGM-lite plates seeded with E. coli OP50. 
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 Bacterial strains 2.3
Host strain Routine use Genotype 
E. coli DH5α Ultra-competent cells for 
cloning 
F-, endA1, glnV44, thi-1, 
recA1, relA1, gyrA96. deoR, 
nupG, Φ80dlacZΔM15, 
Δ(lacZYA-argF)U169, 
hsdR17(rK- mK+), λ- 
E. coli DB3.1 
 
Propagating vectors 
containing ccdB operon 
F- gyrA462 endA1 glnV44 
Δ(sr1-recA) mcrB mrr 
hsdS20(rB-, mB-) ara14 
galK2 lacY1 proA2 
rpsL20(Smr) xyl5 Δleu mtl1 
E. coli OP50 Food-source for C. elegans Ura-  
E. coli HB101 Food-source for C. elegans F- mcrB mrr 
hsdS20(rB- mB-) recA13 
leuB6 ara-14 proA2 lacY1 
galK2 xyl-5 mtl-1 
rpsL20(SmR) glnV44 λ- 
 Growth media 2.4
2.4.1 LB media 
10 g NaCl, 10 g tryptone, 5 g yeast extract were added to 1 L ELGA water and 
autoclaved. 1 % bacteriological agar was added to make LB agar. Antibiotics were 
added at the following concentrations if required: Carbenicillin (100 μg/ml); 
spectinomycin (100 μg/ml); kanamycin (50 μg/ml). 
2.4.2 SOB media 
1.25 g yeast extract, 5 g tryptone, 0.146 g NaCl, 47 mg KCl, 0.508 g MgCl2, 2.5 ml of 1M 
MgSO4 in 250 ml deionised water.  Solution was autoclaved. 
 General solutions composition 2.5
2.5.1 TE buffer 
10 mM Tris HCL, 1 mM EDTA pH 8.0. Solution was autoclaved. 
2.5.2 M9 buffer 
3 g KH2PO4, 6 g Na2HPO4, 5 g NaCl in 1 L deionised water. Solution was autoclaved. 
After cooling, 1 ml of 1M MgSO4 was added.  
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2.5.3 TB solution 
0.302 g PIPES, 0.22 g CaCl2, 1.86 g KCl in 80 ml deionised water. KOH or HCl was used 
to adjust pH to 6.7. 1.09 g of MnCl24H20 was added and the volume adjusted to 100 
ml. Solution was then filter-sterilised with 0.45 µm filter.  
2.5.4 DNA Extraction buffer 
0.1 M NaCl, 10 mM Tris pH8, 10 mM EDTA, 1% SDS, 1% 2-Mercaptoethanol, 100 µg/ml 
proteinase K 
2.5.5 Standard DNA quantification 
When required, DNA was quantified using a Nanodrop 1000.  
 General molecular biology methods 2.6
2.6.1 Extraction of total RNA 
Total RNA was extracted from whole frozen J2s using the Qiagen RNeasy Plant Mini kit, 
following the manufacturer’s instructions. A sterile plastic homogeniser was used to 
thoroughly disrupt J2 tissue in 50 µl of ice-cold RLT buffer. 400µl of RLT buffer was 
added to the sample and the sample was placed in a QIAshredder spin column in order 
to remove undisrupted nematodes and other debris. Ethanol was added to the cleared 
supernatant, and the sample applied to a RNeasy spin column. A 20 minute DNase I 
digestion was performed to remove genomic DNA. The column was then washed with 
RW1 and RPE buffers. RNA was eluted from the column in 30 µl RNase-free water and 
stored at -80°C. Concentration and purity of RNA samples was determined using a 
Nanodrop spectrophotometer.  
2.6.2 Phenol:chloroform extraction of genomic DNA 
Extraction of genomic DNA was carried out using phenol:chloroform. Frozen J2s were 
homogenised in 300 µl extraction buffer. The volume was made up to 750 µl and 100 
µl of 10% SDS was added, mixed by inversion and incubated at 65 °C for 10 minutes. 
250 µl 5M potassium acetate was added, mixed by inversion and incubated on ice for 
20 minutes. Debris was removed by centrifugation at 14,500 rpm for 20 minutes. The 
supernatant was removed to a fresh microfuge tube, and 0.5 ml isopropanol added, 
mixed by inversion, and incubated at -20 °C overnight to allow precipitation of DNA. 
The tube was centrifuged at 14,500 rpm for 15 min and the supernatant discarded. The 
remaining DNA pellet was resuspended in 100 µl of 50 mM Tris, 10 mM EDTA pH8. 
Debris was removed by centrifugation at 14,500 rpm for 5 min and supernatant 
transferred to a fresh microfuge tube. Equal volume of phenol:chloroform was added, 
and the mixture vortexed and centrifuged for 5 min. The upper aqueous phase was 
transferred to a fresh microfuge tube and 10 µl of 3M sodium acetate and 200 µl 
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ethanol was added. DNA was allowed to precipitate for 10 min. DNA was pelleted by 
centrifugation. Ethanol was removed, and the pellet washed with 0.5 ml of 70 % 
ethanol. The tube was centrifuged for 5 min, and ethanol removed. The pellet was 
air-dried for 15 min to allow all ethanol to evaporate. DNA pellet was redissolved in 50 
µl TE buffer and stored at -20 °C. 
2.6.3 Preparation of cDNA 
cDNA was prepared from total RNA using the protocol provided by the manufacturers 
(Superscript II Reverse Transcriptase, Invitrogen). Approximately 500 ng of total RNA 
was added to 1 µl anchored oligodT primers, 1 µl of 10 mM dNTPs and sterile, distilled 
water up to 12 µl. This was incubated at 65°C for 5 minutes and then quick-chilled on 
ice. 4 µl of 5x First Strand Buffer and 2 µl of 0.1M DTT was added and incubated at 
42°C for 2 minutes. 1µl of Superscript II Reverse Transcriptase (200 units) was then 
added and the mixture was incubated at 42°C for 50 minutes, followed by a 15 minute 
incubation at 70°C to inactivate the reaction. This produces single stranded cDNA 
complementary to the mRNA population as the oligodT primers anneal to the poly 
(A)+tails. 
2.6.4 Preparation of ultra-competent cells 
Ultra-competent cells for use in all cloning were prepared following the protocol 
described in (Inoue, Nojima and Okayama 1990). DH5α bacterial cells were streaked 
onto LB agar plates, and cultured overnight at 37 °C. 10 – 12 single colonies were 
transferred to 2x 250 ml SOB medium in 1L flask and grown at 19 °C with vigorous 
shaking until an OD600 of 0.5 was reached (24 - 36 hrs). Flasks were placed on ice for 10 
min, and then the suspension was centrifuged at 4000 x g for 10 min at 4 °C. Cells were 
resuspended in 80 ml ice-cold TB solution and stored on ice for 10 min. The suspension 
was then centrifuged again at 4000 rpm for 10 min at 4 °C. The cell pellet was then 
resuspended in 20 ml ice-cold TB solution and 1.4 ml thawed DMSO was added. 100 µl 
of the cells were aliquoted into microfuge tubes and snap-frozen in liquid nitrogen. 
Cells were stored at -80 °C until required for use.  
2.6.5 Restriction digest 
Routine restriction digests were performed in 20 µl total volume. 1 µg of plasmid DNA 
was used with 1 µl of selected restriction enzyme(s). The appropriate buffer was 
selected as per recommendation from the manufacturer. The reaction was routinely 
incubated at 37 °C for 3 hrs. 
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3. Identification of orthologous genes from 
Caenorhabditis elegans in the Globodera pallida and 
Globodera rostochiensis genomes 
 Introduction 3.1
C. elegans has been used as a model organism for many parasitic-nematodes, despite 
the differences in lifestyles. C. elegans is free-living in the soil, while other parasitic 
nematodes have many different diverse lifestyles including animal-infecting and 
plant-infecting nematodes, which are specific to different hosts. Despite these 
differences in lifestyles, C. elegans remains a popular model organism to guide both 
genomic studies and drug-based studies on parasitic-nematodes.  
The molecular basis of action of many popular anthelmintics has been discovered first 
in C. elegans such as the molecular basis of ivermectin resistance (Dent et al. 2000; 
Cully et al. 1994), rather than within the parasitic nematode that is the intended 
target. Ivermectin is typically used to treat both human and animal infecting 
nematodes and has been credited with controlling devastating nematode diseases 
such as river blindness, caused by Onchocerca volvulus. C. elegans remains at the core 
of research regarding anthelmintic drugs due to the intractability of transformation 
and laboratory maintenance of many parasitic nematodes. It remains a valuable 
resource for investigating increasing incidences of ivermectin resistance in nematode 
populations (Geary 2005). 
With the reducing cost of genome sequencing technology allowing the full genome 
sequences of many parasitic nematodes to be analysed, C. elegans remains at the 
forefront of comparative genomics for newly sequenced nematode species. Of 
particular interest is the diversity of subunits for known targets of anthelmintic drugs, 
and other neuromuscular targets. Comparisons of the newly sequenced nematode 
genome, with the C. elegans genome and the wealth of functional data behind it, 
allows areas of interest to be highlighted due to the under or overrepresentation of 
orthologues in the parasitic genome due to duplications or losses that have occurred 
during the evolutionary timeline. 
Comparison to the genome of the ruminant-infecting nematode Haemonchus 
contortus has identified 5,937 orthology groups between C. elegans and H. contortus 
and highlighted a number of orthology groups in which H. contortus has a significant 
expansion in number of members. Included in this are the glutamate-gated chloride 
channel subunits, where two genes hco-glc-5 and hco-glc-6 are present in the     
H. contortus genome but absent in the C. elegans genome (Laing et al. 2013). Hco-glc-6 
is likely to be involved in ivermectin sensitivity of H. contortus. Expression of hco-glc-6 
in ivermectin insensitive C. elegans mutants was able to restore ivermectin sensitivity 
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(Glendinning et al. 2011). Other targets identified by comparative genomics may guide 
further research.  
In the genome sequence of the animal-infecting nematodes Brugia malayi and 
Trichinella spiralis, a reduction in the number of genes encoding glutamate-gated 
chloride channels subunits was found, following a general trend of a reduction in 
number of cys-loop type subunits in these species (Williamson, Walsh and 
Wolstenholme 2007).  
The G. pallida genome was sequenced recently in partnership with the Wellcome Trust 
Sanger Institute. A number of other plant-parasitic nematode genomes have also been 
published such as the root-knot nematodes Meloidogyne incognita (Abad et al. 2008) 
and M. hapla (Opperman et al. 2008), although the G. pallida genome was the first 
sequenced for a cyst-nematode. The draft sequence was completed in late 2013, 
although earlier iterations of the data set have been available from 2012. A mixture of 
454, Illumina and Sanger sequencing were used to produce the G. pallida genome. In 
addition to the genome sequence, transcriptome data sets were produced at different 
significant life-stages of the G. pallida life-cycle: J2s, females 7 dpi (days post infection), 
14 dpi, 21 dpi, 28 dpi and 35 dpi and males. This allowed examination of the 
expression levels of genes at different life-stages indicating changes in the suite of 
genes required at pre-parasitic and parasitic stages. This expression level was 
quantified for each life-stage. The number of RNA-seq reads per gene model is counted 
and normalised by RPKM (reads per kilobase per million) to account for the increased 
likelihood of longer transcripts having more transcripts matched to their region 
(Cotton et al. 2014).  
As an addition to the G. pallida sequencing project, a draft genome sequence of          
G. rostochiensis was produced. Transcriptome data were also produced for the J2 and 
sedentary female life-stages of G. rostochiensis. As technology and methodology had 
improved since the assembly of the G. pallida genome, and the G. rostochiensis 
population used for sequencing had lower genetic diversity (Bendezu et al. 1998) in 
the UK, this genome assembly proved to be a useful comparison and checkpoint for 
research in G. pallida. 
In this chapter, the focus is on key aspects of the neurobiology of G. pallida and                    
G. rostochiensis. As with previous work on other parasitic-nematodes, C. elegans has 
been used to guide this work allowing comparisons to be made and conclusions about 
the expansion or reduction in members of orthologue groups to be drawn. The genes 
encoding the key enzymes involved in the biosynthetic pathways of neurotransmitters, 
as well as key genes encoding subunits for known and potential targets of anthelmintic 
drugs are the focus of this chapter. Here the best orthologues of C. elegans genes are 
identified in G. pallida and G. rostochiensis and differences between the species are 
identified. 
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Aims 
 
• Identify best orthologues for a variety of neurotransmitter related genes 
 
• Highlight areas of difference between C. elegans and G. pallida 
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 Materials and methods 3.2
3.2.1 Homology searching and cloning using the Globodera pallida genome 
assembly 
The Globodera pallida genome assembly, located on the WTSI (Wellcome Trust Sanger 
Institute, available at https://www.sanger.ac.uk/resources/downloads
/helminths/globodera-pallida.html) was used for primary orthology searching. A list of 
genes, and their roles, that were searched for are found in Table 1. The BLAST server 
on the WTSI site allowed identification of potential homologues to C. elegans proteins 
used as the initial search query. Protein sequences were used in TBLASTN searches 
against the G. pallida genome assembly (scaffolds) (May 2012) database. Positive hits 
provided location of the identified gene on the most current genome assembly. The 
April 2012 assembly was viewed on Gbrowse, and checked visually to identify issues 
with the computer generated predicted gene models. As predicted gene models were 
often unclear or incorrect, several primers were often designed per gene in order to 
amplify full-length product. Sites of primer design were selected to be upstream of the 
predicted initiating methionine, and downstream of the predicted stop codon and 
within areas of gene expression. A list of primers used to amplify final full-length 
products is found in Table 2. 
3.2.2 Amplification and cloning 
Genes were amplified and cloned as detailed in sections 3.2.13 and 3.2.14. 
3.2.3 Quality control of sequences obtained 
Upon cloning and sequencing, in order to determine if a potential orthologue of a   
C. elegans gene had been obtained, the Reciprocal Best Hits (RBH) method was used. 
The translated sequence was used in a reciprocal BLASTP search against the C. elegans 
protein database located at NCBI (http://blast.ncbi.nlm.nih.gov/
Blast.cgi?PAGE=Proteins). If the original C. elegans gene used to find this potential 
orthologue also had the lowest e-value in this search, the G. pallida gene obtained was 
considered to be a potential orthologue for this C. elegans gene and given the name 
gpa-genename. If a different C. elegans gene was returned with the lowest e-value, 
and this gene matched the G. pallida gene with a lower e-value, the identity of the 
cloned G. pallida gene was revised to be an orthologue of this. If multiple potential 
orthologues were identified in G. pallida and both potential orthologues returned the 
same RBH in the C. elegans database, both these genes were considered potential 
orthologues and given the names gpa-genename.1 and gpa-genename.2. 
To determine if a full-length clone had been obtained, the translated amino acid 
sequence of the product was checked for features to confirm the identity of the gene 
and confirm if it was full-length. The presence of a signal peptide was searched for in 
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proteins known to be targeted to the membrane (See 3.2.8). Additionally, the number 
of transmembrane domains was predicted (See 3.2.9) for membrane-spanning 
proteins and compared against the known number for similar proteins in the NCBI 
database. An alignment between the amino acid sequences of the C. elegans and   
G. pallida proteins was used to identify potential gaps or variations in sequence. 
Interpro was also used in some circumstances to identify key domains associated with 
proteins of interest (http://www.ebi.ac.uk/interpro/).  
3.2.4 Analysis of transcriptome assembly and unassembled 454 reads 
In some cases, the assembled genome visible on Gbrowse had limitations which only 
became apparent at a later date. Such issues included: unassembled portions of genes 
absent from the gene model, but present on other contigs; misassembly errors where 
a portion of a gene had been repeated obscuring the true sequence and instances 
where whole genes had either not been predicted (but were present in the assembly) 
or had been omitted from the assembly entirely. 
In order to identify genes where small portions (e.g. the start or end) were missing, the 
original unassembled 454 reads could be used to assemble the gene manually. 
TBLASTN searches were conducted on the G. pallida unassembled 454 reads database 
located at WTSI (https://www.sanger.ac.uk/resources/downloads/helminths/
globodera-pallida.html) using the closest known sequence to the start or end of the 
gene. The resulting 454 reads were then used to assemble the gene manually, using 
several rounds of TBLASTN to identify more up or downstream sequence. 
The unmapped transcriptome assembly for the J2 life-stage could be mined. This was a 
de novo J2 transcriptome assembly produced alongside the G. pallida genome (Cotton 
et al. 2014). This assembly could be searched using command-line BLAST tools 
available from NCBI (http://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&
PAGE_TYPE=BlastDocs&DOC_TYPE=Download). A searchable database was produced 
on a local computer drive using .fasta files containing transcriptome data. TBLASTN 
searches were then carried out via command-line input to identity orthologues present 
in the transcriptome assembly. This method highlighted several genes which were 
completely absent in the final genome assembly. 
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Genes Role 
cel-glc-1; cel-glc-2; cel-glc-3; cel-avr-14; 
cel-avr-15 
Subunits of glutamate-gated chloride 
receptors; target of ivermectin 
cel-mod-5; cel-ser-7 Involved in serotonin signalling 
cel-tph-1 Involved in serotonin biosynthesis 
cel-eat-4 Glutamate transporter 
cel-dat-1 Involved in dopamine biosynthesis 
cel-unc-25 Involved in GABA biosynthesis  
cel-cha-1; cel-unc-17 Involved in acetylcholine biosynthesis 
cel-tbh-1 Involved in octopamine biosynthesis 
Table 1: Summary of C. elegans genes and their roles searched for in initial orthology search 
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Gene Primer Sequence 
gpa-avr-14.1 
F: CCTCCGACTCGTGGAAAATCC 
R: GCCATTTCACATCAAATAGACG 
gpa-avr-14.2 
F: GCCAAAATGTCTTCTCGGC 
R: GATCAGCAACACTATGAAATGATC 
gpa-cha-1 
F: AAAGGGGAATGAACGAGGAG 
R: TGTGCTTCTATAGTTTTTCATTG 
gpa-dat-1 
F: GATGCCACGATTCGTTCAAT 
R: CTTCTACAACAGCACATCGC 
gpa-eat-4 
F: GATCACAGATGCATTCTTCAAG 
R: AGAGAGTATCCAAATGATCAG 
gpa-glc-2 
F: AAATGTTTGTGCCGTTTTGTG 
R: TAACATTTTGCCGAATTTATTG 
gpa-glc-3 
F: GTGACCCTGTCTCGGACACGCA 
R: TGGCCGTCGTGATGGTTAGATG 
gpa-glc-4 (did not produce product) 
F: CCTCCGGCGATGCTTTACC 
R: CGGCTTCATTTGGCGAACTC 
gpa-mod-5 
F: GACGAGAACACGACCACG 
R: CGCTTTTCTTCTAAAGGTGC 
gpa-ser-7 
F: GTTCAGCGCCATGCCAAAAT 
R: CGGTCAGTTGGCCAACGC 
gpa-tph-1 
F: GTAAAAATGGCTTCCGGCATG 
R: CACTTCAATTAGTTGAAATAG 
gpa-unc-17 
F: ATGGCGCAATGTTTTTAAATGAC 
R: GCTAACAAATAAGCGAGGTTC 
gpa-unc-25  
F: AAGCACACGACGAGCAGTGAC 
R: TTGTCCGCGCAATTTTCCGTC 
Table 2: Primers used to amplify full-length products from G. pallida (unless otherwise 
specified) 
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3.2.5 Homology searching in the Globodera rostochiensis genome 
The G. rostochiensis genome was used as both comparison and checkpoint for 
orthologues identified in G. pallida. These two species are closely related, although the 
G. rostochiensis population in the UK is less genetically diverse than the G. pallida 
population. Sequencing of the G. rostochiensis genome followed the sequencing of   
G. pallida.  
Following sequencing and gene prediction, the genome data and transcriptome data 
could be accessed. Translated sequences of C. elegans genes were used in BLAST 
searches (powered by Badger (Elsworth, Jones and Blaxter 2013) available at 
http://globodera.bio.ed.ac.uk/search/species) to identify potential orthologues of 
these genes. The RBH method was used to check potential orthologues. The gene 
model was then viewed on the genome browser Apollo (Lewis et al. 2002) (available at 
http://apollo.nematodegenomes.org/apollo-1.0.4-RC3/sequences) and as manually 
curated based on information available from transcriptome data; available C. elegans 
data and known sequences of cloned G. pallida genes.  
3.2.6 C. elegans sequence 
C. elegans sequences were identified from the NCBI protein database 
(http://www.ncbi.nlm.nih.gov/). In cases where multiple isoforms of the C. elegans 
protein were available, the longest was selected. Uniprot (UniProt 2015) was used to 
annotate amino acid sequence, if reviewed information was available.  
3.2.7 Producing alignments and calculating amino acid identity  
Alignments between amino acid sequences was performed using the 
multiple-sequence alignment tool Clustal Omega, found at http://www.ebi.ac.uk/
Tools/msa/clustalo/ (Sievers et al. 2011). This alignment was visualised in Jalview 
(downloadable from http://www.jalview.org/download). Amino acid identity between 
pairs was determined within Jalview by the Needleman and Wunsch methodology of 
pairwise alignments and a BLOSUM62 matrix (Waterhouse et al. 2009). 
3.2.8 Signal peptide prediction 
SignalP V4.1 was used to predict presence of signal peptides (Petersen et al. 2011). 
Translated cDNA to amino acid sequence was used. SignalP is available at 
http://www.cbs.dtu.dk/services/SignalP/. Examples of output from the program 
showing a positive and negative result can be seen in Figure 3-1. 
3.2.9 Transmembrane domain prediction 
The presence and number of transmembrane domain regions was predicted using 
TMHMM Server V2.0 (Krogh et al. 2001). Phobius was also used as a comparison as a 
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different prediction model is used and models may vary (Käll, Krogh and Sonnhammer 
2007). TMHMM is available at http://www.cbs.dtu.dk/services/TMHMM-2.0/ and 
Phobius is available at http://phobius.sbc.su.se/. 
3.2.10 RaptorX 3D protein modelling 
3D models of protein structure were generated by the webserver RaptorX 
(http://raptorx.uchicago.edu/). RaptorX predicts secondary and tertiary structures of 
amino acid chain by incorporating sequence-based model prediction alongside 
sequence-based alignment models. The algorithm produces a p-value indicating the 
likelihood of the model generated being a result of a random string of amino acids. 
P-values of less than 10e-3 are indicative of good models (Peng and Xu 2011). 
3.2.11 Phylogenetic trees 
Phylogenetic relationships were drawn from Clustal Omega aligned sequence using 
TOPALI v2.5 (PhyML, WAG substitution model, bootstrap value: 500) (Milne et al. 
2009) and visualised using FigTree (Rambaut 2009). Topali v2.5 is available to 
download at http://www.topali.org/ and FigTree is available to download at 
http://tree.bio.ed.ac.uk/software/figtree/ 
3.2.12 Bioassays 
3.2.12.1 Application of exogenous serotonin to G. pallida J2s 
20 J2s were added in 90 µl water on a glass slide. 10 µl of 62.5 mM serotonin (treated) 
or 10 µl water (control) was added. After 10 minutes J2s were observed for stylet 
thrusting under 40 x magnification. Individual J2s were observed for 60 secs and 
number of stylet thrusts counted. 
3.2.12.2 Application of exogenous octopamine to G. pallida J2s 
Speed of J2s was assessed as described in 5.2.1.2, except plates were made to contain 
50 mM octopamine (treated) or M9 (control). Speed was assessed after four hour 
exposure and 24 hour exposure.  
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Figure 3-1: Examples of positive and negative signal peptide prediction outputs generated by 
SignalP v4.1 
a) Output for amino acid sequence (EGL-3) with a positive signal peptide prediction. Cleavage 
site is predicted between amino acid residues 22 and 23. b) Output for negative signal peptide 
(UNC-25) prediction. C score predicts probability of the signal peptide cleavage site, the S score 
predicts signal peptide sequence and the Y score combines both C and S score to determine 
maximum likely signal peptide cleavage location. 
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3.2.13 Product amplification by polymerase chain reaction and product isolation 
3.2.13.1 Screening for working primer pairs 
PCR was conducted using a total reaction volume of 50 µl containing 0.2 mM of each 
dNTP, 1 µM each of the forward and reverse primer; MgCl2 at 2 mM, 1 unit of Platinum 
Taq (Invitrogen), the appropriate buffer and template cDNA. The thermocycling 
program was conducted on a Biorad Thermocycler (T100) and comprised of an initial 
denaturing step at 94°C for 2 min, 30 steps of denaturing at 94°C for 30 secs, annealing 
at 55°C for 1 minute, and an extension at 72°C for 3 min (1 min/kb of amplified 
product). A final extension step of 10 min at 72°C was used. PCR products (5 µl) were 
analysed by agarose gel electrophoresis. 
3.2.13.2 Gradient PCR for optimisation of amplification 
The annealing temperature can affect the successful amplification of the correct PCR 
product. A master mix totalling 90 µl with the same protocol as in 3.2.13.1 was used 
for each primer combination and 10 µl was pipetted into an 8-strip PCR tube. The 
themocycler was used on the same settings as in 3.2.13.1, except the annealing 
temperature was set to perform a gradient across the plate. Annealing temperatures 
used were 50°C, 51.0°C, 52.9°C, 55.7°C, 59.1°C, 62.0°C, 63.8°C and 65°C. The PCR 
products were analysed by gel electrophoresis and the optimum annealing 
temperature chosen. An example of gradient PCR is shown in Figure 3-2. 
3.2.13.3 Amplification of products for cloning  
Products for cloning were prepared as 3.2.13.1 with the exception that the enzyme 
used was Platinum Taq Hi-Fidelity (Invitrogen) which has a proof-reading component. 
Extension temperature was 68°C. Products were analysed by gel electrophoresis. 
3.2.13.4 PCR clean-up 
PCR reactions yielding a single product were cleaned using a QIAquick PCR Purification 
Kit to removed unincorporated nucleotides and primers. 5 volumes of buffer PB was 
added to the PCR sample. pH of the solution was assessed by a colour indicator. If 
required, 10 µl of 3 M sodium acetate was added to bring the solution to an efficient 
pH for DNA binding. The mixture was added to a QIAquick spin column to bind DNA, 
and centrifuged for 30 sec. The flow-through was removed, and the membrane was 
washed by addition of 0.75 ml PE buffer. Flow-through was removed, and the column 
centrifuged again for 1 min to remove excess PE buffer from the membrane. DNA was 
eluted in 30 µl EB buffer and stored at -20 °C.  
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Figure 3-2: Selection of optimum annealing temperature by gradient PCR 
A reduction in non-specific amplification of undesired bands is seen as annealing temperature 
increases. Good amplification of the desired product (1.8 kb) without non-specific 
amplification is seen at an annealing temperature of 62 °C and above. 
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3.2.13.5 DNA isolation from agarose gel 
PCR reactions yielding multiple products required isolation of the correct product size. 
Products were separated by gel electrophoresis and the correct product size excised 
from the gel. DNA extraction from the gel slice was carried out using the Qiagen Gel 
Extraction Kit. 3 times volume of QG buffer was added to the gel slice, and solubilised 
at 50 °C. The mixture was then added to a QIAquick column for DNA binding. The 
column was centrifuged for 30 sec and the flow-through discarded. 0.75 buffer PE was 
added to wash the column, and centrifuged again. The flow-through was discarded 
and the column centrifuged to remove excess PE from the membrane. DNA was eluted 
in 30 µl EB buffer and stored at -20 °C.  
3.2.14 Cloning and sequencing  
3.2.14.1 A-tailing of PCR products 
 
Purified PCR product was used in an A-tailing reaction to ensure maximum number of 
A-tailed PCR products for TOPO TA cloning. For each product, a 10 µl reaction was set 
up with 0.2 mM dATP, 5 units of Biotaq red (Bioline, UK), 2 mM MgCl2, the appropriate 
buffer, and PCR product up to 10 µl. This was incubated at 72°C for 30 minutes. 
3.2.14.2 Cloning reaction 
pCR™8/GW/TOPO® TA Cloning® kit (Invitrogen) (Figure 3-3) was used to clone freshly 
amplified PCR products following the protocol stated by the manufacturer. Briefly, 4 µl 
of the freshly A-tailed PCR product was used in a cloning reaction along with 1 µl salt 
solution and 1 µl of cloning vector. The cloning reaction was allowed to proceed for 10 
minutes at room temperature before being placed on ice.  
3.2.14.3 Transformation 
2 µl of the cloning reaction were added to One-Shot® E. coli competent cells 
(Invitrogen) on ice. The cells were heat-shocked in a water-bath at 42°C for 30 seconds 
before 250 µl of LB media at room-temperature was added to each transformation. 
The cells were allowed to recover at 37°C for 1 hour in an incubator shaking at 200 
rpm. Cells were then plated out onto LB-agar containing spectinomycin (Sigma) at 100 
µg/ml and allowed to dry under a Bunsen burner for 15 minutes. Plates were then 
incubated at 37°C overnight.  
3.2.14.4 Screening of colonies by Colony PCR 
Selection of colonies containing plasmids with the correct insert in the correct 
orientation was achieved by PCR analysis using the M13F (-20) primer as the forward 
primer, and the gene-specific reverse primer. A pipette tip was touched briefly to an 
individual colony, and the bacteria re-suspended in 20 µl of autoclaved ELGA water. 
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Figure 3-3: Vector map of pCR™8/GW/TOPO®  
pCR™8 was used for gene cloning. The plasmid contains a spectinomycin resistance gene for 
antibiotic selection. The plasmid is provided by the manufacturer linearised at the attL1 and 
attL2 sites with Topoisomerase I covalently linked to the ends. M13 F, M13 R and T7 primers 
can be used to sequence the insert. 
Spectinomycin R 1064..2074
pCR8
2817 bp
M13-fwd 536..553
attL1 569..668
M13-rev 852..832
T7 833..812
attL2 795..696
pBR322_origin 2151..2770pBR 322 origin
Spectinomycin
resistance
M13 Rev
T7
attL2
attL1
13-Fwd
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A master mix per primer pair was produced that comprised of 0.4 mM of each dNTP, 1 
µl of both the forward and reverse primer, 10 µM MgCl2 at 2 mM, the appropriate 
buffer and 2 units of BIOTAQ red (Bioline) per 20 µl of reaction. 1 µl of the bacterial 
suspension was added to 19 µl of the master mix. The amplification reaction was 
carried out by an initial denaturing step at 94°C for 10 min to break open the bacterial 
cells. 25 steps of denaturing at 94°C for 30secs, annealing at 55°C for 30 secs, then 
extension at 72°C for 90 secs (30 secs/kb of amplified product) followed. The PCR 
product was analysed by gel electrophoresis allowing positive colonies to be identified. 
3.2.14.5 Plasmid preparations 
Colonies identified as per 3.2.14.4 were grown in 5 ml LB broth with 100µg/ml 
spectinomycin at 37 °C overnight. To extract plasmid, 3 ml of the culture was used and 
prepared with the QIAprep Spin Miniprep Kit (Qiagen) according to manufacturer’s 
instructions. Briefly, 3 ml of cultured colonies was centrifuged at 6800 x g to pellet 
bacterial cells. The supernatant was discarded and 250 μl of buffer P1 with RNase A 
was added. The bacterial cells were resuspended and 250 μl of buffer P2 was added 
and mixed. 350 μl of buffer N3 was added, mixed and centrifuged for 10 minutes at 
17,900 x g. The supernatant was transferred to a QIAprep spin column and centrifuged 
for 30 secs to bind DNA. The QIAprep spin column was washed with 500 μl of PB 
buffer, centrifuged and the flow-through discarded. 750 μl of PE buffer was added and 
centrifuged for 60 seconds and the flow-through discarded. The column was 
centrifuged for an additional 60 seconds to remove all traces of PE buffer. Plasmid DNA 
was eluted in 50 μl EB buffer. 
3.2.14.6 Sequencing of plasmid inserts 
Sequencing of plasmid insert was carried out by Beckmann Coulter Genomics, UK using 
the M13F and M13R primers. A minimum of three clones were sequenced for each 
gene. Sequencher 5.2.2 (Gene Codes) was used to analyse sequencing results.  
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 Results 3.3
Unless specified otherwise, all G. pallida genes discussed in this section have been 
cloned and sequenced from cDNA, while data from G. rostochiensis is bioinformatic, 
although manually curated. In this section, orthologues of the C. elegans gene 
(cel-genename) identified as the best match in G. pallida and G. rostochiensis are given 
the nomenclature gpa-genename and gro-genename respectively. The translated 
amino acid sequence is used to assess features of the protein. Percentage amino acid 
identity is given as those which match exactly, but does not take into account positives 
(which are amino acids which share similar characteristics). Percentage identity 
between the orthologous G. pallida gene and the G. rostochiensis gene is typically over 
90%.  
3.3.1  Acetylcholine genes – metabolism and synthesis 
Genes involved in the synthesis and metabolism of acetylcholine were identified and 
cloned from G. pallida and identified in G. rostochiensis.  
3.3.1.1 Cel-cha-1 
Cha-1 encodes a choline acetyltransferase which synthesises acetylcholine. The 
orthologue of Cel-CHA-1 found in G. pallida shared 40% identity with Cel-CHA-1 and in                        
G. rostochiensis, 42% amino acid identity was shared with Cel-CHA-1. This low 
percentage identity is likely due to an expanded region of 73 amino acids in G. pallida 
and G. rostochiensis genes which shares no homology to Cel-CHA-1 located between 
position 185 and 186 of the Cel-CHA-1. Potential residues involved in enzyme function 
can be identified in the G. pallida sequence such as co-factor binding and proton 
acceptor sites (Alfonso et al. 1994) (Figure 3-4).  
3.3.1.2 Cel-unc-17 
Cel-unc-17 is a synaptic acetylcholine transporter. The best orthologue identified in    
G. pallida and G. rostochiensis shared 63% and 58% amino acid identity with 
Cel-UNC-17 respectively. As Cel-UNC-17 is a membrane bound transporter, TMHMM 
was used to predict the number of transmembrane domains. Cel-UNC-17 has 12 
transmembrane domains, and in Gpa-UNC-17, 12 transmembrane domains are 
predicted by TMHMM. Predicted N-glycosylation sites (Alfonso et al. 1993) from 
Cel-UNC-17 are present (Figure 3-5). 
In C. elegans cel-cha-1 and cel-unc-17 are in an operon structure with cel-cha-1 directly 
downstream of cel-unc-17 (Rand 1989). In both G. pallida and G. rostochiensis, this 
operon-like structure seems to be maintained, although evidence could not be found 
of the shared untranslated exon (Figure 3-6). 
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Figure 3-4: Amino acid alignment of Cel-CHA-1 with Gpa-CHA-1 and Gro-CHA-1 
Green circle indicates proton acceptor site. Orange circle indicates residues involved in 
cofactor binding.  
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Figure 3-5: Alignment of Cel-UNC-17 with Gpa-UNC-17 and Gro-UNC-17 
Red boxes indicate transmembrane regions from Cel-UNC-17 (confirmed in Uniprot database) 
and Gpa-UNC-17 (predicted). Purple circles indicate possible glycosylation sites. 
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Figure 3-6: Structure of unc-17 cha-1 operon in C. elegans and G. rostochiensis 
a) cel-unc-17 cel-cha-1 operon as viewed on C. elegans Gbrowse. The genes are orientated 
right to left. Shown is RNAseq data (black bars) representing expression levels. “Curated 
genes” shows gene structure. Black lines are introns, blue boxes are translated exons. The 
shared grey box in the two gene models is the shared untranslated exon. b) gro-unc-17 
gro-cha-1 operon model as viewed on Apollo for G. rostochiensis. The genes are orientated left 
to right. Shown is RNAseq data (dark blue peaks) and gene structure. Grey lines are introns and 
blue boxes are exons. There is no evidence of a shared untranslated exon and RNAseq data 
does not support this as a possibility.  
55 
 
 
3.3.2 Acetylcholine genes – receptor subunits 
Investigation of genes encoding subunits of nicotinic acetylcholine receptors will be 
covered in detail in Chapter 4. 
3.3.3 Glutamate genes – synthesis and metabolism 
3.3.3.1 Cel-eat-4 
Cel-eat-4 encodes a vesicular glutamate transporter. Orthologues of this gene were 
identified and cloned in G. pallida and identified in G. rostochiensis. The amino acid 
identity shared between Gpa-EAT-4 and Cel-EAT-4 is 63%, and between Gro-EAT-4 and 
Cel-Eat-4 is 62%.  
Cel-EAT-4 is a membrane bound transporter and in C. elegans is reported to have 12 
transmembrane domains (Lee et al. 1999). Phobius analysis of the translated sequence 
of gpa-eat-4 predicts 12 transmembrane domains as expected (Figure 3-7). 
3.3.4 Orthologues of C. elegans glutamate-gated chloride channel subunit genes 
These genes encode subunits of glutamate-gated chloride channels, which may be 
homomeric or heteromeric. Some members of this gene family present in C. elegans 
are absent in G. pallida and G. rostochiensis, and some seem to have undergone 
duplication. Members of this class of genes should contain both a signal peptide for 
targeting to the secretory pathway towards their site in the plasma membrane, and 
four transmembrane spanning domains (Thompson, Lester and Lummis 2010). The 
amino acid sequences were also examined for presence of extracellular loops; residues 
involved in glutamate binding and residues involved in ivermectin binding as identified 
from X-ray crystal structures of Cel-GLC-1 (Hibbs and Gouaux 2011). A schematic of 
these residues is shown in (Figure 3-8). The details of shared percentage identity and 
presence of signal peptides, transmembrane domains and receptor-type features are 
summarised in Table 3.  
3.3.4.1 Cel-glc-1 
An orthologue of Cel-glc-1 is absent in both G. pallida and G. rostochiensis genome 
assemblies. The transcriptome assemblies available were also searched for a cel-glc-1 
without an orthologue being detected.  
3.3.4.2 Cel-glc-2 
There is a long region of low sequence homology between TM3 and TM4 of the 
orthologue of Cel-GLC-2 in G. pallida and G. rostochiensis. Both Gpa-GLC-2 and 
Gro-GLC-2 are 133 amino acids longer than Cel-GLC-2 due to this expanded region 
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between TM3 and TM4. All extracellular loops can be identified in Gpa-GLC-2, as well 
as key residues in glutamate binding. Some residues involved in ivermectin binding can 
be identified in Cel-GLC-2 and Gpa-GLC-2 (Figure 3-9). 
TMHMM analysis of Gpa-GLC-2 and Gro-GLC-2 predicts five transmembrane regions 
for each, where Cel-GLC-2 contains four. This additional transmembrane region 
coincides with the expanded region of Gpa-GLC-2 and Gro-GLC-2 (Figure 3-10). 
However, 3D modelling of the amino acid sequence by RaptorX predicts a long 
intracellular TM3-TM4 loop rather than an additional transmembrane domain. For 
comparison, the predicted model of Cel-GLC-2 has a much shorter TM3-TM4 loop 
(Figure 3-11). 
3.3.4.3 Cel-glc-3 
There is a long region of low sequence homology between TM3 and TM4 of the 
orthologue of Cel-GLC-3 in G. pallida and G. rostochiensis. Modelled by RaptorX, the 
prediction is for a long intracellular TM3-TM4 loop. Features characteristic of a 
glutamate-gated chloride subunit are identified in Gpa-GLC-3 and Gro-GLC-3. Most 
residues involved in ivermectin binding can be identified in Gpa-GLC-3 (Figure 3-12).  
3.3.4.4 Cel-glc-4 
Cel-glc-4 encodes a putative glutamate-gated chloride channel in C. elegans. 
Orthologues for this putative gene could be identified in G. pallida from transcriptome 
data and in G. rostochiensis, but were not cloned. Between TM3 and TM4 there is a 
region of low sequence homology. Analysis of the amino acid sequence identifies 
glutamate binding residues and some residues which may play a role in ivermectin 
binding. However, a highly conserved arginine residue in Loop G that is linked to 
glutamate binding (Lynagh et al. 2015) is absent in the predicted amino acid sequence 
for Gpa-GLC-4 and Gro-GLC-4 (Figure 3-13). 
3.3.4.5 Cel-avr-14 
Two orthologues of cel-avr-14 were identified and cloned from G. pallida and 
identified in G. rostochiensis. These are separate genes, rather than different isoforms 
of the same gene. These genes have been termed gpa/gro-avr-14.1 and gpa/gro-
avr-14.2. The percentage identity between Gpa-AVR-14.1 and Gpa-AVR-14.2 is 41% 
(Figure 3-14). 
In Gpa-AVR-14.1, there is a region of low amino acid sequence identity between TM3 
and TM4. Features of a glutamate gated chloride channel subunit are present in the 
predicted amino acid sequence. Most residues involved in ivermectin binding are 
present. No signal peptide is detected by SignalP for either Gpa-AVR-14.1 or 
Gro-AVR-14.1. This may coincide with an expansion in the amino acid sequence for 
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Gpa-AVR14.1 and Gro-AVR14.1 at the N-terminal region. There are possible residues in 
this region which suggest a signal peptide may have been lost at some point in time 
(Figure 3-15).  
A second orthologue to cel-avr-14 was identified from the G. pallida transcriptome and 
was cloned. In RBH searches to the C. elegans protein database, the highest match was 
cel-avr-14 so this gene was considered to be a second orthologue in G. pallida and 
termed gpa-avr-14.2. This orthologue was also identified in G. rostochiensis. Five 
transmembrane domains are predicted by TMHMM. One region is towards the 
N-terminal end of the amino acid chain, which may actually indicate a signal peptide. 
However, SignalP does not predict a signal peptide for Gpa-AVR-14.2 or Gro-AVR-14.2 
(Figure 3-16). 
3D modelling of the two identified orthologues produces two different structures. Both 
have longer TM3-TM4 intracellular loops than Cel-AVR-14. Gpa-AVR-14.2 is predicted 
to have additional helical structures in the extracellular domain (Figure 3-17). 
3.3.4.6 Cel-avr-15 
An orthologue of cel-avr-15 is absent in both the G. pallida and G. rostochiensis 
genome assemblies. Transcriptome databases were also searched for a cel-avr-15 
orthologue without success. 
3.3.4.7 Phylogenetic relationship of cloned subunits of glutamate-gated chloride 
channels 
The relationship between the cloned subunits of glutamate-gated chloride channels 
from G. pallida, the identified subunits from G. rostochiensis and the C. elegans 
subunits is described by a maximum likelihood phylogenetic tree. The outgroup used 
was the sequence of an ancestral glutamate-gated chloride channel identified from the 
sea slug Aplysia californica.  
Orthologues identified cluster together, with G. pallida and G. rostochiensis being 
more closely related to each other than to the C. elegans subunits. Gpa-AVR-14.2 
clusters with Cel-AVR-14, and Gpa-AVR-14.1 and Gro-AVR14.1 but is more distantly 
related (Figure 3-18). 
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Figure 3-7: Alignment of Cel-EAT-4 with Gpa-EAT-4 and Gro-EAT-4 
Red boxes indicate transmembrane regions for Cel-EAT-4 (confirmed in Uniprot database) and 
Gpa-EAT-4 (estimated by Phobius).  
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Figure 3-8: Schematic of residues involved in ivermectin binding identified from X-ray crystal 
structure 
The residues involved in ivermectin binding have been shown by x-ray structure analysis of 
crystallised Cel-GLC-1. Residues highlighted in grey are involved in van der Waal interactions 
with ivermectin. Residues highlighted in yellow are involved in hydrogen bonding with 
ivermectin. Involvement of residues from Gpa-AVR-14.1 is inferred from Cel-GLC-1 data. Figure 
adapted from Hibbs and Gouaux 2011 
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Gene name 
(gpa/gro) 
Percentage ID Ce to Gpa Percentage ID Ce to Gr Signal Peptide prediction Transmembrane 
prediction 
Receptor features 
Glc-1 no orthologue identified no orthologue identified - - - 
Glc-2 50% 51% Cleavage between 
residues 21 and 23 
5 predicted 
(not supported by 3D 
model) 
Cys-loop present 
Extracellular loops 
present 
Glc-3 56% 57% Cleavage between 
residues 32 and 33 
4 predicted Cys-loop present 
Extracellular loops 
present 
Glc-4 60% 61% Cleavage between 
residues 23 and 24 
4 predicted Cys-loop present 
Extracellular loops 
present 
Avr-14.1 61% 62% None predicted 4 predicted Cys-loop present 
Extracellular loops 
present 
Avr-14.2 45% 51% None predicted 5 predicted 
(additional coiled in 
extracellular domain)  
Cys-loop present 
Extracellular loops 
present 
Avr-15 No orthologue identified No orthologue identified - - - 
Table 3: Summary of features of orthologues of glutamate-gated chloride channel subunits cloned from G. pallida and identified in G. rostochiensis 
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Figure 3-9: Alignment of Cel-GLC-2 with Gpa-GLC-2 and Gro-GLC-2 
Red arrows indicate signal peptide cleavage sites. Black lines indicate the different extracellular 
loops presents. Orange boxes indicate paired cysteines of a cys-loop receptor. Red boxes 
indicate predicted transmembrane regions. Green boxes indicate residues involved in 
glutamate binding. Blue boxes indicate residues involved in ivermectin binding, that match 
consensus. Pink boxes indicate residues in positions that may interact with ivermectin, but do 
not fit consensus. 
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Figure 3-10: Output from TMHMM prediction server for Cel-GLC-2, Gpa-GLC-2 and Gro-GLC-2  
a) Prediction for Cel-GLC-2 predicts four membrane spanning domains. b-c) predictions for 
Gpa-GLC-2 and Gro-GLC-2 predict five transmembrane regions, with an additional 
transmembrane region predicted between amino acids 400 – 500.  
63 
 
 
Figure 3-11: 3D model of Cel-GLC-2 and Gpa-GLC-2 
a) 3D model of Cel-GLC-2 as built by RaptorX. Template is based on PDB: 3rhwA. P-value for 
model 1.47e-15. b) 3D model of Gpa-GLC-2 as built by RaptorX. Template based on PDB: 3rhwA. 
P-value for model 1.01e-15. Protein models are coloured by secondary structure: α helix 
(turquoise), β sheet (red) and loops (pink). Cel-GLC-2 and Gpa-GLC-2 share the same overall 
features, although the TM3-TM4 intracellular loop is elongated in Gpa-GLC-2. A fifth 
transmembrane domain for Gpa-GLC-2 is not predicted by the model.  
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Figure 3-12 : Alignment of Cel-GLC-3 with Gpa-GLC-3 and Gro-GLC-3 
Red arrows indicate signal peptide cleavage sites. Black lines indicate the different extracellular 
loops presents. Orange boxes indicate paired cysteines of a cys-loop receptor. Red boxes 
indicate predicted transmembrane regions. Green boxes indicate residues involved in 
glutamate binding. Blue boxes indicate residues involved in ivermectin binding, that match 
consensus. Pink boxes indicate residues in positions that may interact with ivermectin, but do 
not fit consensus. 
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Figure 3-13: Alignment of predicted amino acid sequence of Cel-GLC-4 with Gpa-GLC-4 and 
Gro-GLC-4 
Red arrows indicate signal peptide cleavage sites identified. Black lines indicate the different 
extracellular loops presents. Orange boxes indicate paired cysteines of a cys-loop receptor. 
Red boxes indicate predicted transmembrane regions. Green boxes indicate residues involved 
in glutamate binding. Blue boxes indicate residues involved in ivermectin binding, that match 
consensus. Pink boxes indicate residues in positions that may interact with ivermectin, but do 
not fit consensus. 
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Figure 3-14: Alignment of Cel-AVR-14a with Gpa-AVR-14.1 and Gpa-AVR-14.2 
Red arrows indicate signal peptide cleavage sites identified. Black lines indicate the different 
extracellular loops presents. Orange boxes indicate paired cysteines of a cys-loop receptor. 
Red boxes indicate predicted transmembrane regions. Green boxes indicate residues involved 
in glutamate binding. Blue boxes indicate residues involved in ivermectin binding, that match 
consensus. Pink boxes indicate residues in positions that may interact with ivermectin, but do 
not fit consensus. 
67 
 
 
Figure 3-15: Alignment of Cel-AVR-14 (isoform a) with Gpa-AVR-14.1 and Gro-AVR-14.1. 
Red arrows indicate signal peptide cleavage sites identified. The purple box indicates region of 
sequence similarity with the Cel-AVR-14 signal peptide. Black lines indicate the different 
extracellular loops presents. Orange boxes indicate paired cysteines of a cys-loop receptor. 
Red boxes indicate predicted transmembrane regions. Green boxes indicate residues involved 
in glutamate binding. Blue boxes indicate residues involved in ivermectin binding, that match 
consensus. Pink boxes indicate residues in positions that may interact with ivermectin, but do 
not fit consensus. 
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Figure 3-16: Alignment of Cel-AVR-14 (isoform a) with Gpa-AVR-14.2 and Gro-AVR-14.2 
Red arrows indicate signal peptide cleavage sites identified. Labelled red box indicates 
predicted transmembrane region towards N-terminal end, but is a possible lost signal peptide. 
Black lines indicate the different extracellular loops presents. Orange boxes indicate paired 
cysteines of a cys-loop receptor. Red boxes indicate predicted transmembrane regions. Green 
boxes indicate residues involved in glutamate binding. Blue boxes indicate residues involved in 
ivermectin binding, that match consensus. Pink boxes indicate residues in positions that may 
interact with ivermectin, but do not fit consensus. 
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Figure 3-17: 3D models of Cel-AVR-14a, Gpa-AVR-14.1 and Gpa-AVR-14.2 
a) 3D model of Cel-AVR-14a as built by RaptorX. Template is based on PDB: 4.43e-16. P-value for 
model 1.47e-15. b) 3D model of Gpa-AVR-14.1. Template: 3rhwA. P-value 1.37e-15 c) 3D models 
of Gpa-AVR-14.2. Template: 3rhwA. P-value 5.92e-15. Protein models are coloured by secondary 
structure: α helix (turquoise), β sheet (red) and loops (pink). Gpa-AVR-14.1 and Gpa-AVR-14.2 
differ from Cel-AVR-14a and each other. TM3-TM4 region is elongated in both Gpa models.  
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Figure 3-18: Phylogeny of glutamate-gated chloride channel subunits identified from    
G. pallida and G. rostochiensis with C. elegans subunits 
Maximum likelihood phylogeny using predicted protein alignment of glutamate-gated chloride 
channel subunits. Bootstrap values for 500 iterations labelled on nodes. Scale bar represents 
average number of substitutions per site. Subunits cluster by orthology groups rather than 
species. 
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3.3.5 Orthologues of C. elegans genes involved in serotonin synthesis and 
metabolism 
3.3.5.1 Cel-tph-1 
Cel-tph-1 encodes a tryptophan hydroxylase that catalyses the rate-limiting step in 
serotonin biosynthesis. Percentage identity between Cel-TPH-1 and Gpa-TPH-1 is 66% 
and between Cel-TPH-1 and Gro-TPH-1 is 66%.  
Known cofactor binding sites present in Cel-TPH-1 are present in Gpa-TPH-1 (UniProt 
2015) (Figure 3-19). 
3.3.5.2 Cel-ser-7 
Application of exogenous serotonin stimulates stylet thrusting of G. pallida J2s (Figure 
3-21a). Serotonin-induced stylet thrusting is accompanied by cessation of movement in 
liquid. This response indicates that receptors present for serotonin are present in   
G. pallida. 
An orthologue for cel-ser-7, which encodes a serotonin receptor, was identified. 
Percentage identity between Cel-SER-7 isoform b and Gpa-SER-7 is 40%, and between 
Cel-SER-7 isoform b and Gro-SER-7 is 40%.  
A signal peptide is predicted for Gpa-SER-7 and Gro-SER-7. However, SignalP does not 
predict a signal peptide for Cel-SER-7. Cel-SER-7 is known to contain seven 
transmembrane domains (Hobson et al. 2003). TMHMM predicts seven 
transmembrane domains for Gpa-SER-7. 
PKC phosphorylation sites have been predicted in Cel-SER-7, which can take place at 
serine or threonine residues. Two of these potential phosphorylation sites are present 
in Gpa-SER-7, and three are present in Gro-SER-7. A PKA phosphorylation site was also 
predicted in Cel-SER-7, but a serine or threonine is not present in Gpa-SER-7 in this 
position (Hobson et al. 2003)(Figure 3-20). 
3.3.5.3  Cel-mod-5 
Cel-mod-5 encodes a serotonin transporter present on neurosecretory neurons 
responsible for reuptake of serotonin from the synaptic cleft.  
The percentage identity between Cel-MOD-5 and Gpa-MOD-5 is 58% and between 
Cel-MOD-5 and Gro-MOD-5 is 57%. There is a conserved aspartate residue present in 
serotonin and dopamine transporters (Ranganathan et al. 2001), which can be 
identified in Gpa-MOD-5. 
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TMHMM model predicts 12 transmembrane domains for both Gro-MOD-5 and 
Gpa-MOD-5 which is characteristic of this type of transporter (Figure 3-22). 
3.3.6 Orthologues of C. elegans genes involved in GABA synthesis 
3.3.6.1 Cel-unc-25 
Cel-unc-25 encodes a glutamic acid decarboxylase, involved in the synthesis of GABA. 
Percentage identity between Cel-UNC-25 and Gpa-UNC-25 is 70%, and between 
Cel-UNC-25 and Gro-UNC-25 is 68%.  
The NPHK tetrapeptide which binds the pyridoxal phosphate cofactor and is 
characteristic of glutamic acid decarboxylases, can be identified in Gpa-UNC-25 (Jin et 
al. 1999) (Figure 3-23). 
3.3.7 Genes involved in dopamine metabolism 
3.3.7.1 Cel-dat-1 
Cel-dat-1 encodes a dopamine transporter responsible for reuptake of dopamine from 
the synaptic cleft (Jayanthi et al. 1998). Percentage identity between Cel-DAT-1 and 
Gpa-DAT-1 is 63%, and between Cel-DAT-1 and Gro-DAT-1 is 63%. The amino acid 
sequence contains the conserved aspartate residue common to dopamine and 
serotonin transporters (Ranganathan et al. 2001). 
This class of transporter has 12 transmembrane domains. Both Gro-DAT-1 and 
Gpa-DAT-1 are predicted 12 transmembrane domains by the TMHMM; however the 
location of the predicted transmembrane domain regions differs between Cel-DAT-1 
and Gpa-DAT-1 (Figure 3-24). 
3.3.8 Orthologues of C. elegans genes involved in octopamine synthesis 
3.3.8.1 Cel-tbh-1  
Cel-tbh-1 encodes a tyramine β-hydroxylase and is involved in the synthesis of 
octopamine (Alkema et al. 2005). A potential orthologue of tbh-1 was identified in         
G. pallida, but could not be cloned. An orthologue of tbh-1 was also identified in           
G. rostochiensis. The orthologues as identified from bioinformatic data had low 
percentage identity to Cel-TBH-1 with percentage identity to Gpa-TBH-1 being 31% and 
to Gro-TBH-1 being 33% (Figure 3-25).The predicted amino acid sequence obtained is 
not predicted a signal peptide, while Cel-TBH-1 has a signal peptide. However, analysis 
by Interpro both identifies it as a tyramine β-hydroxylase and identifies key domains in 
the predicted Gpa-TBH-1 sequence, which are present in Cel-TBH-1 such as the 
DOMON domain, involved in extracellular adhesion (Aravind 2001). 
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G. pallida J2s were exposed to 50 mM octopamine to determine if exogenous 
application of the neurotransmitter caused an effect. After 24 hours exposure, 
octopamine treated J2s moved significantly faster than control worms (Figure 3-21b). 
3.3.9 Expression analysis of identified orthologues at different life-stages of                
G. pallida 
Expression data obtained from RNASeq results from life-stages show that the genes 
identified are most highly expressed in the eggs, J2s and males. Expression level in 
sedentary stages is low (Figure 3-26) apart from for gpa-dat-1. Expression of gpa-tbh-1 
remains low throughout although is slightly elevated during the sedentary life stages.  
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Figure 3-19: Alignment of Cel-TPH-1 with Gpa-TPH-1 and Gro-TPH-1 
Red squares indicate known cofactor binding sites in Ce-TPH-1 
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Figure 3-20 : Alignment of Cel-SER-7 (isoform b) with Gpa-SER-7 and Gro-SER-7 
Red arrows indicate cleavage site of signal peptide identified by SignalP. Red boxes indicate 
transmembrane domain regions. Yellow diamonds indicate potential PKC phosphorylation 
sites. Green squares indicate potential PKA phosphorylation sites.  
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Figure 3-21: Application of exogenous neurotransmitters to G. pallida J2s 
a) Application of 6.25 mM serotonin to G. pallida J2s stimulates stylet thrusting. In the absence 
of serotonin, J2s do not stylet thrust (ANOVA, p= <0.001) b) Application of octopamine to   
G. pallida J2s increases speed of movement at 4 hours and 24 hours exposure. (Two-way 
ANOVA, p=<0.001). Error bars represent SEM. 
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Figure 3-22: Alignment of Cel-MOD-5 with Gpa-MOD-5 and Gro-MOD-5 
Red boxes indicate transmembrane regions. Blue diamond indicates a conserved aspartate 
residue common to serotonin and dopamine transporters. 
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Figure 3-23: Alignment of Cel-UNC-25 with Gpa-UNC-25 and Gro-UNC-25 
Yellow box indicates the NPHK tetrapeptide characteristic of a glutamic acid decarboxylase. 
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Figure 3-24: Alignment of Cel-DAT-1 with Gpa-DAT-1 and Gro-DAT-1 
Transmembrane domain regions are indicated by red boxes. The transmembrane domains for 
Cel-DAT-1 are confirmed, whereas the transmembrane domain regions for Gpa-DAT-1 are 
predicted. The blue diamond indicates the presence of an aspartate residue common to 
serotonin and dopamine receptors.  
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Figure 3-25: Alignment of Cel-TBH-1 with predicted amino acid sequence of Gpa-TBH-1 and 
Gro-TBH-1 
Red arrow indicates signal peptide cleavage site. Blue box highlights the DOMON domain for 
Cel-TBH-1 (Uniprot) and Gpa-TBH-1 (as predicted by InterPro). 
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Figure 3-26: Expression of transcripts for identified orthologues over the life-stages of    
G. pallida 
Expression in the eggs, the motile stages (J2s and males) and sedentary stages (7-35 dpi 
females) for a) the neurotransmitter synthesis genes b) the genes encoding subunits of 
glutamate-gated chloride channels. 
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 Discussion 3.4
3.4.1 Quality of bioinformatic data sources must be assessed to determine 
confidence in results 
Potential orthologues of C. elegans genes have been identified and cloned for     
G. pallida for all but two of the genes searched for in this chapter. The genome 
assembly of G. rostochiensis has acted as a valuable extra resource for this work. Due 
to the reduced genetic diversity of G. rostochiensis in the UK (Bendezu et al. 1998) 
compared to G. pallida the genome assembly produced was more robust. This allowed 
a second set of orthologues to C. elegans genes to be identified using bioinformatic 
methods alone in G. rostochiensis with a higher degree of confidence in the data set. 
It is important to assess the quality of source data when searching for orthologues of 
genes by purely bioinformatic methods. Many sources of error can be introduced in 
the production of a genome sequence. The DNA collected must be of good quality and 
free from contamination. Due to variation between individuals, and as the individual 
DNA of one plant-parasitic nematode was not sufficient to sequence a genome, it 
helps to have a source of DNA with low allelic variation. The production of inbred lines 
prior to DNA collection to reduce variability can be helpful.  
The choice of sequencing technology is also important, and sequencing technology is 
improving rapidly as time progresses. Sanger sequencing led the field of sequencing for 
over 25 years (Sanger, Nicklen and Coulson 1977), but next-generation sequencing has 
made improvements in speed, cost and accuracy. Next-generation sequencing 
methods include Roche 454 sequencing (generates up to 800 bp reads), Illumina HiSeq 
sequencing (150bp) and Pacific Biosciences (up to 5 kb) (Ekblom and Wolf 2014). 
Choice of sequencing technology impacts the coverage required (typically shorter 
reads require a deeper sequencing coverage to ensure enough overlapping sequence 
for genome assembly) and impacts choice of assembly algorithm downstream as 
algorithms differ between short-read assembly and long-read assembly. The ease of 
assembly is also affected by presence of repetitive sequences and highly variable 
regions at any stage can complicate final assembly. In these cases, the repetitive 
sequences may be incorporated erroneously into the assembly. If sequencing has not 
been conducted to an appropriate depth, large amounts of sequence data may be 
omitted from the final assembly. Preassembly, the sequencing data can be checked for 
low-quality reads and contaminating sequence from other organisms.  
Genes are then predicted by gene prediction programs such as Augustus. Modelling 
genes is complex, and must take into account large introns present in eukaryotic 
genomes, and the ability to determine the start and end of genes. The production of 
transcriptome data mapped onto an assembled genome can provide information 
about the quality of gene model prediction, particularly the accuracy of mapping 
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intron-exon boundaries. The biological role of predicted genes can be annotated 
through databases such as gene ontology (GO) terms which yields functional 
information, but such methods are likely to miss novel genes which may be of 
particular interest in parasitic genomes, such as effector genes. Comparison to a 
closely related species can aid genome annotation, as well as manual annotation by 
trained researchers.  
In the case of the G. pallida genome assembly, many practical hurdles had to be 
overcome. The G. pallida populations in the UK are very genetically diverse. As    
G. pallida must be cultured on potato plants, and each female nematode may be 
fertilised by multiple males, the production of inbred lines would have been difficult 
and time-consuming. Although all material for the G. pallida genome originated from 
an individual field site, there was clearly high genetic diversity in the starting material. 
To produce enough genetic material for DNA sequencing, a strategy known as Whole 
Genome Amplification (WGA) was initially used, this unfortunately introduced a large 
number of inverted repeats into the starting material after amplification. As 
sequencing occurred over several years in which the technology was improving, three 
different types of reads generated by different sequencing technologies was 
incorporated into the final pool to be assembled which may have complicated 
assembly (Cotton et al. 2014).  
Without knowledge of the quality of a genome assembly, and the processes that have 
led to the final assembly, it is hard to determine how much trust to place in orthology 
searching that relies solely on bioinformatic methods. If a gene is not identified in an 
assembled genome, its absence cannot be confirmed without analysing other data 
sources. If a gene model predicts a truncated form of the gene, the gene model may 
have mispredicted gene structure or it could be the result of assembly error. 
As G. pallida and G. rostochiensis are closely related, any absences in orthologues for 
C. elegans genes can be stated with confidence as they have not been found in two 
genome assemblies, and at least two sets of transcriptome data. 
3.4.2 Key neurotransmitter synthesis genes are present in the G. pallida and          
G. rostochiensis genome 
Previous work in this field has also indicated that the same major neurotransmitters 
are present and play a major role in nematodes across the clade. This is substantiated 
by the genome data as key enzymes involved in the synthesis and metabolism of 
neurotransmitters have been identified and cloned in G. pallida and identified 
bioinformatically in G. rostochiensis indicating that the same neurotransmitters are 
likely to be present and active between C. elegans and both Globodera spp.  
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Acetylcholinesterase-inhibitors disrupt chemoreception in G. pallida and H. glycines 
(Winter, McPherson and Atkinson 2002) and genes encoding acetylcholinesterases, 
involved in the removal of acetylcholine from the synaptic cleft, have been identified in 
M. incognita, M. javanica (Piotte et al. 1999) and G. pallida (Costa et al. 2009). Here, 
genes encoding two key enzymes involved in the production of acetylcholine (cha-1) 
and the loading of acetylcholine into vesicles (unc-17) have been identified.  
Exogenous application of serotonin to J2s of plant-parasitic nematodes causes 
behavioural changes. The stimulation of stylet thrusting is a behavioural change 
common to M. incognita, H. glycines (Masler 2008) and G. pallida (Figure 3-21a). In   
G. pallida this increased stylet thrusting is accompanied by the cessation of worm 
movement, and may possibly indicate that serotonin signalling is involved in the 
invasion process. Here, a gene encoding a key enzyme in the synthesis of serotonin 
(gpa-tph-1) has been identified along with the post-synaptic receptor (gpa-ser-7) and 
the reuptake transporter present on the neurosecretory neuron (gpa-mod-5) 
(Ranganathan et al. 2001). Although there are discrepancies between Cel-SER-7 and 
Gpa-SER-7, primarily the presence of a predicted signal peptide in Gpa-SER-7, but not 
in Cel-SER-7, serotonin is able to activate a receptor as demonstrated by the response 
of G. pallida J2s to exogenous serotonin. The absence of a signal peptide in Cel-SER-7 
may be a result of a false-negative prediction by SignalP or that Cel-SER-7 is targeted to 
the membrane by other mechanisms, such as by signals within the first 
transmembrane domain which has been shown to target Type II receptors. 
Dopamine has been detected by glyoxylic acid fluorescence in G. rostochiensis J2s 
(Sharpe and Atkinson 1980) and has been detected in homogenates of M. incognita J2s 
by HPLC analysis (Stewart, Perry and Wright 2001). Dopamine may be involved in 
different roles, as exogenous application of dopamine to H. glycines at 5 mM 
stimulates body movement, but at 50 mM inhibits it. This inhibition of movement 
caused by 50 mM dopamine is also observed in M. incognita. In this chapter, a gene 
encoding a dopamine reuptake transporter (dat-1) has been identified.  
Putative GABA receptors have been identified in G. pallida (Cotton et al. 2014), 
although the role of this neurotransmitter is not well explored in plant-parasitic 
nematodes. Here the enzyme involved in the synthesis of GABA has been identified, 
indicating that GABA is present in G. pallida.  
Exogenous application of octopamine increases movement of H. glycines at 5 mM, and 
M. incognita at 5 mM and 50 mM (Masler 2008). This indicates that a pathway for 
octopamine recognition is likely to exist in plant-parasitic nematodes, and that 
octopamine is likely to be used as a neurotransmitter in the nervous system. The 
orthologue identified for an enzyme involved in octopamine synthesis TBH-1 had low 
identity to Cel-TBH-1 and could not be cloned, although Interpro analysis showed the 
sequence contained the DOMON domain associated with this enzyme-type (Aravind 
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2001), suggesting that despite the low sequence identity, the orthologue identified in 
G. pallida is likely to be functional. Furthermore, exogenous application of 50 mM 
octopamine to G. pallida J2s had a stimulatory effect after 24 hours exposure (Figure 
3-21b) indicating that a receptor for octopamine is likely to exist, and that octopamine 
functions in the nervous system of G. pallida. 
3.4.3 Some orthologues of C. elegans genes encoding glutamate-gated chloride 
channels can be found in the G. pallida and G. rostochiensis genomes 
Orthologues for the C. elegans genes (cel-glc-1, cel-glc-2, cel-glc-3, cel-glc-4, cel-avr-14 
and cel-avr-15) encoding glutamate-gated chloride channels were searched for in the 
G. pallida genome and G. rostochiensis assembly. Orthologues for cel-glc-1 and 
cel-avr-15 could not be identified in the G. pallida genome assembly. Unassembled 
reads and transcriptome data were also examined for any evidence of orthologues of 
cel-glc-1 and cel-avr-15 that had not been processed into the main genome assembly. 
Once the G. rostochiensis genome assembly could be accessed, and was found to lack 
orthologues of cel-glc-1 or cel-avr-15 their absence in Globodera spp. could be stated 
with more confidence. Orthologues of cel-glc-1 and cel-avr-15 are also absent in          
B. malayi and T. spiralis (Williamson, Walsh and Wolstenholme 2007). 
Orthologues for cel-glc-2, cel-glc-3, cel-glc-4 and two orthologues of cel-avr-14 could 
be identified in both G. pallida and G. rostochiensis. Coding sequences of most of these 
genes were cloned from G. pallida and the predicted amino acid sequences examined 
for features common to glutamate-gated chloride channels. A clone of gpa-glc-4 could 
not be obtained, so the amino acid sequence of this is derived from the G. pallida 
transcriptome and the G. rostochiensis genome. Unless the G. rostochiensis gene 
differed significantly from the G. pallida gene, statements made about the G. pallida 
gene apply equally to the G. rostochiensis gene.  
Features of a glutamate-gated chloride subunit are present in all predicted amino acid 
sequences. Four membrane spanning domains and extracellular loops A-F are present 
and residues known to be involved in glutamate binding are identified in all 
orthologues (Hibbs and Gouaux 2011). The cysteine pair separated by 13 conserved 
amino acids that characterises the cys-loop class of receptor (Thompson, Lester and 
Lummis 2010) is also present in all orthologues.  
Two orthologues of cel-avr-14 have been identified. Gpa-avr-14.1 is more closely 
related to cel-avr-14 than gpa-avr-14.2, although the predicted amino acid sequence 
of gpa-avr-14.2 also has all features that mark a glutamate-gated chloride channel. 
Gpa-AVR-14.1 is predicted to lack a signal peptide, and although the N-terminal end of 
Gro-AVR-14.1 is longer no signal peptide is predicted. It may be that this subunit is not 
targeted to the membrane in G. pallida that it reaches the membrane by other 
mechanisms or that signal peptide prediction by SignalP is not infallible.  
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The predicted amino acid sequence of gpa-avr-14.2 is also not predicted to have a 
signal peptide. However, TMHMM predicts five transmembrane spanning domains 
rather than the four typical for this subunit type. The additional transmembrane 
domain occurs close to the N-terminal end of the amino acid sequence and may itself 
function as a signal peptide, as both signal peptides and transmembrane domains 
share similar features. 
The orthologues of cel-glc-4 identified in G. pallida and G. rostochiensis lack a key 
arginine residue in Loop G, which is replaced by an asparagine. In an R76N mutation 
affecting the loop G arginine of Cel-AVR-14, the channel did not activate in response to 
glutamate when expressed in Xenopus oocytes (Lynagh et al. 2015). As the orthologue 
has not been cloned from either G. pallida or G. rostochiensis, the amino acid 
sequence cannot be confirmed. However, the presence of this residue change in both 
genome assemblies increases the likelihood of this being the genuine sequence.  
One feature common to the predicted amino acid sequences of all orthologues of 
glutamate-gated chloride subunits cloned in Globodera spp. is an extension in the 
amino acid sequence between TM3 and TM4. This is typically an expansion of ~100 
amino acid residues with little sequence homology to the C. elegans protein. In the 
predicted amino acid sequence for gpa-glc-2, this expanded region is predicted to 
include a fifth transmembrane region not present in Cel-GLC-2, although modelling by 
RaptorX does not support the presence of a fifth transmembrane domain (Figure 3-11). 
However, whether or not this predicted transmembrane region occurs in vivo has not 
been confirmed. Modelling of Gpa-AVR-14.1 and Gpa-AVR-14.2 also shows an 
extended TM3-TM4 loop (Figure 3-17). This region between TM3 and TM4 is an 
intracellular loop, which may be involved in aspects which affect receptor function 
such as desensitisation or aggregation (Lo et al. 2008; Kracun et al. 2008) as shown in 
other members of the cys-loop family.  
3.4.3.1 Differences in the complement of glutamate-gated chloride channels may 
affect ivermectin targets 
Ivermectin sensitivity in C. elegans is linked to the genes encoding Ce-GLC-1, 
Ce-AVR-15 and Ce-AVR-14. As orthologues for cel-glc-1 and cel-avr-15 could not be 
identified, the possible contribution of the identified cel-avr-14 orthologues, and the 
remaining subunits, were investigated. G. pallida J2s are sensitive to ivermectin as they 
become paralysed upon exposure therefore the absence of cel-glc-1 and cel-avr-15 has 
not affected sensitivity. However, cel-avr-15 is linked to the high sensitivity of the        
C. elegans pharynx to ivermectin (Dent, Davis and Avery 1997) and the efficacy of 
ivermectin to starve C. elegans at low doses of ivermectin (Dent et al. 2000). As              
G. pallida J2s are non-feeding, and do not stylet thrust, the effect of ivermectin on 
stylet thrusting was not investigated. As serotonin induces stylet thrusting of G. pallida 
J2s, the effect of ivermectin on serotonin-induced stylet thrusting could be examined. 
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In C. elegans, mutation of cel-avr-14, cel-glc-1 and cel-avr-15 together is required for 
high ivermectin resistance (Dent et al. 2000). 
It is likely that the orthologues of cel-avr-14 identified in G. pallida mediate sensitivity 
to Ivermectin. The residues involved in ivermectin binding have been identified by 
X-ray crystal structure in a homomeric pentamer of Cel-GLC-1 (Hibbs and Gouaux 
2011), and the predicted G. pallida orthologues were investigated for the presence of 
these residues (Figure 3-8). 
Gpa-AVR-14.1 shares most of the amino acid residues involved in ivermectin binding 
with Cel-GLC-1, although there is no isoleucine at position 376. This residue is also a 
threonine in Cel-AVR-14, which is known to have a role in ivermectin sensitivity. There 
Alanine replaces threonine at position 388, although again this is present in 
Cel-AVR-14. From study of these residues it seems likely that Gpa-AVR-14.1 is able to 
bind ivermectin as effectively as Cel-AVR-14 and may play a role in sensitivity of             
G. pallida to Ivermectin. Similarly, Gpa-AVR-14.2 shares the same residues associated 
with ivermectin sensitivity as Cel-AVR-14.  
However, it is unclear which of these residues is essential for ivermectin binding. 
Cel-GLC-2 homomers are insensitive to ivermectin when expressed in Xenopus oocytes 
(Cully et al. 1994), though it shares some of the residues highlighted in ivermectin 
sensitivity. These residues are shared by Gpa-GLC-2 suggesting that Gpa-GLC-2 would 
have a similar sensitivity to ivermectin as Cel-GLC-2. Although cel-glc-3 has not been 
linked genetically to ivermectin sensitivity in C. elegans, when the subunit is expressed 
in Xenopus oocytes, a homomeric receptor sensitive to ivermectin is formed (Horoszok 
et al. 2001). The predicted amino acid sequence of Cel-GLC-3 shares most of the 
residues associated with ivermectin sensitivity, and those are mostly present in 
Gpa-GLC-3 as well. From sequence alone it is hard to predict how Gpa-GLC-3 affects 
ivermectin sensitivity, but it may have a role.  
Information about Cel-GLC-4 is still relatively sparse, although examination of the 
amino acid sequence suggests that a similar amount of ivermectin associated residues 
are present as for Cel-GLC-2, leading to a conclusion that it may not play a significant 
role in ivermectin sensitivity. These residues are also shared by Gpa-GLC-4. 
As there is little information about the stoichiometry and location of these different 
channels in native C. elegans, it is difficult to draw too many conclusions from the 
channels that are present and which residues are present within them. It is unknown 
which are expressed in the same neurons and therefore whether homomeric or 
heteromeric receptors are formed. This would also affect ivermectin binding as it binds 
between subunits (Hibbs and Gouaux 2011).  
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3.4.4 Gene expression analysis highlights importance of neurotransmitter-related 
genes at motile life-stages or stages which must respond to hosts 
Analysis of gene expression over different life-stages (Figure 3-26) shows that generally 
these orthologues identified in G. pallida are most highly expressed at life-stages that 
are non-parasitic and require either motility or response to host cues (Den Nijs and 
Lock 1992). Eggs must be able to hatch in response to host-derived cues, and J2s must 
be able to locate and move towards a suitable host. The males of G. pallida are motile, 
and must seek the sedentary female within the root. There is some indication that 
dopamine may be involved in the maintenance of parasitism, as gpa-dat-1 expression 
remains elevated at 21 dpi. It may be expected that, as cel-eat-4 is involved in 
pharyngeal pumping and feeding in C. elegans (Lee et al. 1999) and that during the 
sedentary parasitic stages, G. pallida must feed, expression of gpa-eat-4 would remain 
high throughout parasitism. However, expression of gpa-eat-4 is low during these 
sedentary stages. Gpa-tbh-1 expression is generally low throughout, although 
expression is slightly higher in the sedentary stages.  
3.4.5 Confidence in orthology 
It can be difficult to establish orthology with confidence from bioinformatic data alone. 
Several methods have been used to determine that the orthologue identified in    
G. pallida and G. rostochiensis is the best possible. 
The Reciprocal Best Hits (RBH) system can be robust, particularly when the species are 
closely related. However, using this methodology may lead to missing other 
orthologues when gene duplication leads to two genes being potential orthologues 
(Gabaldón 2008) such as with gpa-avr-14.1 and gpa-avr-14.2.  
To confirm if these orthologues identified in G. pallida are likely to share the same 
function as in C. elegans, more experimentation would be required. The ability of the 
G. pallida version of the gene to complement C. elegans mutants of the same gene and 
rescue the mutant phenotype would be a good way to prove functional orthology. 
Indeed, gpa-tph-1, gpa-ser-7 and gpa-eat-4 have been used to rescue the respective    
C. elegans mutants to a near wild-type phenotype, indicating that the G. pallida genes 
are able to function in the same role (Anna Crisford, unpublished). In the absence of 
similar data for the rest of the orthologues identified here, the amino acid sequence 
can be searched to identify known features common to proteins of that function. Here, 
the use of signal peptide and transmembrane predictions provide evidence for the 
targeting of the protein, its location in the cell, and the number of any transmembrane 
domains. Additionally some enzymes have cofactor binding sites and other motifs 
which identify them as members of particular enzyme classes.  
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Some C. elegans genes have very specific expression patterns. For example, cel-eat-4 is 
expressed weakly in the extrapharyngeal nervous system and strongly in the pharynx 
(Lee et al. 1999). The expression of the glutamate-gated channel subunit cel-glc-2 is 
restricted solely to the metacorpus of the pharynx (Laughton, Lunt and Wolstenholme 
1997). Analysis of the expression patterns of the G. pallida orthologues would allow 
further inferences to be made about their function.  
3.4.6 Identification of isoforms 
Many of the C. elegans genes discussed in this chapter are known to encode different 
protein isoforms, produced by differential splicing of the mRNA transcripts. To date, no 
evidence for different isoforms of G. pallida orthologues has been found but this has 
not yet been investigated extensively. 
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Summary 
 
• Key genes involved in neurotransmitter synthesis, metabolism and transduction 
are present in G. pallida and G. rostochiensis 
 
• G. pallida and G. rostochiensis have a different complement of glutamate-gated 
chloride channel subunits than C. elegans  
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4. Identification of Globodera pallida orthologues of 
Caenorhabditis elegans genes that encode nicotinic 
acetylcholine receptor subunits  
 Introduction 4.1
More than 30 genes in C. elegans encode subunits of nicotinic acetylcholine receptors, 
leading to a predicted large diversity of nicotinic acetylcholine receptors in nematodes 
(Jones and Sattelle 2004; Jones et al. 2007). They are involved in behaviours such as 
locomotion, chemosensation and egg-laying (Kim et al. 2001a). They are divided into 
five main groups by sequence homology and are named after the first member of the 
group to be identified. A summary of C. elegans nicotinic acetylcholine receptor 
subunits can be found in Table 4.  
The exact roles of many of these genes have not yet been characterised, and many do 
not have a clear phenotype in mutagenesis experiments. However, roles can be 
inferred from expression pattern of particular genes. The roles of some are beginning 
to be elucidated. Cel-acr-12 is expressed exclusively in neurons and loss of cel-acr-12 
affects the balance between relaxation and contraction that drives locomotion in            
C. elegans (Petrash et al. 2013; Gottschalk et al. 2005). Cel-acr-2 is also expressed 
exclusively in the neurons (Philbrook, Barbagallo and Francis 2013). Cel-eat-2 is 
expressed in the pharyngeal muscle and mutants of cel-eat-2 are deficient in 
pharyngeal pumping, indicating that cel-eat-2 is involved in feeding behaviours (McKay 
et al. 2004). Cel-acr-23 is expressed in body-wall muscle and is the target of the 
anthelmintic monepantel (Rufener et al. 2013). Cel-acr-5 and cel-acr-15 are involved in 
nicotine-induced locomotory behaviours, and were found to influence this behaviour 
in the neurons rather than in the muscle (Sellings et al. 2013). Mutations in cel-deg-3 
lead to degeneration of certain neurons and cel-des-2 is necessary for the cel-deg-3 
mutant phenotype (Treinin et al. 1998). 
4.1.1 The structure and function of nAChRs 
nAChR subunits all belong to the cys-loop ligand-gated ion channel class. Each subunit 
characteristically has four transmembrane spanning domains rich in hydrophobic 
amino acids (TM1-4). TM2 of each subunit contributes towards the lining of the central 
pore and determines ion selectivity. The intracellular loop between TM3 and TM4 is 
involved in localisation of the receptor and helps to modulate receptor function (Jones 
and Sattelle 2004). A cys-loop in the long N-terminal region is characterised by the 
presence of two cysteine residues separated by 13 amino acids (Corringer, Le Novere 
and Changeux 2000). Subunits are further defined as α or non-α. α-subunits are 
characterised by the presence of an YxxCC motif towards the N-terminus, while 
non-alpha subunits lack this motif (Lewis et al. 1980; Kao et al. 1984; Lukas et al. 1999). 
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A single type of α-subunit may form a pentamer, producing a homomeric receptor. 
Acr-16 forms a homomeric receptor, and is present in body-wall muscle. Expression of 
this single subunit with the required ancillary factors is sufficient to generate a 
functional receptor in Xenopus oocytes (Touroutine et al. 2005). Heteromeric 
receptors are formed when more than one subunit type forms the pentamer. With the 
number of nAChR subunits encoded in the C. elegans genome, the interacting partners 
that produce different heteromeric receptors is not clearly defined. As heteromeric 
receptors consisting of different combinations of nAChR subunits are likely to have 
different pharmacological characteristics, they are also likely to play different 
biological roles. There is also overlap between the different types of heteromeric 
receptors formed, with some subunits being present in more than one subtype of 
heteromeric receptor. The composition of some of these receptors has been 
elucidated. A neuronal receptor comprising Cel-ACR-12, Cel-ACR-2, Cel-ACR-3, 
Cel-UNC-63 and Cel-UNC-38 has been identified (Jospin et al. 2009), although 
Cel-ACR-12 has also been identified as a member of a separate receptor type present 
in the GABAnergic neurons that drive relaxation of body-wall muscle (Petrash et al. 
2013). The nAChR present in body-wall muscle that is the target of levamisole 
comprises Cel-UNC-38, Cel-UNC-63, Cel-UNC-29, Cel-LEV-1 and Cel-LEV-8 (Fleming et 
al. 1997; Towers et al. 2005; Lewis et al. 1980). These five genes, along with genes 
encoding ancillary factors necessary for receptor assembly, are sufficient to produce 
functional receptors when expressed in Xenopus oocytes (Boulin et al. 2008). 
Heteromeric receptors may consist of a mix of α and non-α-subunits.  
Acetylcholine binds in a pocket formed between the positive face of an α-subunit and 
the negative face of a complementary subunit, which can be α or non-α. Much of the 
structural understanding of receptor binding came from work conducted on the 
acetylcholine binding protein, found in the snail Lymnaea stagnalis (Brejc et al. 2001). 
This protein lacks the transmembrane and intracellular domains of nAChRs, but is 
homologous to the extracellular binding domain (Smit et al. 2001). Other work in Mus 
musculus (mouse) nAChRs demonstrates that the binding pocket forms between the 
principal face of an α-subunit and the negative face of another subunit. The α-subunit 
is comprised of three loops (A-C). From loop A, residues W86 and Y93 contribute to 
ligand binding; loop B, residues W149,Y151 D152 and G153 and loop C, residues Y190, C192, 
C193 and Y198 (Arias 2000; Corringer, Le Novere and Changeux 2000). These residues are 
generally well conserved in nematode α-subunits, although there is some variation in 
Loop B (Figure 4-1b). 
The negative face contributes four loops (D-F). from loop D, residues W55 and E57 
contribute to forming the complementary face; loop E, residues L109, S111, C115, I116 Y117 
and from Loop F, residues F172, D174 and E183 (Arias 2000; Corringer, Le Novere and 
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Changeux 2000). These complementary face residues interacting with acetylcholine 
appear to be less well conserved in nematode nAChRs. Studies on the nematode 
binding pocket identify residues W55 and Q57 as important in loop D and A119 in Loop E 
of UNC-63 and W55 in loop D and V117 in Loop E of Cel-UNC-29 or Cel-LEV-1 (Bartos et 
al. 2009; Hernando et al. 2012). Loop F has not been modelled due to its sequence 
variation, so little is known about contribution of residues from this loop (Figure 4-1c) 
4.1.2 The neuromuscular system is a target for novel anthelmintic discovery 
Many anthelmintic drugs, such as pyrantel, levamisole and DMPP target the 
neuromuscular system, and it is an attractive target for novel anthelmintic discovery. 
Targeting the neuromuscular system allows paralysis to be induced in the parasite, 
which inhibits its ability to reach the host organism, and may lead to starvation. As 
there seems to be high diversity in the number of nAChRs in the different species of 
the phylum Nematoda, study of this group of receptor may allow novel targets to be 
identified. A summary of nAChRs identified in parasitic nematodes can be found in 
Holden-Dye et al. (2013). The nAChR complement in plant-parasitic nematodes has not 
been studied in detail, although some attention has been given to the neuromuscular 
targets for disrupting flp gene signalling (Kimber and Fleming 2005). 
The levamisole-sensitive nicotinic acetylcholine receptor (L-nAChR) is the most studied 
of these nAChRs and is one of three acetylcholine receptor types in body wall muscle 
of C. elegans (Jones and Sattelle 2004; Rufener et al. 2013; Touroutine et al. 2005). It is 
a heteromeric receptor comprising Cel-LEV-1, Cel-LEV-8, Cel-UNC-38, Cel-UNC-63 and 
Cel-UNC-29 (Lewis et al. 1980; Boulin et al. 2008). The anthelmintic levamisole targets 
this receptor by binding to and activating the receptor. It acts to paralyse the worm by 
prolonged activation of the muscle, leading to uncoordinated movement and 
ultimately hyper-contraction and paralysis of the worm. Mutation of any one of 
cel-unc-38, cel-unc-29 or cel-unc-63 leads to an uncoordinated phenotype and 
increased levamisole resistance in C. elegans, showing that they are essential for 
receptor formation and function. Mutation of cel-lev-1 or cel-lev-8 also confers partial 
resistance to levamisole, although they are non-essential to receptor formation 
(Towers et al. 2005; Culetto et al. 2004; Fleming et al. 1997). The precise arrangement 
of the subunits is not known, although potential arrangements as proposed in the 
literature are shown in Figure 4-1a. 
4.1.3 Expression analysis and transformation by bombardment 
Information about the expression patterns of genes can provide insight into their roles. 
Different nAChR subunits as members of different receptors, and are expressed in 
different locations within the nervous system. Expression pattern analysis may allow 
identification of which nAChR subunits are part of the same receptor and allow their 
role to be elucidated. C. elegans has been used as a heterologous expression system to 
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analyse spatial expression of plant-parasitic nematode genes using promoter-GFP 
fusions (Qin et al. 1998; Costa et al. 2009). In this chapter, the possibility of using 
promoters of the G. pallida nAChRs, in a similar way to infer spatial expression was 
explored. 
DNA transformation by microparticle bombardment is a method used to transform     
C. elegans and produces integrative transformants (Praitis et al. 2001). DNA is coated 
onto gold particles which are bombarded into worms using a “gene gun” producing 
transformants. Selection of transformants is mediated by the rescue of the mutant 
phenotype of the bombarded nematode strains. The unc-119(ed3) strain is typically 
used, which are severely uncoordinated, unable to form dauer larvae and dumpy in 
appearance (Maduro and Pilgrim 1995). The bombarded construct contains the 
unc-119 gene to facilitate rescue of the unc-119(ed3) phenotype and provide a method 
for identifying transformants. The construct also contains the promoter region of 
interest upstream of the coding region of GFP. Unlike microinjection, an alternate 
transformation method, bombardment generates low-copy transformants reducing 
the possibility of observed GFP expression being due to high copy numbers of a 
transgene. 
In this chapter, an overall bioinformatic survey of nAChRs in the G. pallida and    
G. rostochiensis genomes assemblies has been undertaken. Expansions or reductions in 
members of particular groups in comparison to C. elegans have been considered 
together with the impact that any such changes may have on the efficacy of 
anthelmintics. 
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nAChR 
subunit 
Group Type Comments 
Cel-UNC-38 UNC-38 α Part of Lev-sensitive receptor (Fleming 
et al. 1997) 
Cel-ACR-6 UNC-38 α (Mongan et al. 1998) 
Cel-UNC-63 UNC-38 α Part of Lev-sensitive receptor (Culetto 
et al. 2004) 
Cel-UNC-29 UNC-29 non-α Part of Lev-sensitive receptor (Fleming 
et al. 1997) 
Cel-ACR-2 UNC-29 non-α Operon with acr-3 (Squire et al. 1995) 
Cel-ACR-3 UNC-29 non-α Operon with acr-2 
Cel-LEV-1 UNC-29 non-α Part of Lev-sensitive receptor (Fleming 
et al. 1997) 
Cel-ACR-8 ACR-8 α (Mongan et al. 1998) 
Cel-LEV-8 ACR-8 α (Mongan et al. 1998) 
Cel-ACR-12 ACR-8 α (Mongan et al. 1998) 
Cel-ACR-16 ACR-16 α (Ballivet et al. 1996) 
Cel-ACR-7 ACR-16 α (Mongan et al. 1998) 
Cel-ACR-9 ACR-16 non-α (Mongan et al. 1998) 
Cel-ACR-10 ACR-16 α (Mongan et al. 1998) 
Cel-ACR-11 ACR-16 α (Mongan et al. 1998) 
Cel-ACR-14 ACR-16 non-α (Mongan et al. 1998) 
Cel-ACR-15 ACR-16 α (Mongan et al. 1998) 
Cel-ACR-19 ACR-16 α (Mongan et al. 2002) 
Cel-ACR-21 ACR-16 α (Mongan et al. 2002) 
Cel-EAT-2 ACR-16 non-α (McKay et al. 2004) 
Cel-DEG-3 DEG-3 α Operon with des-2 (Treinin et al. 1998) 
Cel-ACR-5 DEG-3 α (Mongan et al. 1998) 
Cel-ACR-17 DEG-3 α (Mongan et al. 1998) 
Cel-ACR-18 DEG-3 α (Mongan et al. 1998) 
Cel-ACR-20 DEG-3 α (Mongan et al. 1998) 
Cel-ACR-23 DEG-3 α (Mongan et al. 1998) 
Cel-DES-2 DEG-3 α Operon with deg-3 (Treinin et al. 1998) 
Cel-ACR-24 DEG-3 α Predicted 
Table 4: Summary of nAChR subunits in C. elegans 
Adapted from Wormbook. Subunits are categorised by group. Each group is named after the 
first member that was identified for it.  
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Figure 4-1: Schematics of the levamisole-sensitive nicotinic acetylcholine receptor of                
C. elegans 
a) Two schematics representing possible conformations of the C. elegans L-nAChR. Blue circles 
represent α-subunits, grey subunits represent non-α. Red circles represent inferred 
acetylcholine binding pocket. b) Residues from an α-subunit provide the principal face of the 
acetylcholine binding site with Loops A-C. Red boxes highlight residues involved in the             
M. musculus receptor and orange indicate equivalent residues in C. elegans subunits. 
Numbering is for the M. musculus α-subunit. c) Residues involved in providing the 
complementary faces of the acetylcholine binding site with Loops D and E. Red boxes highlight 
residues involved in M. musculus γ subunit and green boxes highlight residues from C. elegans 
subunits identified as being involved by modelling. Loop F is not shown as it could not be 
effectively modelled. Numbering is for the M. musculus γ subunit. 
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Aims 
 
• Investigate nicotinic acetylcholine receptor subunits of G. pallida 
 
• Identify differences which may affect diversity of receptors in G. pallida 
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 Materials and methods 4.2
All methods used for gene cloning and sequence analysis are described in 3.2. A table 
of primers used for cloning is found in Table 5. 
4.2.1 Identification of orthologues for other nematodes 
Sequences of C. elegans genes or proteins were obtained from Wormbase (Wormbase 
2009). Meloidogyne incognita genes were identified from the M. incognita genome at 
http://www.inra.fr/meloidogyne_incognita/sequencing. Meloidogyne hapla sequences 
were obtained from Wormbase. Ascaris suum and H. contortus sequences were 
obtained from the NCBI database. Bursaphelenchus xylophilus sequences were 
obtained from http://www.genedb.org/Homepage/Bxylophilus. Sequences of               
R. reniformis, Nacobbus aberrans, H. schachtii and H. avenae were obtained from 
preliminary transcriptome databases produced within this laboratory. 
Accession numbers for amino acid sequences used that are publically available are 
found in Table 6. 
4.2.2 Analysis of GFP expression regulated by nAChR promoters from G. pallida 
4.2.2.1 Production of expression vector 
An expression vector for this work was constructed to include the cbr-unc-119 gene, 
multiple restriction enzyme cloning sites and the coding region of GFP. The vector 
pPD95_75 (Addgene plasmid #1494) was selected for the backbone. Caenorhabditis 
briggsae unc-119 and its promoter region were obtained from the vector pPK719 
(Addgene 38149). The C. briggsae orthologue of the cel-unc-119 cassette was selected 
due to its shorter length than cel-unc-119. The cbr-unc-119 and promoter cassette was 
digested from pPK719 using restriction enzymes SalI and XbaI (NEB) in accordance with 
manufacturer’s recommendations. Vector pPD95_75 was digested with the same 
enzymes under the same conditions. Ligation reaction was carried out at a 4 (insert) to 
1 (vector) ratio in a 20 µl reaction as follows: T4 DNA ligase (NEB) (1 µl), vector (as 
calculated), insert (as calculated), 10x T4 Ligase buffer (2 µl), nuclease-free water (to 
20 µl). Ligation was conducted at 4°C for 16 hours. 2 µl of the ligation reaction was 
then transformed as described in 3.2.14.3. Plasmid DNA prepared from individual 
colonies was screened for the insert by restriction digest (SalI and XbaI) and confirmed 
by 3.2.14.6 (using M13R primer). This vector was termed GFPexpress. A restriction 
map of the vector can be seen in Figure 4-2. 
4.2.2.2 Cloning of promoter regions from gDNA 
Promoter regions of gpa-acr-2 and gpa-unc-63 were cloned from gDNA of G. pallida. A 
total of 2kb upstream sequence from the initiating methionine (or to the end of an 
upstream gene) was selected as the promoter region to produce a transcriptional 
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fusion. The promoter region was amplified as described in 3.2.13.3, and cloned into 
the pCR™8 vector as described in 3.2.14.2. Primers used for pgpa-acr-2 were: F: 
AATTCGCCCTTCCTCTCCCA and R: GCCCAACGATACTGCTGGAGAC and for pgpa-unc-63 
were: F: GTATTGGACTGAAGGTACTC and R: AAACTTTAAATGTTTTTTGGAC. The cloned 
promoter region was sequenced as described in 3.2.14.6. Appropriate restriction 
enzymes were selected for cloning into the expression vector and primers were 
designed with restriction sites tagged onto the end. The restriction enzymes XbaI and 
KpnI were used for both constructs. 
4.2.2.3 Production of expression clone 
Products produced in 4.2.2.2 were cloned into pGFPexpress (produced in 4.2.2.1) by 
restriction enzyme cloning as described in the previous sections. Restriction enzyme 
digestions were conducted as per manufacturer’s instructions. Positive clones were 
selected by colony PCR (3.2.14.4) using the gene-specific forward and GFP-REVchk 
primer (CAAATTTTCTGTCAGTGGAG).  
4.2.2.4 Gold particle preparation 
1 ml 70% ethanol was added to 30 mg gold particles (Sigma) and vortexed for 5 mins to 
suspend the particles. The particles were settled for 15 mins, then pulsed in a 
microcentrifuge to pellet. The supernatant was removed by pipetting then 70% 
ethanol was added, the tube vortexed for 1 min, settled for 1 min then pulsed in a 
centrifuge and the supernatant removed. This process was repeated a further two 
times. The pellet was resuspended in 500 µl sterile 50% glycerol. This preparation of 
gold particles was kept at 4 °C for up to 1 month.  
4.2.2.5 Preparation of plasmid for bombardment 
The expression clone produced in 4.2.2.3 was prepared for bombardment. 18 µl 
(minimum concentration 400 ng/µl) of each expression clone was linearised. 2.5 µl 
ApaI (NEB), 3.5 µl buffer and 11 µl Elga water was added to the plasmid, and digested 
at 37°C for 2 hours. On the day of bombardment, the gold beads prepared in 4.2.2.4 
were vortexed for 20 mins. For each construct to be bombarded, 70 µl of gold bead 
suspension was added to a non-stick 1.5 ml microfuge tube. The linearised expression 
clone was added to the gold beads, which were kept in suspension on a vortex mixer 
throughout the process. Two aliquots of 150 µl 2.5 M CaCl2 and 112 µl of 0.1 M 
Spermidine were added drop-wise to the tube. The tube was then vortexed for 5 mins 
and then pulsed in the centrifuge. The supernatant was removed by pipetting and the 
gold beads resuspended in 800 µl of 70% ethanol. The tube was pulsed again, the 
supernatant removed and the gold beads resuspended in 70 µl 100% ethanol. After 
this point, the tube was vortexed constantly to keep the beads in suspension until used 
for bombardments. 
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4.2.2.6 Preparation of unc-119 cultures 
The unc-119 (ed3) strain was used for microparticle bombardments. The phenotype of 
this line is uncoordinated movement, “dumpy” appearance and inability to survive 
dauer formation (Maduro and Pilgrim 1995). 
Unc-119 (ed3) worms were grown on 5 cm NGM-lite plates seeded with E. coli (HB101) 
for 2 weeks until mainly L1/L2s were present on the plates. These were used to start a 
liquid culture containing approximately 50,000 worms. 50 ml of M9 buffer was used, to 
which was added 150 µl 1M MgSO4, 300 µl 0.5M CaCl2 , 50 µl cholesterol (final 
concentration 8 µg/ml), 500 µl antibiotic mix (penicillin/streptomycin/neomycin final 
concentration 5/5/10 µg/ml), 50 µl Nystatin (final concentration 10 µg/ml) and 3 ml of 
HB101 food source. The worms were grown at 18 °C at 200 rpm, checked daily and 
additional E. coli added if appropriate, until the majority had reached the young adult 
life-stage. 
4.2.2.7 Growth of HB101 as food source for liquid culture 
HB101 was grown in 1.4 L cultures of Superbroth media (15.68 g K2HPO4, 2.89 g 
KH2PO4, 15 g bacto-tryptone, 30 g yeast extract, 10 ml 50% glycerol, 1.4 L distilled 
water – autoclaved). A 5 ml overnight culture of HB101 was inoculated into a 2 L flask 
containing 1.4 L Superbroth and grown at 37 °C for approximately 24 hours at 150 rpm. 
The culture was divided between 12 x 250 ml centrifuge bottles and centrifuged at 4 °C 
and 8000 x g for 8 mins. Each E. coli pellet was resuspended in 6 ml M9 by shaking at 
200 rpm for 15 minutes. The resulting suspension was transferred to a 15 ml sterilin 
tube and frozen at -20 °C. When required, this was defrosted and used as a food 
source for liquid cultures of C. elegans.  
4.2.2.8 Microparticle bombardment of unc-119(ed3)  
Liquid cultures containing young adults (as cultured in 4.2.2.6) were poured into 50 ml 
Polypropylene tubes and allowed to settle at room temperature for 10 mins. Older 
worms (young adults) would settle to the bottom of the tube during this time and 
were collected for use in bombardments. The supernatant was transferred to a fresh 
tube and transferred to ice where the younger worms were allowed to settle for 20 
minutes. The younger worms were collected and stored in order to set up subsequent 
liquid cultures of C. elegans. 1 ml of young adult C. elegans was applied between seven 
target regions on a 9 cm NGM-lite plate seeded with E. coli (HB101). The prepared DNA 
from 4.2.2.5 was applied evenly between seven macrocarrier discs (Bio-Rad) which had 
previously been cleaned by dipping in isopropanol. The macrocarrier discs were loaded 
into the bombardment compartment with a stopping screen and rupture disc (1350 
psi, Bio-Rad). The hepta-adaptor (PDS100/ HE system, Bio-Rad) was secured inside the 
chamber, and all components were aligned so that the gas acceleration tube was 
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directly above a macrocarrier disc and worm target. The Biolistics system used was 
PDS-1000-HE Biolistic® Particle Delivery System. A vacuum inside the chamber was 
established (27 inHg) and a shot was fired. 1 ml M9 buffer was applied to each 
bombarded plate, and the nematodes left to recover for 1-2 hours. Subsequently, 4 ml 
of M9 buffer was used to wash worms from the bombarded plate and distribute them 
evenly across 8 seeded 9 cm NGM-Lite plates. 
4.2.2.9 Selection of positive transformants 
Bombarded worms were allowed to starve for 4-5 weeks at 20°C before selection. A 
section of NGM-lite seeded with HB101 was placed face-up on the starved lawn of 
each bombardment plate and left for 16 hours. Transformed worms will have survived 
dauer formation and will move like wild-type (fast and coordinated) and will 
congregate on the new source of food. Non-transformed uncoordinated worms will 
not be able to reach the new food source. Four transformed worms from each plate 
were taken and transferred individually to a 5 cm seeded NGM-lite plate.  
4.2.2.10 Visualization and photography of GFP expression 
Transformed worms were mounted on 4% agarose pads and immobilised with 25 mM 
sodium azide. A coverslip was applied and sealed with varnish. For each line, 
approximately 15 worms were observed and representative images of GFP expression 
taken. For all lines, a 5s exposure time was used to capture images. Leica Leitz DMRB 
binocular microscope with GFP filters were used for visualisation. Images were 
captured with QCapture Pro 6 software. 
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Gene Primer Sequence 
gpa-acr-12 
 
F: GCGATGATTGCCATTGCCA 
R: CCATTCATTTATTCCGCCGTT 
 
 
gpa-acr-2 
 
F: GCTCAAATTGGTTATTTGTCC 
R: GCGCTTTAATTGGGACAGAA 
 
gpa-acr-3 
 
F: GGCGACGGATGAAAAGAA 
R: CTTTTCCCCCAATTTTGCGC 
 
gpa-acr-6 
 
F: GTTTGGGGAATGCCTTTCC 
R: GGCGGGTGTTTAACTCAAAA 
 
gpa-acr-8 
 
F:AATGCCTCGGGGCTTTGC 
R: GGGTAAGCAATCACAGAATG 
 
gpa-unc-29.1 
 
F: GGTTACAATTCTCTGATCCAA 
R: GTTCGATTAAAACAATTGGT 
 
gpa-unc-29.2 
 
F: TCGGTTCAAATGATTGACAACG 
R: GGTAACGCCGAAGAAAACGT 
 
gpa-unc-38.1 
 
F: CTGATGGTCTATCACCGGAA 
R: GGTATATGCAAACAATATGCTTT 
 
gpa-unc-38.2 
 
F: AGAAACAATTGGCGCGAAGT 
R: GTTGCGCAGTTTCACCAGTA 
 
gpa-unc-63 
 
F: TGCCGCTTTATGCCGACC 
R: CAACAACAAATCGAATAATGCG 
Table 5: Primers used for amplification of nAChR subunit-encoding genes 
 
 
 
 
 
 
103 
 
Gene Species Accession Number Source 
cel-unc-38 C. elegans WP:CE24908  Wormbase 
bbr-unc-38 C. briggsae CAP37493 NCBI 
mha-unc-38 M. hapla MhA1_Contig1335.frz
3.fgene2 
http://www.wormbase.org/ 
species/m_hapla#043--10 
min-unc-38 M. incognita Minc17141 http://www6.inra.fr/meloidogy
ne _incognita/Meloidogyne 
asu-unc-38 A. suum ABS95448 NCBI 
hco-unc-38 H. contortus HCOI01939400.t1 NCBI 
ode-unc-38 O. dentatum AFY08299 NCBI 
cel-acr-2 C. elegans WP:CE07380  Wormbase 
cel-acr-3 C. elegans WP:CE28345 Wormbase 
cel-lev-1 isoform a C. elegans WP:CE24888 Wormbase 
cel-unc-29 C. elegans WP:CE13451  Wormbase 
cel-acr-6 C. elegans WP:CE46851  Wormbase 
cel-unc-63 C. elegans WP:CE30706 Wormbase 
cel-acr-12 C. elegans WP:CE29334  Wormbase 
cel-acr-8 C. elegans WP:CE36679  Wormbase 
acetylcholine 
receptor subunit 
alpha precursor 
M. musculus NP_031415 
 
NCBI 
acetylcholine 
receptor subunit 
gamma precursor 
M. musculus NP_033734 
 
NCBI 
Table 6: Sources for amino acid sequence for subunits of nAChRs identified in other 
nematode species 
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Figure 4-2: Vector map of pGFPexpress 
Expression vector contains the cbr-unc-119 gene and its promoter region and terminator and 
the coding region for GFP. A multiple cloning site is present upstream of GFP to allow insertion 
of a promoter region. Other restriction sites present facilitate linearisation of the vector. The 
vector also contains an ampicillin resistance gene. 
artificial intron 2264..2305
pGFPexpress vector
6689 bp
ColE1 origin 5494..6176
GFP(65C) 2336..3202
AmpR 4737..5396
cbr-unc-119  43..2232
M13-rev 6544..6564
LacO 6516..6538
M13-RevM13-Rev
AmpR
GFP
Artificial i tron
Cbr-unc-119
ColE 1 Ori
LacO
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 Results 4.3
4.3.1 Complement of all known nicotinic acetylcholine receptors in G. rostochiensis 
and G. pallida 
Orthologues of genes known to encode nicotinic acetylcholine receptors in C. elegans 
(cel-genename) were searched for in the genome assemblies of G. pallida and              
G. rostochiensis. In order to identify possible novel nAChR genes, all genes with 
features of a cys-loop receptor were analysed.  
There is a reduction in orthologues of the ACR-16 group, with orthologues for only four 
of the ten members of this group having orthologues in G. pallida and G. rostochiensis. 
Orthologues for most members of the DEG-3 group could be identified, except for 
cel-acr-23 and cel-acr-18.  
Orthologues of the genes (cel-unc-29, cel-unc-63, cel-unc-38, cel-lev-1 and cel-lev-8) 
that comprise the levamisole-sensitive nicotinic acetylcholine receptor were of 
particular interest. Multiple orthologues were found for some genes, whilst other 
genes do not have orthologues in the two Globodera species. All other members of the 
UNC-38, UNC-29 and ACR-8 groups have identified orthologues in G. pallida and          
G. rostochiensis (Table 7). 
The members of the UNC-38, UNC-29 and ACR-8 groups were selected for further 
analysis, and were cloned from G. pallida. Bioinformatic data has been used 
throughout this chapter for the G. rostochiensis orthologues. Genes identified in           
G. pallida and G. rostochiensis were termed gpa-genename and gro-genename 
respectively. The loops and cys-loop characteristic of this subunit class were present in 
the predicted amino acid sequence of all cloned genes. 
4.3.2 Orthologues of components of the levamisole-sensitive nicotinic 
acetylcholine receptor of C. elegans 
4.3.2.1 Orthologues of cel-lev-1 and cel-lev-8 could not be identified 
Orthologues of cel-lev-1 and cel-lev-8 were not identified in G. pallida or                         
G. rostochiensis in any of the databases available for searching. This included 
transcriptome data and unassembled 454 reads to allow for the possibility that the 
genes may not have been assembled correctly into the finalised genome assemblies. 
4.3.2.2 Two orthologues of Cel-UNC-29 are present 
Two orthologues for cel-unc-29 were identified in both G. pallida and G. rostochiensis. 
Both genes were identified as good candidates for cel-unc-29 and both returned 
cel-unc-29 as the best hit using the RBH method. There is 66% identity between the 
predicted amino acid sequences of the two orthologues of cel-unc-29 cloned for             
106 
 
G. pallida (Figure 4-3). These two orthologues are also identified in G. rostochiensis. As 
it is not clear due to lack of functional testing if both these genes are functional 
orthologues of cel-unc-29, or if they are paralogues of each other, the terminology 
gpa-unc-29.1 and gpa-unc-29.2 has been adopted. 
Between Cel-UNC-29 and Gpa-UNC-29.1, the identity is 68% and between Cel-UNC-29 
and Gro-UNC-29.1 the identity is 67%. A signal peptide cleavage site between amino 
acids 24 and 25 and four transmembrane domains are identified. Cel-UNC-29 is a 
non-α-subunit, and may contribute as the negative face of the binding pocket. 
Residues involved in forming the negative face are present (Figure 4-4) 
Between Cel-UNC-29 and Gpa-UNC-29.2, identity is 68%. Between Cel-UNC-29 and 
Gro-UNC-29.2, the identity is 67%. However, the start of this gene is unclear. A clone 
from cDNA generates an amino acid product that is not predicted to encode a signal 
peptide. There is another methionine at residue 19 in the amino acid chain that, if 
taken to be the initiating methionine, does result in a signal peptide being predicted 
for Gpa-UNC-29.2, which is the case for Gro-UNC-29.2 as well. Additionally, for both 
Gpa-UNC-29.2 and Gro-UNC-29.2, only three transmembrane domains are predicted in 
the correct positions. A fourth transmembrane domain is predicted at the N-terminus 
of the amino acid chain, but this is potentially a signal peptide and is not in an 
expected position for a transmembrane domain in this class of protein. Characteristics 
of a non-α-subunit were identified (Figure 4-5). 
4.3.2.3 An orthologue of cel-unc-63 is present 
Amino acid identity between Cel-UNC-63 and Gpa-UNC-63 is 65%. And between 
Cel-UNC-63 and Gro-UNC-63 the amino acid identity is 66%. There are some 
differences between the sequence of the cloned gpa-unc-63 and the gro-unc-63 which 
has been bioinformatically identified. The main difference is in the predicted 
N-terminal amino acid sequence. The gene model in G. rostochiensis predicts 50 
additional amino acids at the start of the protein sequence. It is not clear which 
prediction is correct or if these genes differ between G. pallida and G. rostochiensis. A 
signal peptide is not predicted for either Gpa-UNC-63 or Gro-UNC-63. Four 
transmembrane domains are predicted for both Gpa-UNC-63 and Gro-UNC-63. There is 
a region of amino acids approximately 100 amino acids into Gpa-UNC-63 and 
Gro-UNC-63 which may indicate a residual signal peptide (Figure 4-6) 
Cel-UNC-63 is an α-subunit. Residues involved in forming the principal binding site 
were identified in the sequence of Gpa-UNC-63 and Gro-UNC-63. Cel-UNC-63 has been 
hypothesised to contribute to the negative face of the binding pocket in some 
arrangements of the receptor, and most residues involved in binding the 
complementary face were also identified. However the alanine at position 119 in 
Cel-UNC-63 is replaced by a threonine in Gpa-UNC-63 and Gro-UNC-63.  
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4.3.2.4 Two orthologues of Cel-UNC-38 are present both with differences in key 
residues 
Two orthologues of cel-unc-38 were cloned from G. pallida and these were also 
identified in the genome of G. rostochiensis. The identity between the two orthologues 
identified in G. pallida is 54% (Figure 4-7). 
The first orthologues identified for each species were termed gpa-unc-38.1 and 
gro-unc-38.1. The amino acid identity between Cel-UNC-38 and Gpa-UNC-38.1 is 56% 
and between Cel-UNC-38.1 and Gro-UNC-28.1 the amino acid identity is 57%. A signal 
peptide cleavage site is predicted between amino acids 23 and 24 in Gpa-UNC-38.1 
and Gro-UNC-38.1. Four transmembrane domains are predicted.  
Cel-UNC-38 is an α-subunit. However, there are key differences in the amino acid 
sequence of Gpa-UNC-38.1 and Gro-UNC-38.1. In Loop A, where in Cel-UNC-38 a 
tyrosine residue is involved in acetylcholine binding, an isoleucine is present in both 
Gpa-UNC-38.1 and Gro-UNC-38.1. Loop B also differs in amino acid sequence between 
Cel-UNC-38 and Gpa-UNC-38. In particular, the YxxCC motif that defines α-subunits is 
absent from Loop C of Gpa-UNC-38 and Gro-UNC-38. The equivalent of Y198 is present 
in Loop C (Figure 4-8) 
A second orthologue of cel-unc-38 was also identified. The amino acid identity 
between Cel-UNC-38 and Gpa-UNC-38.2 is 58%. Between Cel-UNC-38 and 
Gro-UNC-38.2 the identity is 55%, although some data is missing for the sequence of 
Gro-UNC-38.2 in the second transmembrane domain region, due to incomplete 
genome assembly. A signal peptide cleavage site between amino acids 21 and 22 and 
four transmembrane domains are predicted. 
The tyrosine involved in binding in loop A is present. The loop B region differs from 
Cel-UNC-38, although the glutamate residue of loop B is predicted to be present in                  
G. rostochiensis, but not in G. pallida. In Loop C, the tyrosine (Y190) of the YxxCC motif is 
present, but the vicinal cysteines are absent. The equivalent of Y198 in Loop C is absent 
(Figure 4-9). 
In both cel-unc-38 orthologues identified from the plant-parasitic nematodes these 
variations in amino acid identities at key positions may have an impact on agonist 
binding. 
4.3.3 The UNC-29 group of nAChR subunits 
In C. elegans, the UNC-29 group comprises Cel-UNC-29, Cel-LEV-1, Cel-ACR-2 and 
Cel-ACR-3. Orthologues of cel-unc-29 and cel-lev-1 are discussed above. The 
orthologues of the remaining members were cloned from G. pallida, and identified in 
G. rostochiensis and were analysed further.  
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4.3.3.1 The acr-2 acr-3 operon structure is an example of synteny between the        
C. elegans, G. pallida and G. rostochiensis genome 
Cel-acr-2 and cel-acr-3 in C. elegans are found in an operon-like structure with 
cel-acr-3 located approximately 280 bp downstream of cel-acr-2 (Figure 4-10b) (Baylis 
et al. 1997). G. pallida and G. rostochiensis orthologues for both cel-acr-2 and cel-acr-3 
have been identified. A similar gene order and distance is present in both G. pallida 
and G. rostochiensis, although the distance between gpa-acr-2 and gpa-acr-3 is 
approximately 100 bp shorter. In the genome assemblies of both species the 
orthologues of cel-acr-2 and cel-acr-3 are predicted as a single gene. In both G. pallida 
and G. rostochiensis, gpa/gro-unc-29.1 is located approximately 400 bp downstream of 
gpa/gro-acr-3 (Figure 4-10c). In C. elegans, an unrelated gene cel-nas-11, is located 
downstream of cel-acr-3. It may be that the gpa/gro-unc-29.1 is also in an operon with 
gpa/gro-acr-2 and gpa/gro-acr-3 in G. pallida and G. rostochiensis. 
4.3.3.2 The orthologue of cel-acr-2 is present as a full-length gene  
Between Cel-ACR-2 and Gpa-ACR-2 the amino acid identity was 51%, and between 
Cel-ACR-2 and Gro-ACR-2 the amino acid identity was 49%. A signal peptide cleavage 
site was predicted between position 20 and 21 in both G. pallida and G. rostochiensis 
and four transmembrane domains are predicted (Figure 4-11). Cel-ACR-2 is a 
non-α-subunit and the sequence of Gpa-ACR-2 contains sequences associated with 
contributing to the complementary face of the acetylcholine binding pocket.  
4.3.3.3 Orthologue of Cel-ACR-3 may lack a signal peptide 
The percentage identity between Cel-ACR-3 and Gpa-ACR-3 or Gro-ACR-3 was 58% and 
60% respectively. Four transmembrane regions were predicted. A signal peptide could 
not be identified in Gpa-ACR-3 (Figure 4-12). Gpa-acr-2 and gpa-acr-3 is predicted as a 
single gene in G. pallida, but primers designed to amplify this whole region did not 
produce a product. Primers were then designed to amplify gpa-acr-2 and gpa-acr-3 
separately based on homology to cel-acr-2 and cel-acr-3. On analysis, sequence 
contributing to the beginning of gpa-acr-3 could be found at the end of the gpa-acr-2 
clone. Additionally, at the beginning of the gpa-acr-3 clone, the end of gpa-acr-2 could 
be found. This allowed the region between gpa-acr-2 and gpa-acr-3 to be 
concatenated. Homology between Gpa-ACR-3 and Cel-ACR-3 was high at the 
N-terminal end, although Gpa-ACR-3 lacked a signal peptide. Multiple stop codons are 
found between the end of Gpa-ACR-2 and the beginning of Gpa-ACR-3 with no 
evidence of a signal peptide (Figure 4-10a). Bioinformatic analysis of the region 
between gro-acr-2 and gro-acr-3 in the G. rostochiensis genome assembly also yielded 
the same presence of stop codons and absence of a signal peptide. 
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Cel-ACR-3 is a non-α-subunit. The sequence of Gpa-ACR-3 contains the residues 
associated with forming the complementary face of acetylcholine binding pocket 
(Figure 4-12). 
4.3.4 The UNC-38 group of nAChRs 
In C. elegans, the UNC-38 group comprises Cel-UNC-38, Cel-UNC-63 (discussed above) 
and Cel-ACR-6. An orthologoue for the remaining member of this group cel-acr-6 was 
cloned from G. pallida and identified in G. rostochiensis. Percentage identity between 
Cel-ACR-6 and Gpa-ACR-6 was 45%, and between Cel-ACR-6 and Gro-ACR-6 the 
percentage identity was 44%. A signal peptide cleavage site is predicted between 
positions 24 and 25 and four transmembrane regions are predicted (Figure 4-13). 
Cel-ACR-6 is an α-subunit. The sequences of Gpa-ACR-6 and Gro-ACR-6 contain all the 
residues associated with providing the positive face of the acetylcholine binding 
pocket. 
4.3.5 The ACR-8 group of nAChRs 
The C. elegans ACR-8 group comprises Cel-ACR-8, Cel-LEV-8 and Cel-ACR-12. An 
orthologue of Cel-LEV-8 was not found. Gpa-acr-8 and Gpa-acr-12 were cloned from        
G. pallida and identified in G. rostochiensis. 
4.3.5.1 Orthologues of Cel-ACR-8 and Cel-ACR-12 are present 
Percentage identity between Cel-ACR-8 and Gpa-ACR-8 was 54% and between 
Cel-ACR-8 and Gro-ACR-8 was 53%. A signal peptide cleavage site is predicted between 
position 25 and 26 and four transmembrane domains are predicted (Figure 4-14). 
Cel-ACR-8 is an α-subunit. The sequence of Gpa-ACR-8 and Gro-ACR-8 contain the 
same residues associated with providing the positive face of the acetylcholine binding 
pocket as Cel-ACR-8.  
The percentage identity between Cel-ACR-12 and Gpa-ACR-12 was 57% and between 
Cel-ACR-12 and Gro-ACR-12 was 56%. A signal peptide cleavage site is predicted 
between position 21 and 22 and four transmembrane domains are predicted (Figure 
4-15). Cel-ACR-12 is an α-subunit. The sequences of Gpa-ACR-12 and Gro-ACR-12 
mostly contain the same residues associated with providing the positive face of the 
acetylcholine binding pocket as Cel-ACR-12, however the equivalent residue of Y198 in 
Cel-ACR-12 is a phenylalanine residue in Gpa-ACR-12 and Gro-ACR-12.  
4.3.6 nAChR subunit genes are most highly expressed at life stages involved in 
locomotion or host-sensing 
Expression data obtained from RNASeq from life-stages of G. pallida show that the 
nAChR subunit genes identified are most highly expressed in the eggs, J2s and males. 
Expression in sedentary stages is generally low, although gpa-acr-8 expression remains 
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relatively high at 7dpi (Figure 4-17). The expression of gpa-acr-2 and gpa-acr-3 is 
shown together as gene prediction algorithms predicted this as a single large gene. 
Expression data for gpa-unc-38.2 was unavailable, as this was not predicted in the 
initial gene prediction sets. 
4.3.7 Phylogeny of genes and in the UNC-38, UNC-29 and ACR-8 groups 
A phylogenetic tree was generated from C. elegans, G. pallida and G. rostochiensis 
subunits from these groups in order to demonstrate that the orthologues identified in 
G. pallida and G. rostochiensis, cluster with their predicted C. elegans orthologue and 
within their predicted group. Gpa-UNC-29.1 and Gpa-UNC-29.2 are predicted to share 
a common ancestor, and possibly result from gene duplication. Gpa-UNC-38.1 and 
Gpa-UNC-38.2 are also predicted to share a common ancestor (Figure 4-16). 
4.3.8 Promoters of nAChRs from G. pallida are functional in C. elegans 
As composition of the L-nAChR of G. pallida is likely to differ from that of C. elegans, a 
method was sought to analyse the expression pattern of nAChR genes identified in   
G. pallida in order to determine where in the nervous system they are expressed. Due 
to an absence of transgenic techniques for G. pallida, the use of C. elegans as a 
heterologous system to analyse the expression pattern of GFP regulated by promoter 
regions of nAChRs from G. pallida was explored. 
Successful transformants were generated for the promoter regions of gpa-acr-2 and 
gpa-unc-63. As cel-acr-2 is part of the neuronal nAChR (Jospin et al. 2009) and 
cel-unc-63 is part of the muscle nAChR (Boulin et al. 2008), the promoter regions of 
orthologues of these genes from G. pallida were selected to examine the difference in 
their expression patterns. 
GFP expression from all transgenic reporter lines was low, indicated by the low-level of 
GFP fluorescence. The auto-fluorescence observed in the gut of the N2 controls is not 
GFP expression, and is probably due to the presence of gut granules (Coburn and Gems 
2013). For reference, auto-fluorescence of untransformed worms is shown in Figure 
4-18. 
In contrast, GFP expression of lines carrying pgpa-acr-2 from G. pallida was observed 
along the ventral nerve cord and in the region around the pharyngeal bulb (nerve ring). 
This expression was observed at all life stages, but was particularly clear in the younger 
worms (L1-L3s) (Figure 4-19a). When the nematode is orientated with the vulva facing 
upwards, faint GFP expression can be seen across the ventral nerve cord punctuated 
with distinct clusters of GFP expression. Very faint extensions across to the dorsal side 
of the body can be seen which may be the commissures which link the ventral nerve 
cord to the dorsal cord (Figure 4-19b). This pattern of GFP expression in the pgpa-acr-2 
line was consistent across worms and lines examined. 
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The GFP expression of the pgpa-unc-63 line was more variable between individual 
worms observed. In some, GFP expression was clustered around the pharyngeal bulb 
(Figure 4-20a). In others, GFP expression is observed along the ventral side of the body 
and in two paired points in the tail region (Figure 4-20b). It is difficult to determine if 
the expression of GFP in the pgpa-unc-63 line is in the ventral nerve cord or in the 
body wall muscle. The differences observed in expression of pgpa-unc-63:GFP did not 
correlate with different life-stages. 
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nAChR 
subunit 
Group Type In G. pallida? 
 
In G. rostochiensis? 
Cel-UNC-38 UNC-38 α Y (2) Y (2) 
Cel-ACR-6 UNC-38 α Y (1) Y (1) 
Cel-UNC-63 UNC-38 α Y (1) Y (1) 
Cel-UNC-29 UNC-29 non-α Y (2) Y (2)  
Cel-ACR-2 UNC-29 non-α Y (1) Y (1) 
Cel-ACR-3 UNC-29 non-α Y (1) Y (1)  
Cel-LEV-1 UNC-29 non-α N N  
Cel-ACR-8 ACR-8 α Y (1) Y (1) 
Cel-LEV-8 ACR-8 α N  N  
Cel-ACR-12 ACR-8 α Y (1) Y (1) 
Cel-ACR-16 ACR-16 α Y (1) Y (1)  
Cel-ACR-7 ACR-16 α N N 
Cel-ACR-9 ACR-16 non-α N N 
Cel-ACR-10 ACR-16 α N N 
Cel-ACR-11 ACR-16 α N N 
Cel-ACR-14 ACR-16 non-α N N 
Cel-ACR-15 ACR-16 α N N 
Cel-ACR-19 ACR-16 α Y (1) Y (1)  
Cel-ACR-21 ACR-16 α Y (1) Y (1) 
Cel-EAT-2 ACR-16 non-α Y (1) Y (1) 
Cel-DEG-3 DEG-3 α Y (1) Y (1)  
Cel-ACR-5 DEG-3 α Y (1) Y (1) 
Cel-ACR-17 DEG-3 α Y (1) Y (1) 
Cel-ACR-18 DEG-3 α N N 
Cel-ACR-20 DEG-3 α Y (1) Y (1)  
Cel-ACR-23 DEG-3 α N N 
Cel-DES-2 DEG-3 α Y (1) Y (1)  
Cel-ACR-24 DEG-3 α Y (1) Y (1) 
Table 7: Summary of orthologues of C. elegans nAChR genes identified in G. pallida and                     
G. rostochiensis 
Number in brackets indicates the number of orthologues found in each species. 
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Figure 4-3: Alignment of Cel-UNC-29 with Gpa-UNC-29.1 and Gpa-UNC-29.2 
Predicted signal peptide cleavage sites shown by a red arrow. Regions contributing to loops are 
labelled with a black bar above residues. Residues involved in providing the complementary 
face to agonist binding are highlighted with green boxes. Cysteines involved in forming the 
cys-loop are highlighted with yellow boxes. Transmembrane regions predicted by TMHMM are 
highlighted by red boxes. 
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Figure 4-4: Alignment of Cel-UNC-29 with Gpa-UNC-29.1 and Gro-UNC-29.1 
Red arrows indicate predicted signal peptide cleavage location. Regions contributing to loops 
are labelled with a black bar above residues. Residues involved in providing the 
complementary face to agonist binding are highlighted with green boxes. Cysteines involved in 
forming the cys-loop highlighted with yellow boxes. Transmembrane regions predicted by 
TMHMM are highlighted by red boxes and labelled.  
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Figure 4-5: Alignment of Cel-UNC-29 with Gpa-UNC-29.2 and Gro-UNC-29.2 
Red arrow indicates predicted signal peptide cleavage location. Purple box indicates possible 
signal peptide in Gpa-UNC-29.2 and Gro-UNC-29.2 sequence. Regions contributing to loops are 
labelled with a black bar above residues. Residues involved in providing the complementary 
face to agonist binding are highlighted with green boxes. Cysteines involved in forming the 
cys-loop are highlighted with yellow boxes. Transmembrane regions predicted by TMHMM are 
highlighted by red boxes. 
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Figure 4-6: Alignment of Cel-UNC-63 with Gpa-UNC-63 and Gro-UNC-63 
Red arrows indicate predicted signal peptide cleavage site. Purple box indicates possible 
residual signal peptide sequence in Gpa-UNC-63 and Gro-UNC-63. Regions contributing to 
loops are labelled with a black bar above residues. Residues involved in providing the principal 
face of agonist binding are highlighted in orange. Residues involved in providing the 
complementary face to agonist binding are highlighted with green boxes. Cysteines involved in 
forming the cys-loop are highlighted with yellow boxes. Transmembrane regions predicted by 
TMHMM are highlighted by red boxes and labelled. 
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Figure 4-7: Alignment of Cel-UNC-38 with Gpa-UNC-38.1 and Gp-UNC-38.2 
Red arrow indicates predicted signal peptide cleavage site. Regions contributing to loops are 
labelled with a black bar above residues. Residues involved in providing the principal face of 
agonist binding are highlighted in orange. Residues involved in providing the complementary 
face to agonist binding are highlighted with green boxes. Blue box highlights differences in the 
Loop C region in both G. pallida orthologues compared to the Ce-UNC-38. Purple box highlights 
residue changes in loop B which may affect levamisole sensitivity. Cysteines involved in 
forming the cys loop highlighted with yellow boxes. Transmembrane regions predicted by 
TMHMM are highlighted by red boxes and labelled. 
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Figure 4-8: Alignments of Cel-UNC-38 with Gro-UNC-38.1 and Gro-UNC-38.1 
Red arrow indicates predicted signal peptide cleavage site. Regions contributing to loops are 
labelled with a black bar above residues. Residues involved in providing the principal face of 
agonist binding are highlighted in orange. Residues involved in providing the complementary 
face to agonist binding are highlighted with green boxes. Blue box highlights differences in the 
Loop C region, where the YxxCC motif is absent. Purple box highlights residue changes which 
may affect levamisole sensitivity. Cysteines involved in forming the cys-loop highlighted with 
yellow boxes. Transmembrane regions predicted by TMHMM are highlighted by red boxes and 
labelled. 
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Figure 4-9: Alignments of Cel-UNC-38 with Gpa-UNC-38.2 and Gro-UNC-38.2 
Some data is missing for Gro-UNC-38 sequence between residue 303 and 313. Red arrow 
indicates predicted signal peptide cleavage site. Regions contributing to loops are labelled with 
a black bar above residues. Residues involved in providing the principal face of agonist binding 
are highlighted in orange. Residues involved in providing the complementary face to the 
agonist binding are highlighted with green boxes. Blue box highlights differences in the Loop C 
region, where the YxxCC motif is absent. Purple box highlights residue changes which may 
affect levamisole sensitivity. Cysteines involved in forming the cys-loop are highlighted with 
yellow boxes. Transmembrane regions predicted by TMHMM are highlighted by red boxes and 
labelled. 
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Figure 4-10: Schematics of the acr-2 acr-3 operon in C. elegans and G. pallida 
a) Translated sequence from cDNA of the gpa-acr-2 gpa-acr-3 region from G. pallida. Dark blue 
shading highlights open reading frames. Light blue shading highlights region with sequence 
homology to cel-acr-3. Unhighlighted sequence contains stop codons indicated by *. b-c) 
Schematic order of genes from b) C. elegans and c) G. pallida. Black box indicates presence of 
signal peptide. Red box indicates stop codon. Distances between genes are genomic distances. 
Intron/exon boundaries are not represented. The gene structure is the same in G. rostochiensis 
as in G. pallida. 
MSLFGILLPFLAGILNGSNGVTFSTDSGHPPSTVRSPLYANNEDEERLGIDLFRGY
NALIRPSPCQNSSVVHVDFGMAMILLINVDEKNQIMQSNVWLTLRWNDCRFAWSPA
DYGGLESLRVPVDRVWVPDIVLFNNADGNYEVSYQSNVVVDHQGNVSWVPPAIYKS
SCRIDVEYFPFDEQTCVLLFGSWTYGSDEVQLRWYNNRRFVELEDYSPSGIWDLMD
VPGRMSADRSRIAFYIVIRRKTLFYTVILIIPTVLMAFLSMLAFYLPAECSEKITL
AISILLALVVFLLLGSKILPPTSDTIPLMAKYLLMTFVLNIVTIVSTVAVINVYFR
SAITHTMPGWVRHLFLHLLPTLLAMKRPRQREMFRGTSVEEYQATANAEPAEPEGL
DTNLAMGPSTMAATMLPFLGQIGSVAHQKRQSWRQKSRRQRQKRRSDELDEAAEAD
DAAASPASSSLRSLSRSPSPLPQLMRRSWTGANLSMTGGGPRRGNRQICAQITGMM
DEQRMSKKLRLTIEAIAFIAEHIKAEMSDKKVRDDWRFISMVVDRVLLLLFFGITL
GGTIGILFSVPHAFELVDQQDILRRLSVRAQQLEGDG*KEMEFDRNLNSIFCFLSQ
LKPIFEVVPIRLGQKSATQF*RLQ*KYTNSVITSDVEERLIADLFRGYNHLIRPVL
NVSSTPLEIRFSLALTLLINVDEKNQIMQTNVWPTMRWVDYQMQWNPLEYGNIRTI
RVPPDKVWLPDIVLFNNADGNYEVSFYSNVVVEHNGEMLWVPPAIYKSSCIIDVEF
FPFDEQICAMIFGSWTFNKDEVVISYLNNKRQAELNDYSESGIWDIMEVPGQLIHQ
KSKIAYQIRIRRKTLFYTVILIIPVILIIPTVLMAFLSMLVFYLPAEADEKITLAI
SILLALVVFLLLVSKILPPTSDTIPLIAKYLLMTFVMNIITILVTVIIINIYFRGP
TTHTMPEWVRTEFLRYLPLFLMMNRPRRDSSEDPVGVAINRPGAHKSRLNAKAIKR
QNVGRNSISSFLGNTEDGIELGERARSQRQLRFMPGQFIEMSHSRREIRHHPRCSE
YAAATEAVQRRVDHLRRRRMSQPVITPARFPTHRDLGSDLSDMLTDQALQALDAVE
YITEHLRRDNLDKKIREQWKFVAMVIDRLLLYVFFGVTAGGTMGILFSAPNVFEYV
NQTAVIEELKRTAEAEMNL*
gpa-acr-2 gpa-acr-3 gpa-unc-29.1
~400 bp
~180 bp
cel-acr-2 cel-nas-11cel-acr-3
~280 bp ~650 bp
b
a
c
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Figure 4-11: Alignment of Cel-ACR-2 with Gpa-ACR-2 and Gro-ACR-2 
Red arrow indicates predicted signal peptide cleavage location. Regions contributing to loops 
are labelled with a black bar above residues. Residues involved in providing the 
complementary face to the agonist binding are highlighted with green boxes. Cysteines 
involved in forming the cys-loop are highlighted with yellow boxes. Transmembrane regions 
predicted by TMHMM are highlighted by red boxes and labelled.  
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Figure 4-12: Alignment of Cel-ACR-3 with Gpa-ACR-3 and Gro-ACR-3 
Red arrow indicates predicted signal peptide cleavage location. Signal peptide is missing for 
Gpa-ACR-3 and Gro-ACR-3. Regions contributing to loops are labelled with a black bar above 
residues. Residues involved in providing the complementary face to the agonist binding site 
are highlighted with green boxes. Cysteines involved in forming the cys-loop are highlighted 
with yellow boxes. Transmembrane regions predicted by TMHMM are highlighted by red 
boxes and labelled. 
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Figure 4-13: Alignment of Cel-ACR-6 with Gpa-ACR-6 and Gro-ACR-6 
Red arrows indicate predicted signal peptide cleavage site. Regions contributing to loops are 
labelled with a black bar above residues. Residues involved in providing the principal face of 
the agonist binding site are highlighted in orange. Cysteines involved in forming the cys-loop 
are highlighted with yellow boxes. Transmembrane regions predicted by TMHMM are 
highlighted by red boxes and labelled. 
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Figure 4-14: Alignment of Cel-ACR-8 with Gpa-ACR-8 and Gro-ACR-8 
Red arrows indicate predicted signal peptide cleavage site. Regions contributing to loops are 
labelled with a black bar above residues. Residues involved in providing the principal face of 
the agonist binding site are highlighted in orange. Cysteines involved in forming the cys-loop 
are highlighted with yellow boxes. Transmembrane regions predicted by TMHMM are 
highlighted by red boxes and labelled. 
125 
 
 
 
Figure 4-15: Alignments of Cel-ACR-12 with Gpa-ACR-12 and Gro-ACR-12 
Red arrows indicate predicted signal peptide cleavage site. Regions contributing to loops are 
labelled with a black bar above residues. Residues involved in providing the principal face of 
agonist binding highlighted in orange. Residue highlighted in blue is a residue change that may 
affect acetylcholine binding. Cysteines involved in forming the cys-loop are highlighted with 
yellow boxes. Transmembrane regions predicted by TMHMM are highlighted by red boxes.  
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Figure 4-16: Phylogenetic tree of relationship between C. elegans, G. pallida and                           
G. rostochiensis nAChR subunits of the UNC-38, UNC-29 and ACR-8 groups 
Maximum likelihood phylogeny using predicted protein alignment of nicotinic acetylcholine 
receptor subunits. Bootstrap values for 500 iterations are labelled on nodes. Scale bar 
represents branch times. Subunits cluster by expected orthologues. 
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Figure 4-17: Expression levels of transcripts for identified orthologues of C. elegans genes 
from the UNC-38, UNC-29 and ACR-8 groups over the life-stages of G. pallida 
Expression levels in the eggs, the motile stages (J2s and males) and sedentary stages (7-35 dpi 
females) for nicotinic acetylcholine receptor subunit genes in groups UNC-38, UNC-29 and 
ACR-8. Expression is generally higher in eggs, J2s and males. 
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Figure 4-18: Auto-fluorescence of gut granules in N2 worms 
Auto-fluorescence observed under GFP filters of the gut granules of an N2 worm. a) 
bright-field image of an adult hermaphrodite b) auto-fluorescence is typically brighter towards 
the anterior of the intestine and has a speckled appearance (Coburn and Gems 2013).  
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Figure 4-19: GFP expression of pgpa-acr-2 GFP reporter construct 
a) GFP expression is seen in the ventral nerve cord (i) along the length of the nematode and in 
the nerve ring anterior to the pharyngeal bulb (ii) b) When the worm is orientated with the 
vulva facing upwards, GFP expression is observed along the whole length of the ventral nerve 
cord punctuated with clusters of brighter GFP expression (i). c) Very faint extensions from the 
ventral nerve cord to the dorsal cord can be seen which may represent the commissures (ii). 
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Figure 4-20: GFP expression of pgpa-unc-63 GFP reporter construct 
GFP expression directed by pgpa-unc-63 was more variable between individual nematodes 
observed of the same line a) GFP expression was observed around the pharyngeal bulb in 
some individuals and possibly in the nerve ring (i). In other individuals, GFP expression was 
observed along the ventral side of the body but whether this represented expression in the 
ventral nerve cord or in the body wall muscle is not clear (ii). GFP expression was also observed 
at two paired locations in the tail region (iii).  
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 Discussion 4.4
4.4.1 G. pallida and G. rostochiensis have fewer members of the ACR-16 group 
Few orthologues were identified for C. elegans genes in the ACR-16 group of nicotinic 
acetylcholine receptors (Table 7). Cel-acr-16 itself is present in body-wall muscle of    
C. elegans and is involved in locomotion (Touroutine et al. 2005; Towers et al. 2005). 
An orthologue of this gene is present in both G. pallida and G. rostochiensis. The roles 
of the other members of the ACR-16 group in C. elegans are not well characterised. 
Cel-acr-7 is known to be expressed in the pharynx (Saur et al. 2013). Cel-acr-15 is 
predicted to be expressed primarily in the neurons of C. elegans (Sellings et al. 2013) 
but an orthologue of this gene was not identified in G. pallida and G. rostochiensis. 
There is little published evidence of the expression pattern of the other group 
members. It may be postulated that this reduction in the acr-16 group is due to a 
difference between a free-living life-style and a parasitic one, however the ruminant 
parasite H. contortus has a full complement of orthologues for members of the acr-16 
group (Laing et al. 2013). It may, however, be a feature of the more distantly related 
plant-parasitic nematodes and the difference in their life-style. 
An orthologue of cel-acr-23 is also absent in G. pallida and G. rostochiensis. This gene 
has been linked to monepantel sensitivity and is expressed in body wall muscle 
(Rufener et al. 2013), and its absence may have implications on the effect of 
monepantel on G. pallida and G. rostochiensis J2s. 
4.4.2 The levamisole-sensitive nicotinic acetylcholine (L-nAChR) receptor of              
G. pallida and G. rostochiensis is likely to differ from that of C. elegans  
Orthologues of cel-lev-1 and cel-lev-8 could not be identified in G. pallida or                  
G. rostochiensis suggesting that this receptor type in body-wall muscle must be 
comprised differently in Globodera. The absence of these genes is supported by 
multiple lines of evidence from all available sequence resources. L-nAChRs are diverse 
in their arrangements in other parasitic nematodes, with differing stoichiometries of 
the receptor present in different organisms (Holden-Dye et al. 2013). The absence of 
cel-lev-1 and cel-lev-8 raises the question of which subunits replace them in G. pallida. 
Orthologues for cel-lev-1 and cel-lev-8 are also absent in the animal parasite Ascaris 
suum (Williamson et al. 2009) and although H. contortus contains an orthologue for 
cel-lev-1, it is lacking a signal peptide (Neveu et al. 2010). Oesophagostomum 
dentatum, a close relative of A. suum, also lacks cel-lev-1 and cel-lev-8 orthologues 
(Buxton et al. 2014). 
4.4.2.1 Gpa-ACR-8 is a candidate to replace LEV-8 in the native G. pallida receptor 
Cel-ACR-8 seems to be able to replace Cel-LEV-8 in the C. elegans receptor as channel 
activities elicited by acetylcholine and levamisole are lower in the double null mutant 
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of cel-acr-8 and cel-lev-8 than in either of the single null mutants (Hernando et al. 
2012). Cel-ACR-8 also interacts with the other subunits of the L-nAChR and is 
expressed in body-wall muscle (Gottschalk et al. 2005). Hco-ACR-8 can also replace 
LEV-8 in the H. contortus receptor as expression of hco-unc-29, hco-unc-38, hco-unc-63 
and hco-acr-8 in Xenopus oocytes generates a functional receptor. The resulting 
pentamer must comprise only those subunits, suggesting that LEV-1 is replaced by 
another subunit which is represented twice in the receptor (Boulin et al. 2011). 
As such, Gpa-ACR-8 could be able to similarly replace LEV-8 in the G. pallida receptor. 
An orthologue of cel-acr-8 was cloned from G. pallida and analysis of its sequence 
suggests it would be fully functional as an α-subunit (Figure 4-14). As Gpa-ACR-12 
shows sequence homology with LEV-8, this sequence was also analysed for its 
potential role as an α-subunit. The G. pallida and G. rostochiensis equivalent of Y198, 
one of the residues in loop C involved in acetylcholine binding, is a phenylalanine 
residue. In experiments on mammalian-type α-subunits (Figure 4-15), this Y198F 
mutation does not appear to affect the ability of acetylcholine to bind, but affects the 
binding of curariform drugs (Wang et al. 2003). However, a Y198F mutation in the 
mouse α-subunit did cause a decrease in channel activity elicited by acetylcholine 
(Tomaselli et al. 1991) making the result of this amino acid change unclear. In                  
C. elegans, Cel-ACR-12 can associate with Cel-UNC-38 and Cel-UNC-63, but typically 
forms part of the neuronal nicotinic acetylcholine receptor (Jospin et al. 2009) and is 
only expressed in neurons (Gottschalk et al. 2005). The analysis of expression patterns 
of the orthologues identified in G. pallida would allow identification of genes that are 
expressed in the right location (body-wall muscle) and in the same place as each other, 
allowing the identification of candidates which may comprise the G. pallida L-nAChR. 
4.4.2.2 Several candidates may replace LEV-1 
The role of LEV-1 in H. contortus appears to be replaced by Hco-UNC-29, Hco-UNC-38, 
Hco-UNC-63 or Hco-ACR-8 (Boulin et al. 2011). The native receptors of A. suum may 
only consist of two subunits as expression of only Asu-UNC-29 and Asu-UNC-38 in 
Xenopus oocytes yields a functional receptor. However, no other combinations of 
subunits have been investigated and a functional receptor in Xenopus oocytes may not 
fully reflect the composition of the receptor in the nematode (Williamson et al. 2009). 
As UNC-29 is in the same group as LEV-1, it may be that Gpa-UNC-29.1 replaces LEV-1 
in the G. pallida receptor and is represented multiple times. Gpa-UNC-29.2 is also a 
possible candidate, but may not be functional as it is predicted to lack a fourth 
transmembrane domain (Figure 4-5). 
Gpa-ACR-2 and Gpa-ACR-3 are both non-α-subunits and may be able to take the place 
of LEV-1. Gpa-ACR-2 contains residues that would allow it to provide a complementary 
face for acetylcholine binding, and appears to be fully functional (Figure 4-11). 
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Gpa-ACR-3, however, does not appear to have a signal peptide and is possibly 
non-functional (Figure 4-12). 
4.4.2.3 Gpa-UNC-63 may play an altered role 
The amino acid sequences of Gpa-UNC-63 and Gro-UNC-63 are not predicted to 
contain signal peptides, required for the correct processing of the subunit and 
assembly in the ER, however there is sequence towards the N-terminal end of the 
protein that has some features of a vestigial signal peptide. Gpa-UNC-63 contains all 
important residues for providing the positive face of the acetylcholine binding pocket 
(Figure 4-6). It also contains residues that may contribute towards the complementary 
face of the binding pocket as some models of the C. elegans receptor suggest it may 
provide a complementary role (Hernando et al. 2012). The expression level of this gene 
suggests it is expressed at the same life-stages as the other nicotinic acetylcholine 
subunits (Figure 4-17), although how it is further processed is unknown. Rescue work 
using this gene to rescue cel-unc-63 mutants of C. elegans or expression in Xenopus 
oocytes with other C. elegans receptors could be used to investigate whether or not 
Gpa-UNC-63 is functional. 
4.4.2.4 Gpa-UNC-29.1 is a good orthologue of Cel-UNC-29, but Gpa-UNC-29.2 may 
not be functional 
Gpa-UNC-29.1 contains all the features of a functional subunit, and residues that 
provide the complementary face of the interaction (Figure 4-4). It is likely to be a good 
functional orthologue of Cel-UNC-29. 
Gpa-UNC-29.2 shares the key residues with Gpa-UNC-29.1, but appears to be 
truncated as it lacks a fourth transmembrane domain (Figure 4-5). This may prevent 
the subunit folding properly, and would disrupt the TM3-TM4 loop which is involved in 
receptor clustering (Kracun et al. 2008; Borges and Ferns 2001) and desensitisation (Lo 
et al. 2008). The presence of TM4 is essential for correct receptor assembly 
(Thompson, Lester and Lummis 2010). However, it would be worth confirming that the 
protein produced is non-functional by experimental methods as the results for 
transmembrane domain number are only a prediction. During initial cloning of this 
gene, the reverse primer was designed a further 177 bp downstream of the stop 
codon. However, all clones analysed contain a stop codon in this premature position 
truncating the protein before TM4. Further analysis of these regions by bioinformatics 
in the G. rostochiensis genome assembly also did not produce a protein which a fourth 
transmembrane domain. 
Both Gpa-Unc-29.1 and Gpa-unc-29.2 are expressed at similar levels across the 
different life-stages of G. pallida, which does not exclude either from being a potential 
member of the L-nAChR.  
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Multiple paralogues of UNC-29 are also present in H. contortus (Hco-UNC-29.1-4) 
(Neveu et al. 2010). However, these share much closer homology to each other and to 
Cel-UNC-29 (~75%), than do the two orthologues of Cel-UNC-29 identified in G. pallida 
(~65%). A phylogenetic tree generated from amino acid sequences of UNC-29s 
identified in G. pallida, H. contortus and C. elegans suggests that all of the Hco-UNC-29 
paralogues are more closely related to Cel-UNC-29 than either identified from     
G. pallida or G. rostochiensis (Figure 4-21). 
4.4.2.5 Gpa-UNC-38.1 and Gpa-UNC-38.2 lack important determinants of an 
α-subunit 
Cel-UNC-38 is an α-subunit. A pair of vicinal cysteines in loop C determine whether or 
not a subunit is α or non-α (Lukas et al. 1999). Neither orthologue of cel-unc-38 
identified in G. pallida and G. rostochiensis contains this characteristic vicinal cysteine, 
which may have implications for how the receptor functions (Figure 4-8). 
Gpa-UNC-38.1 does not contain the equivalent of Y93 residue in Loop A, which 
contributes to the acetylcholine binding pocket. The residue in this position is an 
isoleucine. There are no published reports of the effect of a Y93I mutation, but a Y93F 
mutation in a mouse α-subunit causes a 50-fold reduction in activity elicited by 
acetylcholine (Sine et al. 1994). 
In Loop C, the equivalent residue of Y190 is a phenylalanine in Gpa-UNC-38.1. The 
equivalent residue of the vicinal cysteines C192 and C193 is a serine residue, as the loop C 
region is shorter overall. Although the equivalent residue of Y198 is present in 
Gpa-UNC-38.1 the overall Loop C region is very different from that of Cel-UNC-38. 
These differing residues in Loop C could severely affect acetylcholine binding. The 
vicinal cysteines have been reported to be essential for acetylcholine binding (Kao et 
al. 1984). In studies conducted on an α-subunit from Torpedo californica, when either 
of the vicinal cysteines were mutated to a serine, and the mutant subunit expressed in 
Xenopus oocytes, no detectable current could be elicited by acetylcholine (Mishina et 
al. 1985). A Y190F mutation in the mouse α-subunit caused an over 50-fold reduction 
in channel activation by acetylcholine (Tomaselli et al. 1991).  
In Loop B, the W149 equivalent residue is present, but Y152 and G153 are absent. These 
residues are also absent in Cel-UNC-38, which is reported to be an α-subunit in the 
L-nAChR and can assemble to form a functional receptor with non-α ACR-3 in Xenopus 
oocytes. The residues present in Loop B of Cel-UNC-38 are therefore sufficient to bind 
acetylcholine. However, Gpa-UNC-38.1 differs further. The equivalent residue of G153 in 
Cel-UNC-38 is a glutamic acid residue. A G153E mutation in mammalian α-subunits has 
been demonstrated to increase channel opening currents in response to levamisole 
(Rayes et al. 2004) and has been linked to the increased sensitivity of nematode muscle 
to levamisole over mammalian muscle (Martin et al. 2012). The absence of this 
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glutamic acid residue in Gpa-UNC-38.1 may affect the ability of levamisole to bind to a 
receptor containing Gpa-UNC-38.1. A G153S mutation in a mouse α-subunit caused a 
reduction in channel activity elicited by acetylcholine binding (Sine et al. 1995). This 
suggests that these differences in Loop B of Gpa-UNC-38.1 may have effects on the 
ability of acetylcholine and levamisole to bind. 
At position 278 in TM2 of the Cel-UNC-38, there is an isoleucine residue. The 
equivalent residue in Gpa-UNC-38 is a methionine. A mutation to a methionine at this 
position in Cel-ACR-2 has been shown to increase channel opening activity in response 
to acetylcholine receptor agonists (Jospin et al. 2009).  
These changes in the three important loops that contribute to acetylcholine binding 
together with the change in TM2 which lines the channel pore raise important 
questions about the role of this subunit in the receptor. It may no longer be able to 
play the role of an α-subunit, and may be taking on different roles. 
Gpa-UNC-38.2 shares many of the same features of Gpa-UNC-38.1, but differs in some 
regions (Figure 4-9). Y93 of Loop A is present in Gpa-UNC-38.2. Loop B differs from Loop 
B of Cel-UNC-38 and also lacks E153 associated with levamisole sensitivity; however this 
residue is predicted to be present in Gro-UNC-38.2. In Loop C, Y190 is present but the 
vicinal cysteines C152 and C153 are still absent. Y198 is absent, and there is a 
phenylalanine in this position of Gpa-UNC-38.2. A Y198F mutation in the mouse 
α-subunit caused a decrease in channel activity elicited by acetylcholine, but not as 
much as the Y190F mutation (Tomaselli et al. 1991), however another study of this 
mutation showed acetylcholine binding was not affected (Wang et al. 2003).  
Both Gpa-UNC-38.1 and Gpa-UNC-38.2 lack the determinants of an α-subunit which 
may affect acetylcholine binding and the binding of other agonists. Gpa-UNC-38.1 may 
be affected more strongly. If either of these subunits are part of the G. pallida receptor 
they may play an altered role. 
4.4.2.6 UNC-38 orthologues in other plant-parasitic nematodes share the same 
features 
Sequences of UNC-38 from other plant-parasitic nematode were identified from 
available bioinformatic data. The Y to I change at residue 93 and an absence of E153 are 
shared with most plant-parasitic nematodes, except Rotylenchulus reniformis. The 
vicinal cysteines are also absent from all plant-parasitic nematodes sequences. The I to 
M change in TM2 is present in all plant-parasitic nematodes, apart from R. reniformis 
and M. incognita for which data is unavailable for this region. All members of the order 
Tylenchida also shared the absence of the YxxCC motif in the Loop C region. 
Bursaphelenchus xylophilus, although a plant-parasitic nematode, does contain a YxxCC 
motif in Bxy-UNC-38, but is a member of the Aphlenchida in clade 10 rather than the 
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Tylenchida of clade (Figure 4-22). Only one orthologue has been identified from          
H. avenae, R. reniformis, H. schachtii, N. aberrans, M. hapla and M. incognita. Due to 
the quality of the transcriptome databases used to obtain sequences for these 
orthologues, it is not yet possible to definitively determine if the presence of two 
orthologues of UNC-38 is restricted to G. pallida and G. rostochiensis.  
This suggests that information learned from the study of the L-nAChR in G. pallida, may 
extend to other plant-parasitic nematodes as many features identified seem to be 
shared in the order Tylenchida.  
4.4.3 The TM3-TM4 intracellular loop is generally larger in orthologues identified in 
plant-parasitic nematodes than in C. elegans 
A general feature of all of the Globodera nAChRs identified in this chapter except 
Gpa-ACR-6 is that the intracellular region between TM3 and TM4 is longer than in the    
C. elegans orthologue. This same expansion was also seen in the glutamate-gated 
chloride channel class of cys-loop receptors in Chapter 3. As discussed in that chapter, 
this may have an effect on desensitisation or aggregation of the receptor (Lo et al. 
2008; Kracun et al. 2008). 
4.4.4 Work in other parasitic nematodes can provide insight for potential 
stoichiometries of the G. pallida receptor 
Without complete data providing the expression patterns of genes encoding individual 
subunits, it is difficult to establish with certainty which subunits comprise the L-nAChR 
in body wall muscle.  
Some inferences can be made from work conducted on this receptor type in other 
parasitic-nematodes. In A. suum, Asu-UNC-29 and Asu-UNC-38 were shown by 
immunofluorescent labelling to co-localise on A. suum muscle cell. Co-expression of 
cRNAs encoding these transcripts in Xenopus oocytes yielded functional channels and, 
by differing the ratio of subunit transcripts injected, the authors postulated two 
different arrangements of the receptor consisting of Asu-UNC-29 and Asu-UNC-38 can 
form (Figure 4-23a) (Williamson et al. 2009). Although an orthologue of cel-unc-63 
exists in A. suum, the potential role of this subunit was not investigated. 
Functional receptors have also been expressed in Xenopus oocytes using H. contortus 
cRNAs for Hco-UNC-29, Hco-UNC-63 and Hco-UNC-38; and with Hco-UNC-29, 
Hco-UNC-63, Hco-UNC-38 and Hco-ACR-8. The relative current generated by 
acetylcholine was approximately ten times higher for the receptor that included 
Hco-ACR-8 and was more sensitive to levamisole (Boulin et al. 2011). Similar 
combinations of subunits have also been shown to produce functional receptors from 
O. dentatum (Buxton et al. 2014) (Figure 4-23b). 
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From these studies, a starting model of the G. pallida receptor is likely to comprise 
Gpa-UNC-29.1, Gpa-UNC-63, Gpa-ACR-8 and Gpa-UNC-38.1 or .2 and another subunit. 
Gpa-UNC-38.1 lacks the characteristic α-type residues, and may not contribute to the 
acetylcholine binding pocket. As Gpa-UNC-63 lacks a predicted signal peptide, the 
model may also comprise Gpa-UNC-38.1 or .2, Gpa-UNC-29.1 and Gpa-ACR-8 with two 
unknown subunits. Whether a subunit is represented multiple times or another 
subunit is involved which has not yet been shown to form a muscle-type receptor 
cannot be determined with this information (Figure 4-23c). Cel-ACR-2, Cel-ACR-3 and 
Cel-ACR-12 form part of the neuronal-type nicotinic acetylcholine receptor with 
Cel-UNC-29 and Cel-UNC-38 (Jospin et al. 2009), so a receptor involving ACR-2, ACR-3 
or ACR-6 remains a possibility. 
Subunit stoichiometry and identity has been demonstrated to have effects on channel 
opening. The two different functional stoichiometries of H. contortus subunits display 
different channel opening currents in response to levamisole, and are differentially 
activated by different drugs. The L-nAChR comprising Hco-UNC-29, Hco-UNC-38, 
Hco-UNC-63 and Hco-ACR-8 was most sensitive to levamisole, then acetylcholine > 
DMPP > pyrantel > nicotine. The L-nAChR comprising of Hco-UNC-29, Hco-UNC-38, 
Hco-UNC-63 was most sensitive to pyrantel, then DMPP > acetylcholine > nicotine > 
levamisole (Boulin et al. 2011). Injecting different ratios of A. suum subunits into 
Xenopus oocytes (3xUNC-29: 2xUNC-38 or 3xUNC-38:2xUNC-29) produced two 
different functional receptor types; one more sensitive to levamisole then nicotine, the 
other more sensitive to nicotine then levamisole (Williamson et al. 2009). The different 
combinations of receptor subunits in O. dentatum yielded a range of potential 
receptors some with a higher sensitivity to levamisole (Ode-UNC-29, Ode-UNC-63, 
Ode-UNC-38, Ode-ACR-8); some with a higher sensitivity to acetylcholine 
(Ode-UNC-29, Ode-UNC-63, Ode-UNC-38). The calcium permeability of the receptor 
also varied depending on the stoichiometry of the receptor (Buxton et al. 2014). 
It therefore seems likely that the native G. pallida receptor, with its different 
stoichiometry, will have different pharmacological properties from the C. elegans 
receptor. Furthermore, due to differences in the key loops of Gpa-UNC-38 these 
pharmacological properties may be different from those of animal-parasitic 
nematodes. As these differences appear to be shared by other plant-parasitic 
nematodes, it may be that the structure of the native G. pallida receptor is shared 
across plant-parasitic nematodes and may provide a specific target for control. 
4.4.5 The cel-acr-2 cel-acr-3 operon found in C. elegans appears to be conserved in                 
G. pallida, but may include gpa-unc-29.1 
The cel-acr-2 cel-acr-3 (Baylis et al. 1997) operon of C. elegans links the two genes 
together. In G. pallida this operon is conserved, although the translated sequence of 
gpa-acr-3 lacks a signal peptide. The region between the end of gpa-acr-2 and 
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beginning of gpa-acr-3 was cloned from cDNA further substantiating the operonic 
status of the two genes, but no evidence of a signal peptide was found (Figure 4-10a). 
The distance between gpa-acr-2 and gpa-acr-3 was also shorter than between 
cel-acr-2 and cel-acr-3 suggesting there may have been some loss of sequence. 
Amplification of the intervening region between gpa-acr-2 and gpa-acr-3 from cDNA 
may also be beneficial, but may prove difficult if it is rapidly processed. Gpa-unc-29.1 is 
also located 400 bp downstream of the end of gpa-acr-3 (Figure 4-10c), while in               
C. elegans an unrelated gene, nas-11, is downstream of acr-3 (Figure 4-10b). This 
gro-acr-2 gro-acr-3 gro-unc-29.1 structure is conserved in G. rostochiensis. It is possible 
that gpa-unc-29.1 is linked to acr-2 and acr-3 as part of the operon. However, if this 
were the case it may be expected that the expression levels of gpa-acr-2 gpa-acr-3 and 
gpa-unc-29.1 would be closely related to each other (Figure 4-17), although 
post-transcriptional regulation could affect expression levels. The analysis of whether 
gpa-unc-29.1 retains sufficient upstream sequence for a promoter region and 
regulatory elements could determine if these genes are linked. 
4.4.6 Phylogenetic relations of subunits show that orthologues are the best 
identified, despite differences in sequence 
A phylogenetic tree generated to represent the relationship between the nAChR 
orthologues identified in G. pallida and G. rostochiensis shows that they cluster with 
their predicted groups. The tree predicts any gene duplications that have arisen from a 
common ancestor related to the C. elegans gene, and not from a common ancestor 
prior to the C. elegans gene. In other words, the duplication is likely to have occurred 
after Clade 9 and Clades 10-12 diverged from each other. This is the case for the two 
orthologues of Cel-UNC-38 and Cel-UNC-29 identified in G. pallida and G. rostochiensis 
(Figure 4-16). Such duplication and subsequent independent evolution of genes may 
have led to the large diversity of nicotinic acetylcholine receptors in nematodes.  
4.4.7 C. elegans as a heterologous system for analysis of G. pallida promoter 
activity using GFP transcriptional fusions 
Preliminary work showed that the promoter regions of G. pallida are sufficient to drive 
GFP expression in C. elegans despite their evolutionary distance. Although similar work 
has been conducted using promoter regions of other genes to drive GFP expression in 
C. elegans (Qin et al. 1998; Costa et al. 2009), this is the first example of using 
promoter regions of nAChRs from a plant-parasitic nematode to drive GFP expression 
in C. elegans.  
For pgpa-acr-2 the observed pattern of expression is similar to that observed using the 
promoter region of cel-acr-2 of C. elegans. In C. elegans expression is reported in the 
ventral nerve cord, the nerve ring, the vulval muscles and the DA, VB and VA neurons 
(Qi et al. 2013). This pattern of expression is also seen in the G. pallida pgpa-acr-2 lines 
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(Figure 4-19), with expression in the ventral nerve cord, and at distinct clusters (likely 
the DA, VB and VA neurons) and in the nerve ring. However, expression in the vulval 
muscles was not observed as J2s lack this structure. 
For pgpa-unc-63 expression was less consistent between individuals, but in similar 
locations to that for cel-unc-63. In C. elegans, cel-unc-63 is expressed in the body wall 
muscles, the ventral nerve cord, head neurons and in muscles of the sphincter (Culetto 
et al. 2004). Although GFP expression from pgpa-unc-63 is observed in the head region 
(Figure 4-20a) and along the ventral side of the body (Figure 4-20b), it is not clear if 
this expression is in the body wall muscles. GFP expression in the tail region may also 
indicate association with the sphincter muscles. 
Although GFP expression directed in C. elegans by G. pallida promoter regions was 
successful, it was hard to determine if the specific pattern was in agreement with that 
which has been observed for C. elegans. To circumvent this problem, lines expressing 
both the promoter region of C. elegans and the promoter region of G. pallida driving 
two different reporter genes could be generated to determine if the two marker genes 
co-localise. This would be particularly beneficial for determining if expression is seen in 
the ventral nerve cord or in the body wall muscle.  
This work only used transcriptional fusions, using the promoter region directly 
upstream of the coding region for GFP. There is evidence in C. elegans that some 
transcriptional elements are present in the first intronic region of genes in addition to 
the promoter region and may affect expression (Choi and Newman 2006). As the first 
intron was not included in these constructs, some regulatory elements may be absent 
and the expression pattern incomplete. Nevertheless, further analysis of the 
expression patterns for all nAChRs identified in G. pallida will be beneficial to 
determine their potential roles. 
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Figure 4-21: Phylogenetic tree of relationship between paralogues of UNC-29 identified in       
G. pallida, G. rostochiensis, H. contortus and C. elegans 
Maximum likelihood phylogeny (Bootstrap 500) using predicted protein alignments of 
paralogues of UNC-29 identified in G. pallida, G. rostochiensis, H. contortus and C. elegans. 
Scale bar represents branch times. Hco-UNC-29 cluster together, and are more distantly 
related to Gpa- or Gro- UNC-29s than Cel-UNC-29. 
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Figure 4-22: Loops A-C and transmembrane domain 2 of UNC-38 in plant-parasitic nematodes compared to C. elegans, animal-parasitic nematodes and 
the mouse α-subunit 
In Loop A, Y93 is an isoleucine in most plant-parasitic nematodes. In Loop B, G153 is an E in C. elegans and animal-parasitic nematodes, but this residue is 
highly variable in plant-parasitic nematodes. In Loop C, the YxxCC motif is absent from all plant-parasitic nematodes. In TM2, most plant-parasitic 
nematodes have a methionine linked to increased levamisole sensitivity at position 255. Plant-parasitic nematodes are indicated by a green background. 
Residue numbering is given for the α-subunit from Mus musculus (mouse)  
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Figure 4-23: Stoichiometries of L-nAChRs in animal-parasitic nematodes deduced by 
expression in Xenopus oocytes and a starting model for the native G. pallida receptor 
a) Two functional arrangements of the receptor from A. suum b) Two possible arrangements of 
the receptor from H. contortus and O. dentatum c) Potential arrangements of the G. pallida 
receptor. Blue circles are α-subunits, grey circles are non-α. Unknown subunits are bi-coloured.  
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Summary 
 
• There is a reduction in the number of nAChRs in G. pallida and G. rostochiensis 
compared to C. elegans 
 
• Fewer members of the ACR-16 group are present in G. pallida and                       
G. rostochiensis 
 
• The composition of the levamisole-sensitive nicotinic acetylcholine receptor of                 
G. pallida and G. rostochiensis differs from that of C. elegans 
 
• Amino acid sequences of Gpa-UNC-38.1 and Gpa-UNC-38.2 differ in positions 
which may affect function and pharmacology 
 
• Use of G. pallida nAChR promoter regions can direct GFP expression in              
C. elegans which allows spatial expression to be analysed 
 
 
 
 
  
144 
 
5. Characterisation of the effect of levamisole in                  
Globodera pallida and Globodera rostochiensis  
 Introduction 5.1
5.1.1 Determining the effect of levamisole on G. pallida and G. rostochiensis J2s 
Levamisole is used as a veterinary anthelmintic for livestock (Coles, East and Jenkins 
1975). It is a nAChR agonist that belongs to a class of imidazothiazole derivatives. The 
structure of the molecule is shown in Figure 5-1. The mode of action and target of 
levamisole was initially deduced in C. elegans although it had been used as an 
anthelmintic for many years previously and its effect on animal parasitic nematodes 
such as A. suum and O. dentatum had been observed (Harrow and Gration 1985). 
Levamisole elicits spastic paralysis in the target organism by opening L-type nAChRs in 
body wall muscle. Calcium then enters the sarcomere and causes uncoordinated 
muscle contraction leading to paralysis. In C. elegans the EC50 of paralysis is 9 µM after 
1 hour levamisole exposure (Qian et al. 2008). Levamisole additionally stimulates 
egg-laying behaviours of adult hermaphrodites (Trent, Tsung and Horvitz 1983). 
Treatment of adult hermaphrodites with levamisole also causes rapid shrinkage of        
C. elegans to about 90% of the initial body length, due to contraction of body wall 
muscle. This shrinkage occurs within 30 seconds in response to 100 µM levamisole 
(Mulcahy, Holden-Dye and O'Connor 2013), and can be observed in response to as 
little as 10 µM levamisole (Lewis et al. 1980). As J2s of plant-parasitic nematodes do 
not lay eggs, egg-laying behaviour cannot be used to determine levamisole sensitivity. 
However, the effect of levamisole on paralysis and shrinkage can be assessed. 
5.1.2 Use of transgenic C. elegans to investigate endogenous genes of G. pallida 
The ability of orthologous genes identified in a non-model organism to functionally 
rescue mutants of C. elegans allows the function of the gene to be more clearly 
understood. The CGC provides a bank of thousands of mutant lines for individual genes 
which allow such complementation experiments. Most heterologous rescue 
experiments to date have used H. contortus genes to rescue C. elegans mutants. For 
example, C. elegans daf-21 (hsp-90) null mutants can be partially rescued by hsp-90 
from H. contortus (Gillan et al. 2009). The ability of a previously uncharacterised 
glutamate-gated chloride channel subunit (hco-glc-6) to restore ivermectin sensitivity 
to the insensitive C. elegans triple-mutant, contrasting with the lack of rescue by 
hco-glc-2, provided information about the likely roles of these subunits in H. contortus 
(Glendinning et al. 2011). 
Mutant strains of C. elegans are available with mutations in different genes encoding 
L-nAChR subunits from the CGC. The unc-38 mutant lacks a functional L-nAChR 
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receptor in body wall muscle and has reduced thrashing activity in liquid, and 
increased resistance to levamisole (Lewis et al. 1987; Fleming et al. 1997).  
5.1.3 Xenopus oocytes as a heterologous expression system for investigation of ion 
channels and receptors 
The eggs of the South African Tree Frog have been a valuable tool in scientific research 
since the late 1950s. The oocytes are large (1-1.2 mm) and remain viable for long 
periods of time outside of the frog. In the 1970s it was demonstrated that injection of 
haemoglobin mRNA into the oocyte would lead to translation and synthesis of the 
protein (Gurdon 1971). Later work showed that receptors could be expressed on the 
oocyte surface by injection of mRNA-encoding the receptors of interest (Gundersen, 
Miledi and Parker 1983; Miledi, Parker and Sumikawa 1982). Since then, the 
expression of receptors in Xenopus oocytes combined with electrophysiology has been 
used to investigate receptor biology from pharmacology to assembly and 
stoichiometry. Stage V or VI oocytes are used in electrophysiological studies. The 
oocyte has two distinct halves, a dark pigmented animal pole and the non-pigmented 
vegetal pole. It is surrounded by a vitelline membrane, which does not contain 
channels that may interfere with electrophysiological recordings. An outer follicular 
layer with blood vessels and ion channels must be removed prior to working with the 
oocytes. Commonly, cRNAs encoding a receptor or a mix of cRNAs encoding subunits 
of a receptor are injected into the oocyte and are incubated for 2-5 days (depending 
on the type of receptor to be expressed). After incubation, the ion channel or receptor 
is expressed on the oocyte surface and the properties of the channel can be 
investigated by electrophysiology (Bianchi and Driscoll 2006). 
Electrophysiological recordings are carried out by the two-electrode clamp method. 
One electrode (voltage-sensing) penetrates the membrane and measures the 
membrane potential. This is compared to the command voltage (set by user). A second 
electrode (bath-electrode) penetrates the membrane and injects current to bring the 
difference between membrane potential and command voltage to 0. As the oocyte is 
exposed to different receptor agonists, the receptors open causing the membrane 
potential to change. The voltage-sensing electrode detects this change, and the 
bath-electrode records the amount of current required to bring the membrane 
potential back to the command voltage. Larger concentrations of agonists will cause 
larger receptor opening currents and require more current to be injected by the bath 
electrode. The amount the bath-electrode has to inject at each agonist concentration 
to maintain the membrane potential is recorded to produce a dose-response curve 
(Bianchi and Driscoll 2006). 
Expression of receptors in oocytes, and the effect of exposure to various agonists and 
antagonists have allowed the pharmacology of different receptors to be investigated. 
This has been particularly useful for characterising the pharmacology of novel 
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receptors (Dufour et al. 2013; Yassin et al. 2001) or to investigate the effect of 
aberrant mutant phenotypes that may lead to anthelmintic resistance (Boulin et al. 
2011). It has also allowed the native conformation of multimeric receptors to be 
deduced, based on the ability of subunits to assemble and express in Xenopus oocytes. 
The likely native conformation of the C. elegans L-nAChR in body wall muscle (Boulin et 
al. 2008), and of the orthologous receptors in H. contortus (Boulin et al. 2011),            
O. dentatum (Buxton et al. 2014) and A. suum (Williamson et al. 2009) have been 
deduced by this methodology. It has also proved useful for establishing that a single 
subunit is sufficient for robust functional expression of homomeric receptors, 
(Raymond, Mongan and Sattelle 2000). 
In some cases, robust expression in this heterologous system requires addition of 
ancillary factors that assist in assembly of receptors. Three ancillary factors are 
required for robust expression of the C. elegans L-nAChR in Xenopus oocytes. RIC-3 is a 
chaperone protein, present in the endoplasmic reticulum (ER) and involved in the 
folding and processing of the L-nAChR subunits (Millar 2008). UNC-74 is a thioredoxin, 
another ER protein believed to assist in correct protein folding (Haugstetter, Blicher 
and Ellgaard 2005). UNC-50 is present in the Golgi apparatus and appears to be 
essential for trafficking of L-nAChR subunits to the correct location (Eimer et al. 2007). 
However, all of these ancillary factors are not required for all nAChRs as expression of 
ACR-16 is robust with only the addition of RIC-3. The absence of the correct ancillary 
factors may prevent the proper expression of a heterologously expressed receptor, or 
may affect the properties and pharmacology of the expressed receptor as RIC-3 has 
been shown to affect subunit ratios (Ben-Ami et al. 2005). 
There are some species for which heterologous expression of acetylcholine receptors 
in Xenopus oocytes has been troublesome. The study of the nAChRs of insects has 
been hindered by the difficulty expressing insect nAChRs in Xenopus oocytes. To 
investigate the pharmacology of these, α-nAChR subunits from insects are 
co-expressed with β-nAChR subunits from vertebrates to create hybrid receptors 
(Thany et al. 2007).  
In this chapter, the effect of levamisole on G. pallida and G. rostochiensis J2s has been 
investigated. In chapter 2, key residues involved in levamisole sensitivity and that 
define Cel-UNC-38 as an α-subunit have been identified as absent in Gpa-UNC-38.1 
and Gpa-UNC-38.2. In this chapter, the role of Gpa-UNC-38.1 and its ability to replace 
Cel-UNC-38 has been investigated by the use of thrashing assays on a strain of             
C. elegans expressing Gpa-UNC-38.1. Gpa-UNC-38.1 has also been expressed in 
Xenopus oocytes replacing Cel-UNC-38 in the native C. elegans receptor in order to 
characterise these differences.  
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Figure 5-1: Chemical structure of levamisole 
The chemical structure of levamisole. 
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Aims 
 
• Assess effect of levamisole on G. pallida and G. rostochiensis J2s 
 
• Investigate effect of altered L-nAChR subunits  
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 Materials and methods 5.2
5.2.1 Assessment of effect of levamisole on G. pallida and G. rostochiensis J2s 
5.2.1.1 Production of levamisole treatment plates 
9 cm plates containing 10 ml of agar (0.25% Tween-20, 10 mM Hepes and 1% 
high-strength agar at pH 7.2) were produced. Appropriate concentrations of 
levamisole or water control were added to the molten agar before pouring. Plates 
were dried for one hour upside-down on the bench to evaporate excess moisture, and 
then left overnight at room-temperature before use. 
5.2.1.2 Assessment of average speed 
50-100 J2s were placed onto a solid agar plate and left to orientate in the dark for 2 
hours. Two minute video clips of the plates were taken at 0.73x magnification on a 
M165FC Leica microscope at 4 frames per second (fps). These were repeated several 
times per plate in order to sample all worms on the plate and across multiple plates. 
These images were then loaded into ImageJ (Abramoff 2004). Image type was 
converted from RGB to 8-bit. The “subtract background” tool was used to smooth out 
the background of the image (settings: rolling ball radius: 50 pixels; light background, 
sliding paraboloid, disable smoothing). The threshold tool (threshold setting: 
maxentropy) was used to allow only J2s to be selected. The wrMTrck plugin (Pedersen 
2010) was then run to determine maximum speed of worms. An ImageJ macro was 
written to provide the same settings each time this was run: 
run("Set Scale...", "distance=0.1 known=1 pixel=1 unit=um"); 
//setTool("hand"); 
run("wrMTrck ", "minsize=50 maxsize=10000 maxvelocity=100 maxareachange=50 mintracklength=50 
bendthreshold=1 binsize=0 showpathlengths showlabels showpositions showsummary smoothing 
rawdata=0 benddetect=3 fps=4 backsub=1 threshmode=Otsu fontsize=16"); 
 
An example of image processing can be seen in Figure 5-2. 
 
A minimum of 180 worms per levamisole concentration were sampled, over 3 separate 
repeats for G. pallida J2s. For G. rostochiensis J2s a minimum of 20 worms per 
concentration were sampled over 2 separate repeats. 
5.2.1.3 Assessment of shrinkage at 2 hours over a range of levamisole 
concentrations 
The WrMTrck plugin also collects perimeter information for detected objects. The 
perimeter output was divided by two to provide approximated length estimation for 
the range of levamisole concentrations after 2 hours.  
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Figure 5-2: Image processing steps to determine average speed of G. pallida and                     
G. rostochiensis J2s 
a) Snapshot of single frame from raw image collection. The background lighting is uneven and 
contrast between worm objects and background is unclear b) Image after the background has 
been removed (“subtract background”) and image has been processed to highlight objects 
(“threshold”). c) Image after wrMTrck plugin has been run. Individual objects are assigned 
numbers. Data are output to a separate spreadsheet. Red circles indicate numbered objects 
which must be manually removed from the data set as they are non-worm objects, or are not 
fully in the field-of-view. 
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5.2.1.4 Assessment of shrinkage over 20 minutes in response to a high dose of 
levamisole 
To analyse shrinkage, a single J2 was added in 1 µl of water to an agar plate (made as 
in 5.2.1.1) containing either 200 mM levamisole or water. In total, 21 J2s were 
analysed for the control condition and 42 J2s for the levamisole condition. As soon as 
the liquid had absorbed into the plate and the J2 had come into contact with the test 
medium, a reference image was taken (t=0). A further image was taken every minute 
for 20 minutes. Length of the J2 was measured at each time point using the measure 
tool in ImageJ. Length was presented as a percentage of the reference image and 
linear regression was used to determine if the slopes differed significantly. A Leica 
M165FC microscope along with a Qimaging Fast1394 QiCAM camera and Qcapture Pro 
7 software was used to capture images. 
5.2.1.5 Assessment of shrinkage over 24 hours in response to a low dose of 
levamisole 
A single J2 in 1 µl of water was placed on a 5 cm agar plate (made to the same recipe 
as in 5.2.1.1) containing 100 µM levamisole or water. An image was taken immediately 
at t= 0. Plates were covered in foil and left at 20 °C for 24 hours. The J2 was then 
photographed again. Length of J2s at t = 0 and t = 24 were measured using ImageJ. 
5.2.2 Heterologous expression of Gpa-unc-38.1 in C. elegans 
5.2.2.1 Production of the Gpa-unc-38 and Cel-unc-38 line 
Gpa-unc-38.1 and Cel-unc-38 lines were generated by microinjection in Southampton. 
The constructs were generated as described in 6.2.2. Anna Crisford carried out the 
microinjections and selection of the positive lines. The unc-38(x20) line was used as 
the background line for mutant-rescue and was obtained from the CGC. Transgenic   
C. elegans Lines were made by the same methodology as in 6.2.5. 
5.2.3 Selection of C. elegans worms for use in thrashing assays 
Due to the nature of transformation by microinjection, which introduces transgenes by 
formation of extrachromosomal arrays that segregate in a non-Mendelian fashion, not 
all individuals in the line carry the injected transgene. Co-injection of the GFP marker 
gene is necessary for selection. For transgenic lines, 24 hours prior to assay, L4-stage 
hermaphrodites that expressed the GFP marker in the pharynx as visualised using a 
Leica M165FC microscope with Lumen 200 fluorescence illumination system, were 
transferred onto a fresh NGM-lite plate. For control non-transgenic lines the L4-stages 
were selected and transferred onto fresh NGM-lite plates.  
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5.2.3.1 Thrashing assays  
Assays were conducted in 12 well plates. Each well contained 900 µl M9 buffer 
(+0.01% BSA). Six L4+1 worms from each line to be analysed were transferred into 
individual wells. The worms were allowed to rest for 10 mins to allow dissipation of 
changes in behaviour due to handling. The basal thrashing rate of each worm was 
calculated by counting the number of thrashes in a minute. A thrash was counted as 
the bend of the worm from one side of its body to the other and back (Figure 5-3). 
After this 100 µl of the appropriate levamisole solution (10x stock solution in M9 
buffer) was added to make a total volume of 1 ml liquid in each well. Further thrashing 
counts (thrashes / min) were carried out at t = 10 min and t = 30 min. Six worms could 
be analysed in each iteration of the assay. Assays were conducted at room 
temperature, and under 30x magnification. Each day, six individuals of each line were 
analysed to reduce day-to-day variation within the data. The wild-type line (N2), 
background line (unc-30(x20)) and two transgenic lines expressing cel-unc-38 or 
gpa-unc-38.1 were analysed. Assays were conducted at 0, 10, 50 and 100 µM 
concentrations of levamisole. A minimum of 18 worms were assessed for each line at 
each concentration. 
5.2.4 Expression of gpa-unc-38.1 to replace cel-unc-38 in the C. elegans receptor in 
Xenopus oocytes 
Data in this section were collected with the kind help of Claude Charvet, at the INRA 
Loire Valley Centre. 
5.2.4.1 Subcloning of gpa-unc-38.1 into the oocyte expression vector pTB207 
The pTB207 vector was obtained from Claude Charvet, INRA. The Gpa-unc-38.1 cDNA 
sequence was excised from pCR™8 by restriction digest with EcoRI and the DNA 
fragment isolated following gel electrophoresis. pTB207 was cut with EcoRI and 
treated with shrimp alkaline phosphatase (NEB) to prevent religation of the vector. In a 
20 µl reaction, 1 µl of ligase, 2 µl of 10 x ligation buffers and insert to vector DNA in a 
3:1 ratio was added. Ligation of gpa-unc-38.1 into pTB207 was conducted overnight at 
4 °C using T4 ligase (NEB). After transformation into competent cells, positive colonies 
with inserts in the correct orientation were selected by colony PCR using the T7F 
primer and the gpa-unc-38.1 R primer. A map of the vector used is shown in Figure 5-4. 
5.2.4.2 Preparation of vector for cRNA transcription 
The pTB207:Gpa-unc-38.1 vector was linearised in preparation for cRNA transcription. 
Six µg of vector was digested with NheI for 2 hours at 37 °C. The digested DNA was 
cleaned used the NucleoSpin® Gel and PCR clean-up kit according to the 
manufacturer’s instructions. Briefly, 5x volume of buffer NTB was added to digested 
DNA. The DNA was added to the spin column and briefly centrifuged to bind DNA to 
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the column. The membrane was washed by adding 700 µl NT3 followed by brief 
centrifugation. A second wash was performed and the column dried by an additional 
minute of centrifugation. DNA was eluted by adding 30 µl NE buffer to the membrane, 
following by centrifugation. A second elution was taken from the column in order to 
check linearisation by gel electrophoresis.  
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Figure 5-3: Schematic of a single C. elegans thrash in liquid 
A single thrash is counted as the full curl from one side of the body, to the other and back 
again. 
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5.2.4.3 Preparation of cRNAs for injection into Xenopus oocytes 
The mMessage mMachine T7 kit (Ambion) was used to produce cRNAs according to 
the manufacturer’s instructions. Briefly, 1 µl of linearised pTB207:gpa-unc-38.1 was 
used in a 20 µl reaction with 10 µl 2X NTP/CAP, 2 µl 10x reaction buffer, 2 µl enzyme 
mix and nuclease-free water. This reaction was incubated at 37 °C for 2 hours. 30 µl of 
LiCl precipitation solution was added to the reaction to precipitate cRNA. The mixture 
was chilled at -20 °C overnight, and then centrifuged for 15 mins at 4°C and maximum 
speed. The supernatant was removed, and the pellet washed twice with 500 µl 70% 
ethanol. The tube was centrifuged briefly, and the ethanol removed. Pellets were left 
until dry, and then cRNA was resuspended in 65 µl nuclease-free water. Integrity of 
RNA was checked by gel electrophoresis and quantified using a Nanodrop 
spectrophotometer. 
5.2.4.4 Preparation of injection mixes 
 Two injection mixes were produced. 10 µl of mix contained cel-unc-63, cel-lev-1, 
cel-lev-8, hco-ric-3, hco-unc-50, hco-unc-74 (cRNAs provided by Claude Charvet) and 
either gpa-unc-38.1 (for analysis of the chimeric receptor) or cel-unc-38 (for the native 
receptor) at a final concentration of 50 ng/µl. The ancillary factors (RIC-3, UNC-50, 
UNC-74), required for robust expression of L-nAChRs in Xenopus oocytes, from                     
H. contortus were used as they had been demonstrated to be effective previously in 
the laboratory where this experiment was conducted. 
5.2.4.5 Storage and preparation of Xenopus oocytes prior to injection 
Excised Xenopus ovaries obtained from (NASCO Fort Atkinson, Wisconsin, USA) were 
stored in incubation buffer (100 mM NaCl, 2 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 5 mM 
HEPES, 100 mM Na pyruvate, 10 ml penicillin (10,000 units/ml), 10 ml streptomycin 
(10,000 µg / ml)) at 4°C. This solution was changed every two days during storage. 
Prior to injection, oocytes were incubated for 1 hour at room temperature in 2 mg/ml 
collagenase. The oocytes were then washed 3x in incubation buffer. After this, the 
follicular membrane that surrounds the oocytes was removed carefully with 
fine-tipped tweezers.  
5.2.4.6 Injection of Xenopus oocytes with cRNA injection mixture 
Oocytes were microinjected with approximately 72 nl of injection mixture. The needle 
was controlled using a micromanipulator and injection pressure was generated by the 
Nanoject II™. After injection, the oocytes were transferred to individual U-shaped wells 
in a 96-well plate with 200 µl incubation buffer. The injected oocytes were incubated 
at 19 °C for 4-5 days. Incubation buffer was changed every 2 days. 
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5.2.4.7 Voltage-clamp recordings from injected oocytes 
Oocytes were incubated in 200 µl of 100 µM BAPTA-AM (Sigma), a chelating agent, for 
2 hours minimum in order to remove calcium and endogenous Ca2+ dependent 
chloride currents. Oocytes were voltage clamped at -60 mV using an oocyte clamp 
(OC-725C) and amplified with a Digidata 1322A amplifier. Clampex 10.2 was used to 
acquire data on a desktop computer. During recording, the oocyte was continuously 
perfused in a gravity-fed system with recording buffer (100 mM NaCl, 2.5 mM KCl, 1 
mM CaCl2, 5 mM HEPES, pH 7.3). Currents elicited by 1, 3, 10, 30, 100, 300 and 1000 
µM acetylcholine and 1, 3, 10, 30, 100 and 300 µM levamisole were recorded. Dilutions 
of all agonists were made on the day. Agonist was perfused across the oocyte for 10 
seconds. Agonists were perfused starting with the lowest concentration, and the 
membrane potential was allowed to recover to baseline before the next agonist was 
perfused. Clampfit was used to analyse the acquired data. Further characterisation of 
receptor response to other nicotinic acetylcholine receptor agonists was conducted by 
Claude Charvet. This included pyrantel, nicotine and DMPP 
(dimethylphenylpiperazinium). 
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Figure 5-4: Vector map of pTB207 
pTB207 was used to produce cRNAs for injection into Xenopus oocytes. The plasmid contains 
ampicillin resistance and a multiple cloning site facilitates cloning into the vector. 3’ UTR from 
Xenopus β-globin gene aids transcript stabilisation.  
T7 862..881
MCS 882..1036
3' UTR from Xenopus Beta Globin 1037..1201
SP6 1308..1283
M13-rev 1334..1314
LacO 1362..1340
ColE1 origin 2384..1702
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3475 bp
AmpR 3141..2482Ampicillin 
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Lac
13-Rev
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 Results 5.3
5.3.1 G. pallida J2s have higher resistance to levamisole than C. elegans 
The EC50 – the concentration at which 50 % of individuals displayed paralysis – of 
levamisole in C. elegans is 9 μM (Qian et al. 2008). Globodera pallida was found to be 
more resistant to levamisole than C. elegans with a calculated EC50 of 19.7 mM – 
approximately 2000 fold higher than for C. elegans (Figure 5-5a). G. pallida exposed to 
low levamisole (≤ 5 mM) concentrations largely remained unaffected and maintained 
speed similar to that of unexposed J2s after 2 hours. At 2.5 mM levamisole exposure     
G. pallida J2s were observed to increase in speed after 2 hours (Figure 5-5b) 
5.3.2 G. rostochiensis J2s are less resistant to levamisole than G. pallida, but are 
more resistant than C. elegans 
The EC50 of G. rostochiensis J2s was calculated to be 5.6 mM. Although this is less than 
that of the G. pallida J2s, it is still far higher than that of C. elegans (~500 fold higher). 
As for G. pallida, exposure to a low dose of levamisole, 0.625 mM, increased the speed 
of G. rostochiensis J2s, although this increase was not statistically significant (Figure 
5-6). 
5.3.3 Levamisole induces shrinkage of G. pallida J2s 
Levamisole induces rapid shrinkage of C. elegans, mediated by contraction of the body 
wall muscle. The maximal shrinkage rate is ~10% of untreated body length (Mulcahy, 
Holden-Dye and O'Connor 2013). Levamisole also induced contraction of body wall 
muscle and shrinkage in G. pallida, and the maximal shrinkage rate was approximately 
10% of the untreated body length after 2 hr exposure to levamisole. The concentration 
of the drug required to achieve this maximal shrinkage rate was 40 mM, higher than 
that for C. elegans (Figure 5-7a)  
5.3.4 Levamisole induces shrinkage of G. rostochiensis J2s 
G. rostochiensis J2s also shrank in response to levamisole. Maximal shrinkage for         
G. rostochiensis J2s occurred at 10 mM, and the maximal shrinkage rate was 
approximately 20% of untreated body length after 2 hour exposure to levamisole 
(Figure 5-7b). 
5.3.5 Treatment of G. pallida J2s with high concentration of levamisole induces 
shrinkage within a short time period  
To investigate if levamisole entry into G. pallida J2s was responsible for the apparent 
increase in resistance, the shrinkage rate was investigated. Shrinkage is rapid for         
C. elegans and maximal shrinkage occurs within 30 seconds in response to 100 μM 
levamisole (Mulcahy, Holden-Dye and O'Connor 2013), approximately 10x the EC50. 
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Globodera pallida J2s were exposed to 200 mM levamisole, approximately 10x the 
calculated EC50 for this species, or a control plate and individual worms were imaged 
every minute for 20 minutes. J2s exposed to levamisole shrank steadily over 20 
minutes reaching a minimal size of 92% of original length (Figure 5-8a). Shrinkage 
began rapidly as at the first measurement, in the delay between putting the J2 on the 
plate and taking the measurement, at 0 minutes, levamisole exposed J2s were already 
shorter than control J2s (Figure 5-8b). 
5.3.6 Treatment of G. pallida J2s with low concentration of levamisole does not 
induce shrinkage over 24 hours 
It was reasoned that if levamisole could diffuse slowly across the cuticle over time, a 
low dose of levamisole may be sufficient to induce shrinkage if enough time were 
allowed. To investigate this, J2s were exposed to 100 µM levamisole for 24 hours. 
There was no significant difference in length between control J2s and 
levamisole-treated J2s at either 0 or 24 hours. Similarly, there was no significant 
difference between the 0 and 24 hour time points for either treatment (Figure 5-9). 
100 µM levamisole induces shrinkage rapidly in C. elegans, but here it has been 
demonstrated that this concentration does not have a paralytic effect even after 24 
hour exposure.  
5.3.7 Gpa-UNC-38.1 is able to rescue the basal thrashing rate of C. elegans 
unc-38(x20) mutants, but not full sensitivity to levamisole 
The unc-38(x20) mutant strain of C. elegans is functionally null for UNC-38 (Fleming et 
al. 1997). These null mutants display reduced thrashing rate in liquid compared to 
wild-type (N2) and following levamisole exposure, the thrashing rate of the null 
mutants does not decrease to the same level as the wild-type. The ability of 
Gpa-UNC-38.1 to rescue these phenotypes was investigated by microinjection of 
gpa-unc-38.1 cDNA under the control of the myo-3 promoter which directs expression 
in body wall muscle (line created by Anna Crisford, Southampton).  
Gpa-unc-38.1 was able to rescue thrashing rate in the absence of levamisole as no 
significant difference was observed between wild-type (N2) thrashing rate and that of 
unc-38(x20) mutants rescued with gpa-unc-38.1 in the absence of levamisole. On 
exposure to 10 µM levamisole, the thrashing rate of wild-type (N2) worms reduced by 
approximately 20 %. The thrashing rate of Cel-unc-38-rescued mutant worms also 
reduced by approximately 20 % in response to levamisole. In contrast, the thrashing 
rate of gpa-unc-38.1 rescued worms was not reduced in response to 10 µM levamisole 
after 30 minutes (Figure 5-10).  
On exposure to 50 μM levamisole, the thrashing rate of the gpa-unc-38.1 line did not 
reduce to the level seen in the wild-type. Thrashing rate of the gpa-unc-38.1-rescued 
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worms was significantly higher than that of the wild-type worms after 10 minutes and 
30 minutes exposure. In contrast, unc-38(x20) mutants rescued with cel-unc-38 
regained full sensitivity to levamisole as no significant difference in thrashing rate was 
observed from wild-type under 50 μM levamisole exposure (Figure 5-11). On exposure 
to 100 µM levamisole, thrashing rate of the gpa-unc-38.1-rescued lines did not reduce 
to the levels of the wild-type or cel-unc-38-rescued lines (Figure 5-12).  
Examination of the thrashing rates at t = 30 mins, over the full range of levamisole 
concentrations tested showed that the response of the wild-type and cel-unc-38 
rescued line were not significantly different from each other (linear regression, p> 0.1). 
The response of the gpa-unc-38-rescued line was significantly different from the 
wild-type, cel-unc-38-rescued line and unc-38(x20) (Figure 5-12). 
Gpa-UNC-38.1 is able to rescue the uncoordinated phenotype, and seemingly replace 
Cel-UNC-38 in the receptor, although it appears to alter the sensitivity of the receptor 
to levamisole. 
5.3.8 Expression of gpa-unc-38.1 with C. elegans subunits to produce a chimeric 
receptor does not alter response to levamisole compared to the native              
C. elegans receptor. 
cRNA encoding gpa-unc-38.1 was injected into Xenopus oocytes along with cRNAs 
encoding the remaining C. elegans subunits, cel-unc-29, cel-unc-63, cel-lev-8, cel-lev-1 
and the ancillary factors required for robust expression, hco-ric-3, hco-unc-50 and 
hco-unc-74. This mixture produced a functional receptor in Xenopus oocytes 
presumably consisting of the five injected subunits. Oocytes were also injected with 
cRNAs encoding the complete native C. elegans receptor (i.e. using cel-unc-38) to 
compare recordings in response to levamisole and acetylcholine. 
Currents recorded for the chimeric receptor were within the nA (nanoamp) range on 
the first set of oocyte injections, and in the µA range on the second set. A 
dose-response curve was produced in response to acetylcholine and levamisole for 
both the chimeric receptor and the native receptor. The EC50 of acetylcholine was 18.4 
µM for the chimeric receptor, and 19.3 µM for the native receptor. For levamisole, the 
EC50 was 6.6µM for the chimeric receptor and 5.7µM for the native receptor (Figure 
5-14). A representative example of the response of a single oocyte to the full range of 
acetylcholine and levamisole concentrations for both the native and chimeric 
receptors is shown in (Figure 5-15). 
5.3.9 Expression of gpa-unc-38.1 with C. elegans subunits demonstrates the same 
pharmacology as the native C. elegans receptor 
A panel of agonists of nicotinic acetylcholine receptors was used to determine any 
differential pharmacology of the native and chimeric receptors. In addition to 
161 
 
acetylcholine and levamisole, pyrantel (another anthelmintic and agonist of L-type 
nAChRs); nicotine (agonist of N-type nAChRs) and DMPP were used. The native                
C. elegans receptor was activated preferentially by acetylcholine > levamisole > DMPP 
> pyrantel with little response to the addition of nicotine. The chimeric receptor 
produced the same pharmacological response (Figure 5-16).  
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Figure 5-5: Effect of levamisole on Globodera pallida J2s 
Effect of levamisole on G. pallida J2s at a range of levamisole concentrations. a) Percentage of 
J2s paralysed at each concentration was calculated. The EC50 was determined to be 19.74 mM 
by log(agonist) vs response (three parameters) calculations. b) Effect of levamisole 
concentration on average speed of G. pallida J2s. One-way ANOVA (Tukey’s multiple 
comparison) showed significance (p<0.01) for all comparisons, apart from 7.5 mM vs 0, 20 mM 
vs 40 mM and 40 mM vs 80 mM. n-values: 0 (1018), 2.5 mM (416), 5 mM (833), 7.5 mM (339), 
10 mM (597), 20 mM (206), 40 mM (188), 80 mM (185). Error bars represent SEM. 
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Figure 5-6: Effect of levamisole on Globodera rostochiensis J2s 
Effect of levamisole on G. rostochiensis J2s at a range of levamisole concentrations. a) The 
percentage of J2s paralysed at each concentration was calculated. The EC50 was determined to 
be 5.6 mM by log(agonist) vs response (three parameters) calculations. b) Effect of levamisole 
concentration on average speed of G. rostochiensis J2s (One-way ANOVA (Tukey’s multiple 
comparison) showed significance (p<0.01) for comparisons: 0 vs 2.5 mM and 0 vs 10, 20, 40 
mM. b) The percentage of J2s paralysed at each concentration was calculated. The EC50 was 
determined to be 5.6 mM by log(agonist) vs response (three parameters) calculations. 
n-values: 0 (28), 0.625 mM (22), 1.25 mM (39), 2.5 mM (21), 5 mM (29), 10 mM (28), 20 mM 
(20), 80 mM (35). Error bars represent SEM. 
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Figure 5-7: Effect of a range of levamisole concentrations on J2 length after 2 hours exposure 
a) Length of G. pallida J2s after 2 hours exposure to a range of levamisole concentrations. 
Decrease in length of J2s is significant (One-way ANOVA (Tukey’s multiple comparison), 
p<0.01), between 0 mM levamisole and all levamisole concentrations and between 2.5 mM 
levamisole and all other levamisole concentrations. b) Decrease in length of G. rostochiensis 
J2s (One-way ANOVA (Tukey’s multiple comparison, p<0.05). Significant decrease in length 
between 0 mM and 1.25 mM, 10 mM, 20 mM and 40 mM. N-values as described in Figure 5-5 
and Figure 5-6. Error bars represent SEM. 
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Figure 5-8: Effect of high doses of levamisole on G. pallida J2s 
a) The effect of 200 mM levamisole on the length of G. pallida J2s over 20 minutes. 
Control worms (n=21) did not change in length over 20 minutes (linear regression, 
p=0.26). Levamisole-treated worms decreased in length over 20 minutes (linear 
regression, p=<0.0001). b) The immediate effect of a high dose (200 mM) of levamisole 
was also investigated as experimental technique resulted in a delay between first 
exposure of J2 to levamisole and first image capture. Levamisole treated worms (n=42) 
at the first measurement were shorter than control worms (unpaired t-test, p=<0.001), 
indicating an immediate contraction. 
L
e
n
g
th
 (
m
)
L
e
n
g
th
 (
m
)
****
ns
***
b
a
166 
 
 
Figure 5-9: Effect of a low dose of levamisole after 24 hour exposure 
The effect of a low dose (100 µM levamisole) on G. pallida J2s for 24 hours. No 
significant difference was detected between control worms (n=19) between 0 and 24 
hours, or between levamisole-treated (n=20) worms between 0 and 24 hours. There 
was also no significant difference between control and levamisole-treated worms at 0 
hr, or at 24 hr (2-way ANOVA, Sidak’s multiple comparison). Error bars represent SEM. 
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Figure 5-10: Effect of 10 μM levamisole on thrashing rate of C. elegans  
a) Thrashing rate of wild-type (N2) worms decreased by approximately 20 % in response to 10 
μM levamisole. Unc-38(x20) worms did not change in thrashing rate. Thrashing rate of 
Gpa-unc-38.1-rescued worms did not change. Thrashing rate of Cel-unc-38-rescued worms 
decreased by 20% (Two-way ANOVA, Tukey’s multiple comparison test). b) Comparison of 
thrashing rates of the lines at each time point at 10 µM. Lowercase letters indicate statistically 
homogenous subsets (Two-way ANOVA, Tukey’s multiple comparison test). Error bars 
represent SEM. 
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Figure 5-11: Effect of 50 μM levamisole on thrashing rate of C. elegans 
a) Thrashing rate of wild-type (N2) worms decreased by around 90% by end of assay. Thrashing 
rate of Unc-38(x20) remained constant throughout assay. Thrashing rate of 
Gpa-unc-38.1-rescued worms reduced by approximately 50% and Cel-unc-38-rescued by 
around 90%. b) Comparison of thrashing rates of the lines at each time point at 50 µM. 
Lowercase letters indicate statistically homogenous subsets (Two-way ANOVA, Tukey’s 
multiple comparison test). Error bars represent SEM. 
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Figure 5-12: Effect of 100 μM levamisole on thrashing rate of C. elegans 
a) Thrashing rate of N2 and cel-unc-38 reduced by approximately 95% by end of assay. At this 
concentration, unc-38(x20) worms reduced their thrashing rate slightly. Gpa-unc-38.1 worms 
reduced their thrashing rate by approximately 50%. b) Comparison of thrashing rates of the 
lines at each time point at 100 µM. Lowercase letters indicate statistically homogenous subsets 
(Two-way ANOVA, Tukey’s multiple comparison test). Error bars represent SEM. 
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Figure 5-13: Comparison between the lines of thrashing rate after 30 mins exposure to the 
range of levamisole concentrations 
The N2 and cel-unc-38 thrashing rates decreased by the same amounts in response to 
increase in levamisole concentration. The slopes of these lines were not significantly 
different from each other. Gpa-unc-38.1 had a significantly different slope from N2 and 
cel-unc-38, indicating it is more resistant to levamisole (linear regression). Error bars 
represent SEM. 
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Figure 5-14: Dose-response curve for acetylcholine and levamisole on the native and 
chimeric L-type nAChR receptors 
a) Dose response curve for the native C. elegans L-type nAChR receptor expressed in Xenopus 
oocytes for acetylcholine (n=9) and levamisole (n=7). The EC50 of acetylcholine is 19.3 µM ± 1.1 
and of levamisole is 5.7 µM ± 1.2. b) Dose-response for the chimeric-type nAChR receptor for 
acetylcholine (n=7) and levamisole (n=7). The EC50 of acetylcholine is 18.4 µM ± 1.1 and of 
levamisole is 6.6 µM ± 1.5. Current is expressed as relative current, normalised to the current 
elicited by 100 µM acetylcholine. Error bars represent SEM. 
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Figure 5-15: Examples of current recordings for the full range of concentrations of 
acetylcholine and levamisole for the native and chimeric L-type nAChR expressed in Xenopus 
oocytes 
Representative recordings of the current in response to a) acetylcholine for the native (top) 
and chimeric (bottom) receptor and b) levamisole for the native (top) and chimeric (bottom) 
receptor. 
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Figure 5-16: Response of the native and chimeric L-type nAChR in response to a panel of 
nicotinic acetylcholine receptor agonists 
Response of a) the native C. elegans and b) chimeric L-type nAChR receptor to a panel of 
nicotinic acetylcholine receptor agonists; acetylcholine, levamisole, pyrantel, nicotine and 
DMPP. Both are most strongly activated by acetylcholine, then levamisole, then DMPP and 
then pyrantel. Neither is activated by nicotine. 
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 Discussion 5.4
5.4.1 G. pallida and G. rostochiensis J2s are more resistant to levamisole than         
C. elegans.  
G. pallida and G. rostochiensis J2s were observed to be more resistant than C. elegans 
to levamisole. As J2s of plant-parasitic nematodes typically move more slowly than        
C. elegans, a video-capture method was used to assess average speed after 2 hours of 
exposure to a range of levamisole concentrations. This allowed the speed of the worm 
to be calculated over a 2 min time period, and allowed high throughput sampling of 
the speed of many worms as 20-30 worms could be captured per video. This 
demonstrated that G. pallida and G. rostochiensis J2s retain their speed at relatively 
high doses of levamisole compared to C. elegans. There is even some evidence that 
suggests a mild stimulatory action of levamisole as, compared to the control, there is 
an increase in the average speed of G. pallida J2s (at 2.5 mM levamisole exposure) and 
G. rostochiensis J2s (0.625 mM levamisole exposure). The EC50 of paralysis in response 
to levamisole (19.74 mM for G. pallida and 5.6 mM for G. rostochiensis) was calculated 
to be higher than that of C. elegans (9 µM (Qian et al. 2008)). 
It was reasoned that this increased resistance to levamisole may be due to physical 
barriers of levamisole entering the worm, molecular differences of the levamisole 
receptors of G. pallida and G. rostochiensis or a combination of factors. In C. elegans, 
the cuticle is known to partially impede the entry of levamisole as cut nematodes are 
more sensitive to levamisole than intact nematodes (Lewis et al. 1980). Shrinkage 
experiments of G. pallida J2s in response to high doses of levamisole indicated that the 
cuticle is likely to be permeable to levamisole as the J2s shrink in response. However, 
the receptor itself is not activated by low doses as exposure for 24 hours to 100 µM 
levamisole does not induce any change in length. As C. elegans shrinks rapidly (within 
30 secs) in response to a levamisole concentration approximately 10x the EC50 (100 
µM) (Mulcahy, Holden-Dye and O'Connor 2013), it was reasoned that G. pallida J2s 
would also shrink rapidly in response to exposure to a concentration of levamisole 10x 
the EC50 (200 mM) if their cuticle was also permeable. G. pallida J2s did shrink rapidly 
in response to a high dose of levamisole, although the length of the worm steadily 
decreased during the 20 minute duration of the assay. To identify whether low 
exposures of levamisole would diffuse across the cuticle slowly, and be able to induce 
shrinkage after a long period of exposure, J2s were exposed to low doses of levamisole 
for 24 hours. After this time, no significant change was found between levamisole 
treated worms and control treated worms, indicating that the nAChR that is the target 
of levamisole is likely to provide the main mechanism of increased resistance in                 
G. pallida and G. rostochiensis. 
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5.4.2 Analysis of gpa-unc-38.1-rescued C. elegans line suggests gpa-unc-38.1 is 
likely to play a role in this increased resistance  
Previous analysis of the amino acid sequence of gpa-unc-38.1 had highlighted key 
amino acid differences between the G. pallida orthologue and the C. elegans 
sequence. In particular, the YxxCC motif present in Loop C involved in acetylcholine 
binding (Kao et al. 1984) and a glutamate residue linked to levamisole sensitivity 
(Rayes et al. 2004) were absent in the G. pallida sequence. Additionally, a residue in 
transmembrane domain 2 was identified as having potential involvement in affecting 
channel opening properties and levamisole sensitivity (Jospin et al. 2009).  
Unc-38(x20) worms lack a functional unc-38 gene due to the absence of the third exon 
caused by a mutation in the splice acceptor site (Fleming et al. 1997). Absence of the 
UNC-38 subunit prevents assembly of the receptor, leading to the absence of the 
L-type nAChR receptor in the body-wall muscle (Boulin et al. 2008). In thrashing assays, 
the phenotype of this can be observed as a reduction of roughly 50% in the thrashing 
rate in liquid compared to wild-type and increased resistance to levamisole. N-type 
nAChR receptors in the body wall muscle (Touroutine et al. 2005; Richmond and 
Jorgensen 1999) that are unaffected by the absence of unc-38 account for the residual 
movement of the unc-38(x20) worms. 
It was demonstrated by analysis of the transgenic lines, that gpa-unc-38.1 is able to 
rescue basal thrashing, but not levamisole sensitivity of C. elegans unc-38(x20) 
mutants. As both basal thrashing and levamisole sensitivity were fully restored in 
cel-unc-38-rescued lines, this difference in levamisole sensitivity observed in the 
gpa-unc-38.1-rescued lines is unlikely to be a side effect of the microinjection 
technique used to produce the lines. Although data for one line of gpa-unc-38.1 is 
shown in this chapter, two lines were also created and analysed for gpa-unc-38.1, 
which both demonstrated the same behaviour. As the basal thrashing rate of 
unc-38(x20) worms is rescued by transformation with gpa-unc-38.1, it can be assumed 
that gpa-unc-38.1 is able to assemble with the four remaining L-nAChR C. elegans 
subunits and produce a functional receptor which is able to bind acetylcholine. 
There are two possible hypotheses for why gpa-unc-38.1 is able to rescue the binding 
of acetylcholine, despite lacking the vicinal cysteines that define cel-unc-38 as an 
α-subunit. Firstly, gpa-unc-38.1 may bind acetylcholine directly. As discussed in 
previous chapters, this goes against several lines of evidence regarding the role of the 
vicinal cysteines in α-type subunits. Mutagenesis of the vicinal cysteines has 
demonstrated that they are essential, and other residues in Loop C are also involved in 
binding acetylcholine (Mishina et al. 1985; Tomaselli et al. 1991). As these important 
residues are absent in gpa-unc-38.1 it is surprising that this subunit is able to rescue 
the basal thrashing rate of unc-38(x20) mutants. However, an explanation may be 
sought from the contribution of the other subunits in the receptor to acetylcholine 
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binding. As discussed in Chapter 4, there are two proposed conformations of the 
L-type nAChR (Figure 5-17). In one, there are two postulated acetylcholine binding 
sites situated between the positive face of UNC-63 and the negative face of UNC-29, 
and another between the positive face of UNC-38 and the negative face of LEV-1. Two 
non-consecutive binding sites for acetylcholine are sufficient for efficient opening of 
the channel, while a single binding site only provides transient opening currents (Rayes 
et al. 2009). As this conformation of the L-type nAChR has only two binding sites, one 
of which would be disturbed by the substitution of gpa-unc-38.1, this is unlikely to be 
the conformation of the receptor. In the second possible conformation of the receptor, 
there are three postulated acetylcholine binding sites, one between the positive face 
of LEV-8 and UNC-29, one between the positive face of UNC-38 and the negative face 
of UNC-63 and one between the positive face of UNC-63 and LEV-1. Substitution of 
gpa-unc-38.1 would disrupt the agonist binding site between UNC-38 and UNC-63, but 
the others should remain intact providing a sufficient number of non-consecutive 
binding sites between subunits. This model of native conformation of the C. elegans 
receptor, and the effect of substituting Gpa-UNC-38.1 may explain the ability of 
Gpa-UNC-38.1 to rescue the thrashing activity, and thus acetylcholine binding activity 
of the unc-38(x20) mutants despite lacking the key motifs involved in acetylcholine 
binding. This could also still account for the observation that levamisole sensitivity is 
not fully restored to the gpa-unc-38.1 rescued unc-38(x20) mutants as Gpa-UNC-38.1 
has assembled with the receptor, but does not contain the glutamate at position 153 
associated with levamisole sensitivity (Rayes et al. 2004).  
5.4.3 Expression of gpa-unc-38.1 to replace cel-unc-38 in Xenopus oocytes does not 
support a difference in levamisole binding for gpa-unc-38.1 
The expression of chimeric receptors to examine properties of particular subunits is 
done routinely in the studies on insect nicotinic acetylcholine receptors. The nAChRs of 
insects, for reasons that are not well understood, have been difficult to express in 
Xenopus oocytes. Chimeric genes based on vertebrate subunits in which loops from 
insect nAChRs have been substituted have been used to investigate neonicotinoid 
sensitivity (Shimomura et al. 2005). Commonly, α-subunits from insects required the 
expression of β-vertebrate subunits alongside them in order to yield functional 
receptors (Ballivet et al. 1996; Huang et al. 1999; Bertrand et al. 1994). In this work, a 
similar chimeric approach has been taken to investigate the Gpa-UNC-38.1 subunit. 
The expression of gpa-unc-38.1 with the remaining C. elegans subunits (unc-29, 
unc-63, lev-1 and lev-8) and the required ancillary factors (ric-3, unc-50 and unc-74 
from H. contortus) was able to yield a functional receptor in Xenopus oocytes. 
However, the dose-response curve for both acetylcholine and levamisole was 
determined to be very similar between the chimeric receptor (with gpa-unc-38.1) and 
the native receptor (with cel-unc-38). Both the chimeric and native receptors also 
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shared a similar pharmacological response to a panel of nicotinic acetylcholine 
receptor agonists. This evidence suggests that there is no difference in the 
acetylcholine binding activity of the chimeric channel compared to the native channel. 
This is in agreement with the data obtained from the rescue lines, where gpa-unc-38.1 
is able to rescue unc-38(x20) mutant perhaps due to the location of the other agonist 
binding sites on the receptor, which are unaffected by the presence of gpa-unc-38.1 or 
cel-unc-38. 
However, the observation that the EC50 for levamisole does not change between the 
native and chimeric receptor is more surprising, and appears to be contradictory to the 
results obtained from the rescue lines. In theory, the chimeric receptor expressed in 
Xenopus oocytes should be a reconstitution of the receptor in the gpa-unc-38.1 
rescued line and should behave in the same manner. Other factors such as a 
side-effect of the unc-38(x20) background of the mutant worm can be discounted, as 
cel-unc-38 was able to rescue the levamisole sensitivity of the unc-38(x20) worms. 
Additionally, the effects of varying copy number of the heterologously expressed gene 
has been diminished as two separate lines for both cel-unc-38 and 
gpa-unc-38.1-rescued lines were created, which yielded consistent results (Anna 
Crisford, personal communication). It is also contrary to previous studies which identify 
cel-unc-38 and the glutamate at position 153 in loop B as involved in levamisole 
sensitivity (Rayes et al. 2004; Martin and Robertson 2007). It is difficult to reconcile the 
mismatch between the levamisole sensitivity of the rescued lines and the reported 
levamisole sensitivity from the Xenopus oocyte work.  
One explanation may be that Gpa-UNC-38.1 was unable to assemble with the 
remaining C. elegans subunits, and that the recordings obtained for the chimeric 
receptor were actually the recordings for a receptor comprising only of the four 
subunits, cel-unc-29, cel-unc-63, cel-lev-1 and cel-lev-8. Several lines of evidence argue 
against this as a possibility. In Boulin et al. (2008), 8 genes (five subunits and 3 ancillary 
factors) were required for robust expression of the L-type nAChR in Xenopus oocytes. 
Omission of any of the five subunits resulted in channel recordings that were 97% 
lower than that of the complete receptor. A similar reduction in channel opening is 
observed when hco-unc-38 is omitted from the injected cRNAs to produce functional 
L-type nAChRs of H. contortus (Boulin et al. 2011). Functional receptors have been 
produced with only unc-29, lev-1, and unc-38, however the currents obtained for these 
in response to levamisole and acetylcholine are very low (~5nA) (Fleming et al. 1997). 
Additionally, the pharmacology of the chimeric and native receptor are very similar to 
each other (acetylcholine > Lev > DMPP, Pyr > Nic). The pharmacology of the 
three-subunit receptor produced by Fleming et al. (1997) is very different from this 
(Lev > acetylcholine > DMPP), and it might be expected, if only a four subunit-type 
receptor were produced in the chimeric receptor experiment, the pharmacology of 
that receptor would be different. 
178 
 
The role of the ancillary factors used in this experiment may be of consideration. RIC-3, 
UNC-50 and UNC-74 have been identified as essential for robust expression of both the 
C. elegans L-type nAChR (Boulin et al. 2008) and the H. contortus L-type nAChR (Boulin 
et al. 2011). RIC-3 has been shown to affect the arrangement and stoichiometry of 
some receptors. For example, for the DEG-2/DEG-3 type receptor, the presence of 
RIC-3 increases the number of DEG-3 subunits in the receptor (Ben-Ami et al. 2005). It 
is possible, that use of the ancillary factors from H. contortus rather than from                 
C. elegans affects receptor stoichiometry due to the different affinities RIC-3 from both 
species may have. This may lead to a different arrangement of subunits being 
expressed in the gpa-unc-38.1-rescued unc-38(x20) lines compared to the 
arrangement in the heterologous expressed chimeric receptor, which may have an 
impact on how and where levamisole binds. However, this hypothesis does not 
account for the reported importance of the glutamate at position 153 in Loop B of 
Cel-UNC-38. 
Contrary to expectations, a difference in the EC50 values obtained for levamisole 
between the native C. elegans receptor and the chimeric receptor that contains 
gpa-unc-38.1 was not identified. However, the ability of gpa-unc-38.1 to rescue the 
thrashing rate of the unc-38(x20) worms despite lacking key motifs involved in 
acetylcholine binding, but not levamisole sensitivity is consistent in different 
transgenic lines. These contradictory results from two different experiments cannot 
yet be reconciled. Although acetylcholine-binding rescue may be a matter of 
gpa-unc-38.1 filling a purely structural role, its role in levamisole resistance in                    
G. pallida J2s is still unclear.   
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Figure 5-17: Potential changes caused in acetylcholine binding sites on the L-type nAChR 
caused by substituting Gpa-UNC-38.1 on different conformations of the native C. elegans 
receptor 
a) Schematics of one possible conformation of the native L-type nAChR and the possible effect 
on acetylcholine binding sites of substitution of Gpa-UNC-38.1. In the original conformation, 
only two canonical acetylcholine binding sites are present. This is reduced to one if 
Gpa-UNC-38.1 is substituted in place of Cel-UNC-38. b) Another possible conformation of 
native L-type nAChR. Three acetylcholine binding sites are present in this conformation. On 
substitution of Gpa-UNC-38.1, two are present. Potential agonist binding sites are represented 
with a red circle, α-subunits are coloured in blue and non-α are coloured in grey. 
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Summary 
 
• G. pallida and G. rostochiensis are less sensitive to levamisole than C. elegans  
 
• This resistance may be due to the differences in the composition of the 
L-nAChR and key differences in the amino acid sequence of Gpa-UNC-38.1 
 
• Rescue of unc-38(x20) mutants with gpa-unc-38.1 restores basal thrashing 
activity but not full sensitivity to levamisole 
 
• Gpa-unc-38.1 can be used to replace cel-unc-38 to produce a functional 
receptor in Xenopus oocytes, but no difference in current induced by 
levamisole was observed 
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6. Investigation into the significance of key amino acid 
motif differences between Cel-UNC-38 and 
Gpa-UNC-38.1 
 Introduction 6.1
The use of chimeric genes can facilitate the understanding about which key amino acid 
motifs affect aspects of protein function. As discussed in the Introduction, 
transformation techniques have not been developed for plant-parasitic nematodes 
and C. elegans has been used as a heterologous expression system to characterise the 
role of genes from parasitic nematodes. 
6.1.1 Transformation of C. elegans by microinjection 
Transformation by microinjection is a well-established technique in C. elegans and may 
be used to investigate the role of genes by mutant rescue, the down-regulation of 
genes by RNAi, gene expression patterns via promoter-reporter constructs and 
sub-cellular localisation of GFP-tagged proteins. 
DNA is injected into the gonads of young adult hermaphrodites. The two gonads of          
C. elegans are U-shaped structures, connected in the centre at the vulva. Oocytes 
within the gonad follow a continuum of development. Nuclei are individually 
enveloped by plasma membrane, and line up along the proximal arm of the gonad. 
Each oocyte enters the spermatheca, located near the vulva, and is fertilised. 
Developed mature eggs are situated at the vulva ready for egg-laying and mitotic cells 
are present towards the distal ends of the gonad. DNA is injected into the cytoplasmic 
core of the distal germ line where developing germ nuclei arrested in meiosis I are 
abundant. As C. elegans is transparent, the needle can be inserted into the correct 
position and the injection of liquid into the gonad can be easily observed by a visible 
swelling of the organ. Injection in this location allows many nuclei to be bathed in the 
injection mixture (Stinchcomb et al. 1985).  
6.1.2 Fate of DNA introduced by microinjection 
The fate of DNA introduced into the gonad of C. elegans is not well characterised. The 
injected DNA is expressed in the F1 generation following microinjection (generally 
20-50 transgenic individuals are obtained), but mosaic expression is typically observed. 
In some members of the F1 generation, the injected DNA becomes the target of 
recombination reactions which assemble it into large extra chromosomal arrays. Most 
transformants obtained at the F1 generation will not transmit the transgene to the F2 
generation (Mello and Fire 1995). The concentration of DNA injected influences the 
likelihood of large, stable extrachromosomal arrays forming. Total concentrations 
lower than 50 ng/µl are less likely to form stable arrays. Arrays that assemble to a size 
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of over 700 kb become heritable (Mello et al. 1991). It has been estimated that a 
transformed cell contains between 70-300 plasmid copies comprising multiple copies 
of both marker plasmid and transgene plasmid (Stinchcomb et al. 1985). The structure 
of the extrachromosomal arrays is found to be very different between independently 
transformed lines, even if obtained from the same microinjected adult. This leads to 
considerable variation in the copy number of the introduced transgene between 
independent lines. However, within the same transformed line the structure of the 
arrays appears to be stable (Stinchcomb et al. 1985). For this reason, it is preferable to 
generate multiple independently transformed lines in order to determine any effect 
due to variation in copy number. Even in stably transformed lines, the inheritance of 
the extrachromosomal arrays is non-Mendelian. A transformed adult does not pass the 
extrachromosomal array to 100% of its progeny. The percentage of transmission may 
vary from 10 to 90% of the progeny that inherit the extrachromosomal array. 
Extrachromosomal arrays very rarely integrate into the genome, although integration 
can be induced by mutagenesis. Techniques use a mutagenic agent (EMS, X-ray, 
gamma-ray) to induce chromosomal breaks. Subsequent screening for transformed 
lines with 100% transmission rate of the transgenic marker selects for integration of 
the extrachromosomal array into the genome (Mello and Fire 1995). 
As a transgene is often introduced under the control of a promoter on the introduced 
vector, it is possible that this promoter does not fully mimic the endogenous 
expression of the gene. This, along with the copy number issue, must also be 
considered when drawing conclusions from a microinjection experiment.  
6.1.3 Choice of marker gene 
The marker gene allows selection of transformants. It should enable easy identification 
of transformants, but not interfere with any further experimental work. 
The rol-6 gene encodes a collagen gene. Rol-6 is a popular marker due to its easy 
identification under 5x magnification. In L2-stage worms and later, this marker is 
observed as a right-handed rolling phenotype. Unc-22 antisense DNA is a marker which 
interferes with normal expression of UNC-22 (a muscle filament protein). Transformed 
worms have low mobility and a twitching phenotype. Pha-1(+) encodes a bZip-like 
transcription factor. This marker requires the injection of pha-1 (e2123ts) mutant 
animals which are embryonic lethal at 25°C. The Pha-1(+) marker rescues this 
phenotype allowing transformants to be selected by survival of progeny at 25 °C. 
Readily visible expression of GFP under the control of a different promoter is also 
commonly used as a transformation marker. Currently available constructs include 
unc-119::GFP (expressed in neurones), glr-1::GFP (expressed in interneurons) (Hope 
1999) and pmyo-2::GFP (expressed in pharyngeal muscle) (Gonzalez-Serricchio and 
Sternberg 2006). 
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The appropriate marker gene depends on experimental design. Any experiment which 
requires analysis of locomotion in transformants would not favour a marker gene that 
affects normal locomotion behaviour (e.g. rol-6 and unc-22 antisense DNA). Mutant 
rescue experiments which require a particular mutant background line to be injected 
would also not favour a marker gene which requires a particular host strain (e.g. 
pha-1). The use of a GFP reporter construct as a selection marker requires a 
fluorescence microscope for selection of initial transformants and maintenance of the 
transformed line. 
6.1.4 The use of C. elegans to analyse cel-unc-38 and gpa-unc-38.1 chimeric genes 
In order to investigate the significance of the key amino acid differences between 
Cel-UNC-38 and Gpa-UNC-38.1, chimeric genes were generated in which these 
residues were swapped. The rationale behind the selection of these changes is 
discussed in 4.4.2.5. The chimeric genes were transformed into C. elegans 
(background: unc-38(x20)) and the effect of the key amino acid swaps on the ability to 
restore levamisole sensitivity and the ability to restore basal thrashing was analysed. In 
this experiment, pmyo-2::GFP has been selected as the marker gene as it does not 
interfere with locomotion and is only expressed in pharyngeal muscle limiting 
interaction with body-wall muscle.  
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Aims 
 
• Explore key amino acid residues that may account for difference in levamisole 
sensitivity between Cel-UNC-38 and Gpa-UNC-38.1 
 
• Investigate the effect of the absence of the YxxCC motif in Gpa-UNC-38.1 
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 Materials and methods 6.2
6.2.1 Production of chimeric unc-38 coding sequences by Spliced Overlap Extension 
Chimeric genes were produced incorporating sequences from cel-unc-38 and 
gpa-unc-38.1 (Figure 6-1). A two-step process was used to produce chimeric coding 
regions of unc-38 with altered sequences. Each coding region was first amplified in two 
halves by primers designed to introduce the desired sequence change and provide an 
overhang complementary to the other half of the gene. Products were amplified from 
G. pallida unc-38.1 cDNA clone in the pCR™8/GW/TOPO® vector or C. elegans unc-38 
cDNA clone in the pCR™8/GW/TOPO® vector, using Platinum Taq High Fidelity 
(Invitrogen, UK). The thermocycling program was conducted on a Biorad T100 
thermocycler and comprised an initial denaturing step at 94°C for 2 min, 30 steps of 
denaturing at 94°C for 30 secs, 55°C annealing for 30 secs and an extension at 68°C for 
1.5 min (1 min/kb of amplified product). The two products were then isolated by gel 
extraction and 5 μl of each amplified fragment was mixed. A second reaction amplified 
the complete coding region with the altered sequence as the overlapping products 
allowed extension across the whole gene. A schematic of this process can be seen in 
Figure 6-2. Primers used can be found in Table 8. An example of the products of this 
process as seen on an agarose gel is shown in Figure 6-3. Each full-length chimeric 
coding region was cloned into the pCR™8/GW/TOPO® vector to form an entry clone as 
in 3.2.14. Clones were sequenced to ensure that the desired changes had been made, 
and that no errors had been introduced elsewhere in the sequence. 
The constructs produced will be referred to by the following nomenclature for the rest 
of the chapter:  
Gpa-unc-38.1-H236_I234delinsNYPSCCPGSA  
Cel-unc-38-N234_I242delinsHFFASKNGI 
Gpa-unc-38.1-Y175_G178delinsFSEN 
Cel-unc-38-F174_N177delinsYPSG 
Gpa-unc-38.1-M302I 
Cel-unc-38-I301M 
6.2.2 Generation and transformation of constructs 
Gateway® cloning was used to transfer each chimeric gene produced in 6.2.1 to the 
pDEST-myo3 destination vector (obtained from Anna Crisford, University of 
Southampton). The vector contains the promoter region for the myo-3 gene and drives 
expression in body wall muscle (Okkema et al. 1993). Recombination sites downstream 
of the promoter region (attR1 and attL1) allow genes from compatible Entry Clones to 
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be inserted into the vector (Figure 1 5). The destination vector itself was propagated 
by selection on ampicillin/chloramphenicol plates in One Shot® ccdB Survival™ 2 T1R 
Competent cells (Invitrogen, UK). After recombination with an Entry Clone to produce 
an Expression vector, the ccdB gene is excised and the Expression vector may be 
propagated in standard competent cells. 
100 ng of the Entry clone was added to 150 ng of pDEST-myo3 and TE buffer (pH 8) to 
a final volume of 8 µl. 2 µl of thawed LR Clonase™ (Invitrogen, UK) was added to the 
mixture. The reaction was incubated at 25 °C for 1 hr. 1 µl of Proteinase K was added 
to terminate the reaction and incubated at 37 °C for 10 minutes.  
6.2.3 Preparation of other materials for microinjection 
Needles for microinjection were made from aluminosilicate glass tubes (1.0 OD x .5 ID) 
(Sutter, USA). Needles were pulled to a fine point using a needle puller (Sutter 
instruments, P-2000). Agarose pads for mounting worms during microinjection were 
prepared on glass microscope slides. Molten 2% agarose was dropped onto the centre 
of the glass slide. Another glass side was placed at a 90° angle to the bottom slide and 
was used to press the drop of agarose into a thin and smooth surface. 
6.2.4 Production of injection mixture 
An injection mixture was produced comprising 30 ng/µl of an Expression vector and 50 
ng/µl pPD118.33. pPD118.33 was used as a marker gene for the transformation 
process, and contains the myo-2 promoter and the coding sequence for GFP. The 
myo-2 promoter drives expression in the pharyngeal muscles of C. elegans (Okkema et 
al. 1993) providing a clear marker for transformation (Figure 6-4). To remove 
contaminants and allow smooth unhindered flow of injection mixture, the mixture was 
centrifuged at 14,500 rpm three times. Each time, the top half of the injection mixture 
was transferred to a fresh tube and the bottom half discarded. This was carried out 
early on each day of microinjection. Needles were loaded with injection mixture by 
capillary action.  
6.2.5 Transformation of C. elegans by microinjection 
Hermaphrodite C. elegans (Strain, unc-38(x20)) were transformed by microinjection. 
24 hours prior to microinjection, L4 hermaphrodites (identified by a white-patch near 
the centre of the body) were transferred onto a fresh NGM-lite plate to ensure that 
young adult worms would be injected the following day. Individual hermaphrodites 
were mounted onto 2% agarose pads into a drop of halocarbon oil to immobilise them 
for microinjection. Microinjection was carried out using an inverted microscope. 
Needle manipulations were carried out using an Injectman NI 2 micromanipulator. 
Injection pressure was generated by FemtoJet. DNA was injected into the distal arm of 
either one or both gonads until the organs appeared swollen (Figure 6-4a). 
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Microinjected worms were transferred to individual plates in a drop of M9 buffer and 
stored at 20 °C for 3-4 days. Transformants were selected from the progeny of injected 
hermaphrodites by selecting GFP expressing worms, which will additionally contain the 
transgene of interest as well (Figure 6-4b). Individual transformed animals from this F1 
generation were transferred onto fresh plates (1 per plate) and the progeny of these 
examined for GFP expression. Any lines still displaying the GFP marker in the F2 
generation were characterised as stable transformed lines. 
6.2.6 Maintenance of transformed stable lines 
Independent lines resulting from transformation events were maintained separately 
on NGM-lite plates seeded with OP50. Every 3-4 days, 15 GFP-expressing individuals 
per line were transferred to new plates in order to maintain healthy populations.  
6.2.7 Analysis of mutant lines rescued by chimeric genes 
Preliminary analysis of thrashing rate over the full range of levamisole concentrations 
(0, 1, 10, 50, 100 µM) was carried out as described in 5.2.3.1. Undergraduate students 
assisted in collecting preliminary data, allowing a large number of worms to be 
analysed. This data was used subsequently used to select concentrations of levamisole 
at which to conduct more thorough analysis. Each day, per assay, the wild-type (N2), 
the mutant background (unc-38(x20)), the line transformed with cel-unc-38 or the line 
transformed with gpa-unc-38.1 and two independent mutant lines transgenic for one 
the chimeric genes were analysed. The control line used was determined by the 
backbone of the mutant line that was analysed. A minimum of 24 worms per line per 
levamisole concentration were analysed. Each assay was repeated twice. Analysis of 
the Cel-unc-38-F174_N177delinsYPSG line is an exception, due to technical difficulties. 
The effect of the marker gene was tested by analysing the thrashing rate of 
unc-38(x20) worms transformed with pmyo-2::GFP alone. There was no significant 
difference in thrashing rate between unc-38(x20) and mutant worms transformed with 
pmyo-2::GFP. 
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Figure 6-1: Schematic of chimeric genes produced by Spliced Overlap Extension 
a) Alignments between Cel-unc-38 (top) and Gpa-unc-38.1 (bottom) showing key 
amino acid differences in loop B, loop C and transmembrane domain 2. b-d) Schematic 
of chimeric genes produced by spliced overlap extension 
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Table 8: Primers used for Spliced Overlap Extension PCRs  
 
Chimeric gene Process Template Forward Primer Reverse Primer 
G. pallida - 
NYPSCCPQSA 
sequence swap 
PCR1 rxn 1 
PCR1 rxn 2 
G. pallida unc-38 in 
pCR™8/GW/TOPO® 
GGTATATGCAAACAATATGCTTT ctgtggacaacaacttggatagttCTTGTTTCGTTTGGTCGCCTG 
ccaagttgttgtccacagagtgctTACGAAGAGATGGATTTTGACTTGGC GGTATATGCAAACAATATGCTTT 
PCR2 Mixed products of PCR1 CTGATGGTCTATCACCGGAA GGTATATGCAAACAATATGCTTT 
C. elegans - 
HFASKNGI 
sequence swap 
PCR1 rxn 1 
PCR1 rxn 2 
C. elegans unc-38 in 
pCR™8/GW/TOPO® 
ATGCGCTCTTTTTGGTTATTCC accattttttgatgcaaaaaaatgCTTTGCTCTTCTTTTGGCAACTC 
ttttttgcatcaaaaaatggtatcTATATTGATGTTACTTATTACCTCC CTCAGAAACTAATTGGATTAGCAG 
PCR2 Mixed products of PCR1 CTGATGGTCTATCACCGGAA CTCAGAAACTAATTGGATTAGCAG 
G. pallida – 
single I > M change 
PCR1 rxn 1 
PCR1 rxn 2 
G. pallida unc-38 in 
pCR™8/GW/TOPO® 
CTGATGGTCTATCACCGGAA GCAACAAAAAGAAGATTGTGAGAGCGAC 
CACAATCTTCTTTTTGTTGCTTATCGAG GGTATATGCAAACAATATGCTTT 
PCR2 Mixed products of PCR1 CTGATGGTCTATCACCGGAA GGTATATGCAAACAATATGCTTT 
C. elegans – 
single M > I change 
PCR1 rxn 1 
PCR1 rxn 2 
C. elegans unc-38 in 
pCR™8/GW/TOPO® 
ATGCGCTCTTTTTGGTTATTCC GTGAGCAGCAAGAAGAACATAGTCAAGGC 
CCTTGACTATGTTCTTCTTGCTGCTCACT CTCAGAAACTAATTGGATTAGCAG 
PCR2 Mixed products of PCR1 ATGCGCTCTTTTTGGTTATTCC CTCAGAAACTAATTGGATTAGCAG 
G. pallida – 
FSEN > YPSG 
change 
PCR1 rxn 1 
PCR1 rxn 2 
G. pallida unc-38 in 
pCR™8/GW/TOPO® 
CTGATGGTCTATCACCGGAA ttcagaaaAAGTCCAGGATCCAAATTTGAGAAG 
GGACttttctgaaaatCTGCTTCATC GGTATATGCAAACAATATGCTTT 
PCR2 Mixed products of PCR1 CTGATGGTCTATCACCGGAA GGTATATGCAAACAATATGCTTT 
C. elegans – 
YPSG > FSEN 
change 
PCR1 rxn 1 
PCR1 rxn 2 
C. elegans unc-38 in 
pCR™8/GW/TOPO® 
ATGCGCTCTTTTTGGTTATTCC tccagacgggtaTGTCCAGGAGCCGAACT 
tacccgtctggaCTGCTCTCCGTGGAATTGAACGAACCA CTCAGAAACTAATTGGATTAGCAG 
PCR2 Mixed products of PCR1 ATGCGCTCTTTTTGGTTATTCC CTCAGAAACTAATTGGATTAGCAG 
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Figure 6-2: Schematic of Spliced Overlap Extension PCRs 
a) The gene is amplified in two halves in separate PCRs using Primers A and B or Primers C and 
D. Primers B and C are designed to introduce the desired mutation (coloured blue and red). b) 
Products AB and CD are produced, which now incorporate the desired mutation. c) A second 
PCR is conducted using primers A and D to amplify the full gene. The overlap introduced 
between the two halves allows them to anneal, and the complete coding region to be 
amplified. d) The full-length product is produced with the desired mutation. 
Primer B
Product AB Product CD
Primer CPrimer A
Primer D
a
Primer A
Primer D
b
c
d
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Figure 6-3: Products of Spliced Overlap Extension visualised by agarose gel electrophoresis 
Lane 1 and 2 contain products AB and CD respectively after the first round of amplification. 
Lane 3 contains the full length chimeric gene amplified after the second PCR. Invitrogen 1Kb+ 
ladder was used and values are indicated in bp. 
192 
 
 
Figure 6-4: Example of suitable hermaphrodite for microinjection and marker gene for 
selection of transformants 
a) A young-adult hermaphrodite. In the uterus, a row of developed mature eggs can be seen. 
Towards the distal end of the gonad, individual development oocytes are shown. At the distal 
end, the germ line filled with developing nuclei can be seen. Injection in this location floods 
many developing nuclei with the transforming DNA. Image taken under 10x magnification b) 
The pmyo-2::GFP marker gene was used to select positive transformants. This drives GFP 
expression in the pharynx and allows for simple selection. Image taken under 20x 
magnification. 
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Figure 6-5: Vector map of pDEST-myo3 
pDEST-myo3 was used as a destination vector. Chimeric genes produced by spliced overlap 
extension were cloned into pDEST-myo3 by GATEWAY® cloning. The insertion sites are 
downstream of the myo-3 promoter which drives expression in body-wall muscle of C. elegans 
pmyo-3 1..2339
attR1 2387..2487
CmR 2596..3252
attR2 4050..3943
ccdB 3597..3902
LacO 7282..7311
pDEST myo3
7328 bp
ColE1 origin 6267..6949
AmpR 5510..6169
LacO
ColE 1 Ori
Ampicillin 
resistance
attR2
ccdB
chloramphenicol 
resistance
ttR1
Pmyo-3
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 Results 6.3
The chimeric transgene lines were analysed by thrashing assays. Both the ability of the 
chimeric gene to rescue basal thrashing, and its effect on levamisole sensitivity were 
investigated. Each assay analysed the wild-type strain (N2); the mutant strain 
unc-38(x20); the transgenic line rescued with cel-unc-38 (if the chimeric gene was 
based on cel-unc-38) or gpa-unc-38.1 (if the chimeric gene was based on gpa-unc-38.1) 
to allow comparison to the native gene and two independent transgenic lines for one 
of the chimeric genes. Throughout these assays, the thrashing rate of the unc-38(x20) 
does not change significantly unless stated otherwise.  
6.3.1 The YxxCC motif involved in acetylcholine binding 
The effect of addition of the YxxCC motif to Gpa-unc-38.1 and the removal of the 
YxxCC motif from Cel-unc-38 was investigated. 
6.3.1.1 Addition of the YxxCC motif to Gpa-unc-38.1 does not affect ability of 
chimeric genes to rescue basal thrashing or levamisole sensitivity 
Preliminary data collected at a range of levamisole concentrations for wild-type (N2) 
and unc-38(x20) compared to the two independent transformations with 
Gpa-unc-38.1-H236_I234delinsNYPSCCPGSA indicates that this chimeric gene does not 
affect rescue of basal thrashing rate compared to the wild-type of gpa-unc-38.1 and 
that levamisole sensitivity is not affected. To confirm this, further assays were 
conducted at 50 μM levamisole and 100 μM levamisole (Figure 6-6).  
In the assay conducted for 50 μM levamisole, basal thrashing was fully rescued in the 
Gpa-unc-38.1 line and the two lines transgenic for 
Gpa-unc-38.1-H236_I234delinsNYPSCCPGSA (L1 and L2) as the thrashing rates for 
these lines at t= 0 mins were not significantly different from N2. After addition of 
levamisole, at t= 10 mins, the thrashing rates of gpa-unc-38.1 and the two chimeric 
transgene lines were significantly higher than the N2 strain but were not significantly 
different from each other. At t= 30 mins, the thrashing rate of the N2 strain was 
further reduced. The thrashing rates of the gpa-unc-38.1 transgenic line and two 
chimeric transgene lines were not significantly lower than at t= 10 mins and were not 
significantly different from each other (Figure 6-7).  
In the assay conducted for 100 μM levamisole, basal thrashing rate was again fully 
rescued by Gpa-unc-38.1 and one of the two chimeric transgene lines (L1). However, 
whilst the rate of the L2 chimeric transgene line was not significantly different from 
either L1 or gpa-unc-38.1, and it was increased significantly compared to unc-38(x20), 
it was not fully restored to the wild-type. After addition of levamisole, at t= 10 mins, 
the thrashing rates of all lines declined and were not significantly different from each 
other. However, after 30 minutes the N2 thrashing rate had decreased further and was 
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significantly lower than all other lines. The thrashing rates of the gpa-unc-38.1 line and 
two chimeric transgene lines did not decrease after t= 10 mins, and were not 
significantly different from each other at t= 30 mins (Figure 6-8). 
6.3.1.2 Removal of the YxxCC motif from cel-unc-38 does not affect ability of 
chimeric genes to rescue basal thrashing, or affect sensitivity to levamisole 
Preliminary data were collected at a range of levamisole concentrations for the 30 
minute time point for the wild-type (N2), unc-38(x20) and the two independent 
transformations of Cel-unc-38-N234_I242delinsHFFASKNGI. The thrashing rate of the 
two chimeric transgene lines reduce in response to levamisole exposure similarly to 
wild-type (N2). Further assays were conducted at 50 μM and 100 μM (Figure 6-9).  
In the assay conducted for 50 μM levamisole, basal thrashing at t=0 mins for 
cel-unc-38, and the two chimeric transgene lines are rescued fully compared to 
wild-type (N2). On addition of levamisole at t= 10 mins, the thrashing rate of all lines 
(except unc-38(x20)) was found to be not significantly different from each other. At t= 
30 mins, the thrashing rate of all lines (except unc-38(x20)) had reduced further and 
are not significantly different from each other (Figure 6-10).  
At t= 0 mins, for the assay conducted for 100 μM levamisole, basal thrashing rate for 
the cel-unc-38 and two chimeric transgene lines are fully rescued to wild-type. At t= 10 
mins the thrashing rate of all lines (except unc-38(x20)) were significantly reduced and 
were not significantly different from each other. At t= 30 mins, the thrashing rate of all 
lines (except unc-38(x20)) reduced further but remained non-significantly different 
from each other. In this experiment, the thrashing rate of the unc-38(x20) line reduced 
significantly throughout the duration of the experiment to 63% of initial thrashing rate 
(Figure 6-11). 
6.3.2 Investigation into the effect of a glutamate residue in loop B, which may be 
involved in levamisole sensitivity 
The effect of introducing a glutamate into loop B of gpa-unc-38.1 and the removal of 
glutamate from loop B of cel-unc-38 was investigated. This residue had been identified 
as being involved in levamisole sensitivity (Rayes et al. 2004). 
6.3.2.1 Introduction of a glutamate residue in loop B of gpa-unc-38.1 does not 
affect ability of chimeric genes to rescue basal thrashing and does not affect 
levamisole sensitivity 
Preliminary data collected at the 30 minute time point at a range of levamisole 
concentrations for the chimeric lines Gpa-unc-38.1-Y175_G178delinsFSEN suggested 
that these chimeric genes were not more sensitive to levamisole, as they retained 
more resistance to levamisole than the wild-type (N2) worms. Preliminary data also 
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suggested that there may be an effect on basal thrashing. Further experiments were 
conducted at 50 μM and 100 μM (Figure 6-12). 
In the 50 μM levamisole assay, basal thrashing is rescued to wild-type levels for 
gpa-unc-38.1 and both chimeric gene lines at t= 0 mins. At t= 10 mins, the thrashing 
rate of the gpa-unc-38.1 and N2 strain was reduced and are not significantly different 
from each other. The thrashing rates of both chimeric transgene lines are significantly 
higher than the N2 and gpa-unc-38.1 lines. At t= 30 mins, the thrashing rate of the N2 
strain has reduced further, but the thrashing rate of the gpa-unc-38.1 line is 
significantly higher than that of the N2 strain. The thrashing rate of the two chimeric 
transgene lines is reduced from t= 10 mins, and are not significantly different from 
gpa-unc-38.1 (Figure 6-13).  
In the 100 μM levamisole assay, basal thrashing is rescued to wild-type (N2) levels for 
gpa-unc-38.1 and one of the chimeric transgene lines (L1) at t= 0 mins. Although, L2 is 
not rescued to wild-type (N2) levels in this experiment, the basal thrashing rate of the 
L2 line has been seen to be at wild-type levels in previous assays, and is also 
significantly higher than that of the unc-38(x20) line indicating that thrashing rate is 
rescued from the unc-38(x20) background. At t= 10 mins, the thrashing rate of the N2 
strain is significantly lower than all other lines. The thrashing rate of the gpa-unc-38.1 
line is not significantly different from transgenic chimeric line L2. The thrashing rate of 
the chimeric lines L1 and L2 are not significantly different from each other. At t = 30 
mins, the thrashing rate of the N2 strain is significantly lower than at t = 10 mins, and 
lower than all other lines. The thrashing rates of the gpa-unc-38.1 line and L1 and L2 
are significantly higher (Figure 6-14).  
6.3.2.2 Removal of a glutamate residue from loop B of cel-unc-38 does not affect 
ability of chimeric genes to rescue basal thrashing and does not affect 
levamisole sensitivity 
Only preliminary data is available for the chimeric gene 
Cel-unc-38-F174_N177delinsYPSG, as only one independently transformed line was 
successfully generated for this chimeric gene. The line obtained had a low percentage 
of transformants per generation, and was therefore difficult to obtain enough 
transgenic individuals to analyse each assay. The transformants also were 
slow-growing. The line was difficult to maintain and died out before a full analysis 
could be made.  
The preliminary results for this line at a range of levamisole concentrations after 30 
minutes indicated that the response to levamisole is likely to be similar to that of the 
wild-type N2 line (Figure 6-15).  
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In the 50 μM assay, at t= 0 mins, the thrashing rate of the chimeric transgene lines line 
was rescued to wild-type levels and was not found to be significantly different to 
wild-type (N2). A t= 10 mins, the thrashing rate of both the transgenic chimeric line 
and the wild-type line was significantly lower and were not significantly different to 
each other. At t= 30 mins, the thrashing rate of the wild-type (N2) line and the 
transgenic chimeric line reduced further, and were not significantly different from each 
other (Figure 6-16). 
In the 100 μM assay, basal thrashing of the chimeric transgene lines were not found to 
be fully rescued to wild-type levels. At t= 10 mins, the thrashing rate of both the 
chimeric transgene lines line and the wild-type (N2) strain reduced to the same extend 
and were not found to be significantly different from each other. At t= 30 mins, the 
thrashing rate of the wild-type (N2) line and the transgenic chimeric line did not 
reduce significantly further (Figure 6-17).  
6.3.3 Investigation into a single amino acid residue change in transmembrane 
domain 2 which may affect channel opening properties and levamisole 
sensitivity 
The effect of a single amino acid change in the second transmembrane domain of 
cel-unc-38 and gpa-unc-38.1 was investigated. A valine to methionine substitution in 
the neuronal subunit acr-2 has previously been shown to affect channel opening 
properties and cause a hyperactive response to acetylcholine (Jospin et al. 2009).  
6.3.3.1 A methionine to isoleucine change in the TM2 domain of gpa-unc-38.1 
affects the ability of the chimeric gene to rescue basal thrashing, but not 
levamisole sensitivity 
Preliminary results gathered for the 30 minute time point at a range of levamisole 
concentrations for thrashing rates of the line Gpa-unc-38.1-M302I indicated that basal 
thrashing rate may be impaired for this line. Levamisole sensitivity did not appear to 
be affected. Further assays were conducted at 50 µM and 100 µM levamisole (Figure 
6-18). 
In the assay conducted for 50 µM, basal thrashing at t= 0 mins was not rescued to 
wild-type levels for the chimeric transgene lines L1 and L2. The thrashing rate of 
Gpa-unc-38.1 was fully rescued to wild-type (N2) levels, and was not significantly 
different to the wild-type strain. The thrashing rate of the chimeric transgene lines L1 
and L2 are significantly higher than the unc-38(x20) line, indicating that the lines were 
successfully rescued from the mutant background to some extent. At t= 10 mins, 
thrashing rate of the L1 and L2 lines did not decrease from the rate at t= 0 mins. 
Wild-type (N2) thrashing rate decreased and no significant differences in thrashing 
rates were found between any of the lines at this time point. At t= 30 mins, the 
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thrashing rates of the chimeric transgene lines had decreased significantly from t= 10 
mins, but were not significantly different to the gpa-unc-38.1 line or the unc-38(x20) 
line. The wild-type (N2) line decreased significantly from t= 10 mins, and were 
significantly different from all other lines (Figure 6-19). 
In the 100 µM levamisole assay, basal thrashing rate at t= 0 mins was not rescued to 
wild-type (N2) levels for the chimeric transgene lines. Although L1 was found to be not 
significantly different to the unc-38(x20) line in this instance, it was also found to be 
not significantly different to the L2 line. The basal thrashing rate of the gpa-unc-38.1 
line was rescued to wild-type levels. At t= 10 mins, thrashing rates of the chimeric 
transgene lines were significantly reduced, although they were not significantly 
different to each other or the gpa-unc-38.1 line. The thrashing rate of the wild-type 
(N2) line was significantly lower than all other lines. At t= 30 mins, the thrashing rate of 
the wild-type (N2) line is significantly reduced but the thrashing rate of the chimeric 
transgene lines were not significantly reduced from t= 10 mins, and were not 
significantly different from each other (Figure 6-20). 
6.3.3.2 An isoleucine to methionine change in cel-unc-38 increases basal thrashing 
rate and increases levamisole sensitivity  
Preliminary data for the 30 minute time point at a range of levamisole concentrations 
for the transgenic chimeric line Cel-unc-38-I301M indicated rescue of basal thrashing 
to wild-type (N2) levels, but showed an increase in sensitivity to levamisole for the two 
chimeric transgene lines. 10 µM and 50 µM levamisole was selected for further assays 
(Figure 6-21).  
In the 10 µM levamisole assay, the basal thrashing rates at t= 0 mins of the chimeric 
transgene lines were found to be significantly higher than that of the wild-type (N2) 
strain indicating that the worms are thrashing faster. On addition of levamisole, at t= 
10 mins, the thrashing rate of the wild-type (N2) worms reduced by 10% of initial 
thrashing rate, and this reduction is not significantly different to that of the cel-unc-38 
line. In contrast, the thrashing rate of both chimeric transgene lines was reduced by 
over 50% and was significantly different from wild-type (N2) and cel-unc-38 thrashing 
rates. At t= 30 mins, thrashing rates of the N2 and cel-unc-38 lines did not reduce 
significantly from thrashing rates in t= 10 mins. However the thrashing rates of both 
the chimeric transgene lines were further reduced to a total of 10% of initial thrashing 
rate and were not significantly different from each other (Figure 6-22).  
In the assay conducted for 50 µM, the basal thrashing rate at t= 0 mins of the chimeric 
transgene lines was also found to be significantly higher than that of the N2 strain and 
cel-unc-38 lines. At t= 10 mins, thrashing rates of the N2 strain and cel-unc-38 line 
reduced to the same extent, but the thrashing rate of the two chimeric transgene lines 
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was significantly lower. At t= 30 mins, all lines (except unc-38(x20)) were found to be 
not significantly different to each other (Figure 6-23).  
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Figure 6-6: Thrashing rate after 30 mins exposure to a range of levamisole concentrations for 
Gpa-unc-38.1-H236_I234delinsNYPSCCPGSA 
Preliminary data for Gpa-unc-38.1-H236_I234delinsNYPSCCPGSA L1 and L2 indicated that 
these lines had higher levamisole resistance than the wild-type N2. N = 30 for each levamisole 
concentration per line. Error bars represent SEM. 
unc-38(x20)
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Figure 6-7: Effect of 50 µM levamisole on thrashing rate of 
Gpa-unc-38.1-H236_I234delinsNYPSCCPGSA  
N2, unc-38(x20) and gpa-unc-38.1 were used as controls. Same data is presented organised by 
line and by time point a) Thrashing rate of N2 lines is reduced by approximately 90% after 30 
minute exposure to levamisole. Thrashing rate of the two transgenic lines L1 and L2 was 
reduced by approximately 60% by end of assay. Stars indicate significance of change in 
thrashing from t = 0 mins (p= ≤0.5(*); p = ≤.0001 (****)). (Two-way ANOVA, Tukey’s multiple 
comparison). b) Comparison of thrashing rates of all lines at each time point. Letters shared 
between bars indicate statistically homogeneous subsets (Two-way ANOVA, Tukey’s multiple 
comparison). N = 24 for each line. Error bars represent SEM. 
****
ns
**** **** *
****
a a a a
b b b
b b b
c
d
b b b
a
b
unc-38(x20)
unc-38(x20)
gpa-unc-38.1
gpa-unc-38.1
202 
 
 
Figure 6-8: Effect of 100 µM levamisole on thrashing rate of 
Gpa-unc-38.1-H236_I234delinsNYPSCCPGSA  
N2, unc-38(x20) and gpa-unc-38.1 were used as controls. Same data is presented organised by 
line and by time point. a) Thrashing rate of N2 strain reduced by approximately 95% after 30 
minute exposure to levamisole. The thrashing rate of the two transgenic lines L1 and L2 
reduced by approximately 50% by end of assay. Stars indicate significance of change in 
thrashing from t = 0 mins (p = ≤.0001 (****)). (Two-way ANOVA, Tukey’s multiple comparison). 
b) Comparison of thrashing rates of all lines at each time point. Letters shared between bars 
indicate statistically homogeneous subsets (Two-way ANOVA, Tukey’s multiple comparison).  
N = 24 for each line. Error bars represent SEM.  
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Figure 6-9: Thrashing rate after 30 mins exposure to a range of levamisole concentrations for 
Cel-unc-38-N234_I242delinsHFFASKNGI 
Preliminary data for Cel-unc-38-N234_I242delinsHFFASKNGI transgenic lines L1 and L2 
indicated that the levamisole responsiveness of this chimeric gene was similar to that of the 
wild-type N2. N = 30 for each levamisole concentration per line. Error bars represent SEM. 
unc-38(x20)
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Figure 6-10: Effect of 50 µM levamisole on thrashing rate of 
Cel-unc-38-N234_I242delinsHFFASKNGI 
N2, unc-38(x20) and cel-unc-38 were used as controls. Same data is presented organised by 
line and by time point. a) Thrashing rates of all lines (except unc-38(x20)) reduced by 
approximately 95% after 30 minutes exposure to levamisole. Stars indicate significance of 
change in thrashing from t = 0 mins (p = ≤.0001 (****)). (Two-way ANOVA, Tukey’s multiple 
comparison). b) Comparison of thrashing rates of all lines at each time point. Letters shared 
between bars indicate statistically homogeneous subsets (Two-way ANOVA, Tukey’s multiple 
comparison). N = 24 for each line. Error bars represent SEM. 
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Figure 6-11: Effect of 100 µM levamisole on thrashing rate of 
Cel-unc-38-N234_I242delinsHFFASKNGI 
N2, unc-38(x20) and cel-unc-38 were used as controls. Same data is presented organised by 
line and by time point. a) Thrashing rates of all lines (except unc-38(x20)) were reduced by 
over 95% after 30 minutes exposure to levamisole. Stars indicate significance of change in 
thrashing from t = 0 mins (p = ≤.0001 (****)). (Two-way ANOVA, Tukey’s multiple comparison).     
b) Comparison of thrashing rates of all lines at each time point. Letters shared between bars 
indicate statistically homogeneous subsets (Two-way ANOVA, Tukey’s multiple comparison). N 
= 24 for each line. Error bars represent SEM. 
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Figure 6-12: Thrashing rate after 30 mins exposure to a range of levamisole concentrations 
for Gpa-unc-38.1-Y175_G178delinsFSEN 
Preliminary data for Gpa-unc-38.1-Y175_G178delinsFSEN transgenic lines L1 and L2 indicated 
that resistance to levamisole remained high in the chimeric lines compared to wild-type (N2). 
N = 30 for each levamisole concentration per line. Error bars represent SEM. 
unc-38(x20)
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Figure 6-13: Effect of 50 µM levamisole on thrashing rate of 
Gpa-unc-38.1-Y175_G178delinsFSEN  
N2, unc-38(x20) and gpa-unc-38.1 were used as controls. Same data is presented organised by 
line and by time point. a) After 30 minutes exposure to levamisole thrashing rate of all lines 
(except unc-38(x20) had fallen. Thrashing rate of the N2 strain reduced by approximately 95%. 
The thrashing rate of the gpa-unc-38.1, L1 and L2 lines reduced by approximately 40%. Stars 
indicate significance of change in thrashing from t = 0 mins (p = ≤ .001 (***); p = ≤.0001 
(****)). (Two-way ANOVA, Tukey’s multiple comparison). b) Comparison of thrashing rates of 
all lines at each time point. Letters shared between bars indicate statistically homogeneous 
subsets (Two-way ANOVA, Tukey’s multiple comparison). N = 24 for each line. Error bars 
represent SEM. 
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Figure 6-14: Effect of 100 µM levamisole on thrashing rate of 
Gpa-unc-38.- Y175_G178delinsFSEN 
N2, unc-38(x20) and gpa-unc-38.1 were used as controls. Same data is presented organised by 
line and by time point. a) After 30 minutes exposure to levamisole, the thrashing rate of the 
wild-type (N2) strain reduced by over 97%. The thrashing rate of the gpa-unc-38.1, L1 and L2 
lines were significantly higher than wild-type. Stars indicate significance of change in thrashing 
from t = 0 mins (p = ≤.0001 (****)). (Two-way ANOVA, Tukey’s multiple comparison).      
b) Comparison of thrashing rates of all lines at each time point. Letters shared between bars 
indicate statistically homogeneous subsets (Two-way ANOVA, Tukey’s multiple comparison). N 
= 24 for each line. Error bars represent SEM.  
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Figure 6-15: Thrashing rate after 30 mins exposure over a range of levamisole concentrations 
for Cel-unc-38-F174_N177delinsYPSG 
Preliminary data for Cel-unc-38-F174_N177delinsYPSG indicated that it has a similar response 
as the wile-type (N2) strain to levamisole. N = 6 for each levamisole concentration per line. 
Error bars represent SEM. 
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Figure 6-16: Effect of 50 µM levamisole on thrashing rate of 
Cel-unc-38-F174_N177delinsYPSG 
Graphs shown from preliminary data set as only one transformed line was produced for this 
construct, which was difficult to work with technically. N2 and unc-38(x20) were used as 
controls. Same data is presented organised by line and by time point. a) Thrashing rate of L1 
reduced in response to levamisole to the same extent as the wild-type N2 strain. Stars indicate 
significance of change in thrashing from t = 0 mins (p = ≤.0001 (****)). (Two-way ANOVA, 
Tukey’s multiple comparison). b) Comparison of thrashing rates of all lines at each time point. 
Letters shared between bars indicate statistically homogeneous subsets (Two-way ANOVA, 
Tukey’s multiple comparison). N = 6 for each line. Error bars represent SEM. 
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Figure 6-17: Effect of 100 µM levamisole on thrashing rate of 
Cel-unc-38-F174_N177delinsYPSG 
Graphs shown from preliminary data set as only one transformed line was produced for this 
construct, which was difficult to work with technically. N2 and unc-38(x20) were used as 
controls. Same data is presented organised by line and by time point. a) Thrashing rate of L1 in 
response to levamisole was equal to that of the wild-type (N2) strain. Stars indicate 
significance of change in thrashing from t = 0 mins (p = ≤.0001 (****)). (Two-way ANOVA, 
Tukey’s multiple comparison). b) Comparison of thrashing rates of all lines at each time point. 
Letters shared between bars indicate statistically homogeneous subsets (Two-way ANOVA, 
Tukey’s multiple comparison). N = 6 for each line. Error bars represent SEM. 
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Figure 6-18: Thrashing rate after 30 mins exposure over a range of levamisole concentrations 
for Gpa-unc-38.1-M302I 
Preliminary data for the Gpa-unc-38.1-M302I transgenic lines indicated resistance to 
levamisole remained high, but the rescue of basal thrashing may be affected. N = 30 for each 
levamisole concentration for each line. Error bars represent SEM. 
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Figure 6-19: Effect of 50 µM levamisole on thrashing rate of Gpa-unc-38.1-M302I 
N2, unc-38(x20) and gpa-unc-38.1 were used as controls. Same data is presented organised by 
line and by time point. a) The thrashing rate of the L1 and L2 lines was not reduced in response 
to levamisole to the same extent as the wild-type (N2) strain. Stars indicate significance of 
change in thrashing from t = 0 mins (p = ≤.0001 (****)). (Two-way ANOVA, Tukey’s multiple 
comparison). b) Comparison of thrashing rates of all lines at each time point. Letters shared 
between bars indicate statistically homogeneous subsets (Two-way ANOVA, Tukey’s multiple 
comparison). N = 24 for each line. Error bars represent SEM.  
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Figure 6-20: Effect of 100 µM levamisole on thrashing rate of Gpa-unc-38.1-M302I 
N2, unc-38(x20) and gpa-unc-38.1 were used as controls. Same data is presented organised by 
line and by time point. a) The thrashing rate of the L1, L2 and gpa-unc-38.1 lines were less 
affected by levamisole than the wild-type (N2) strain. Stars indicate significance of change in 
thrashing from t = 0 mins (p = ≤.01 (**); p = ≤.0001 (****)). (Two-way ANOVA, Tukey’s multiple 
comparison). b) Comparison of thrashing rates of all lines at each time point. Letters shared 
between bars indicate statistically homogeneous subsets (Two-way ANOVA, Tukey’s multiple 
comparison). N = 24 for each line. Error bars represent SEM.  
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Figure 6-21: Thrashing rate at 30 mins over a range of levamisole concentrations for 
Cel-unc-38-I301M 
Preliminary data for the Cel-unc-38-I301M transgenic lines indicated that these lines are much 
more sensitive to levamisole than the wild-type (N2) strain. This difference was particularly 
evident at 10 µM and 50 µM concentrations of levamisole. N = 30 for each levamisole 
concentration for each line. Error bars represent SEM.  
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Figure 6-22: Effect of 10 µM levamisole on thrashing rate of Cel-unc-38-I301M 
N2, unc-38(x20) and cel-unc-38 were used as controls. Same data is presented organised by 
line and by time point. a) At 10 µM, the thrashing rate of the L1 and L2 lines reduced more 
than the wild-type (N2) strain after 30 minutes levamisole exposure. For the wild-type line, 
thrashing fate fell by approximately 20%, and for L1 and L2 the thrashing rate fell by 90%. Stars 
indicate significance of change in thrashing from t = 0 mins (p = ≤.0001 (****)). (Two-way 
ANOVA, Tukey’s multiple comparison). b) Comparison of thrashing rates of all lines at each 
time point. Letters shared between bars indicate statistically homogeneous subsets (Two-way 
ANOVA, Tukey’s multiple comparison). N = 24 for each line. Error bars represent SEM.  
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Figure 6-23: Effect of 50 µM levamisole on thrashing rate of Cel-unc-38-I301M 
N2, unc-38(x20) and cel-unc-38 were used as controls. Same data is presented organised by 
line and by time point. a) At 50 µM levamisole, the thrashing rate of the wild-type (N2), 
cel-unc-38 and L1 and L2 chimeric lines was reduced. Stars indicate significance of change in 
thrashing from t = 0 mins (p = ≤.0001 (****)). b) Comparison of thrashing rates of all lines at 
each time point. Letters shared between bars indicate statistically homogeneous subsets 
(Two-way ANOVA, Tukey’s multiple comparison). N = 24 for each line. Error bars represent 
SEM.  
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 Discussion 6.4
C. elegans has been used as a heterologous system to investigate anthelmintic 
resistance in parasitic nematodes in previous studies. Resistance of H. contortus to 
benzimidazoles is linked to a single phenylalanine to tyrosine amino acid change at 
position 200 in an allele of tub-1 found in resistant H. contortus populations. C. elegans 
was used as a heterologous system to demonstrate that H. contortus tub-1 containing 
Phe200 was able to rescue the sensitivity of C. elegans ben-1 mutants to 
thiabendazole. In contrast, the Tyr200-containing allele of H. contortus tub-1 was 
unable to rescue the benzimidazole sensitivity, so confirming its role in the observed 
resistance (Kwa et al. 1995).  
Here, a similar approach has been used to investigate key amino acid residues within 
Gpa-UNC-38.1 which may be linked to differing functions of the gene such as its role as 
an α-subunit and the differences in levamisole sensitivity identified in Chapter 5. 
Although two orthologues of Cel-unc-38 were identified, both Gpa-UNC-38.1 and 
Gpa-UNC-38.2 share similar key amino acid differences. For this reason, investigation 
of only gpa-unc-38.1 was undertaken. 
6.4.1 Considerations involved in working with transgenic lines of C. elegans 
Transformation of C. elegans by microinjection does not produce a transgenic line in 
which the transgene perfectly mimics an endogenous gene. The extrachromosomal 
arrays produced by microinjection contain multiple copies of the introduced transgene 
and marker gene and copy number cannot be controlled. Expression level of the 
introduced transgene is therefore unpredictable. For these reasons multiple 
independent lines should be analysed to account for differences due to transgene copy 
number. Here, two independently transformed lines were obtained for each chimeric 
gene (apart from Cel-unc-38-F174_N177delinsYPSG). Additionally, each chimeric gene 
transgenic line was analysed alongside the line rescued with the non-chimeric gene, as 
a control for effects of the transformation technique.  
Off-target effects of the marker gene must also be considered. The myo-2::GFP should 
not interfere with locomotion or thrashing rate, however the growth and development 
of transgenic worms was impaired for some lines (personal observation). This may be 
linked to toxic effects of overexpression of GFP in the pharyngeal muscles of                 
C. elegans, which leads to the impairment of feeding ability (Anna Crisford, personal 
communications (Fleenor et al.)). Where possible, such lines were not used. 
Additionally, some lines exhibited low transmission rates of the extrachromosomal 
arrays to the progeny (e.g. <10%), which made it difficult to select sufficient transgenic 
worms for assays at the correct life-stage. 
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The transgene was expressed under control of the myo-3 promoter which drives 
expression in the body-wall muscle. Cel-unc-38 is expressed both in body-wall muscle 
and in neurones throughout the body (Gottschalk et al. 2005). Cel-UNC-38 has been 
shown to form part of a neuronal nAChR present in motor neurones that innervate the 
ventral and dorsal muscles. This neuronal nAChR forms a functional receptor consisting 
of Cel-UNC-38, Cel-ACR-2, Cel-ACR-3, Cel-UNC-63 and Cel-ACR-12 that is activated by 
acetylcholine, but not levamisole (Jospin et al. 2009). As cel-unc-38 was able to fully 
rescue basal thrashing and levamisole sensitivity under the control of the myo-3 
promoter, and the neuronal receptor is not sensitive to levamisole, the role of this 
receptor was not investigated in this work. It is currently also unknown which subunits 
comprise the neuronal receptor in G. pallida. 
6.4.2 Limitations of thrashing assay analysis 
Thrashing assays are time-consuming to conduct, particularly if multiple lines are to be 
assessed on the same day to control for environmental variables. Preliminary data 
were therefore collected for each chimeric transgene line at all levamisole 
concentrations at a single time point to highlight any differences between these and 
the control lines and to identify which levamisole concentrations were of particular 
interest. Due to the fast thrashing rate of wild-type (N2) worms in liquid, thrashing 
assays are also subject to experimental error and fatigue. Software is available for the 
automated measurements of thrashing (Buckingham and Sattelle 2009). Attempts to 
create and optimise a similar approach with the equipment and software available in 
this laboratory were not successful. 
Other factors such as temperature and age of worms also impact the thrashing rate of 
C. elegans (Mulcahy, Holden-Dye and O'Connor 2013). As ambient temperature of the 
laboratory could not be precisely controlled, this effect was mitigated by analysis of all 
lines for each levamisole concentration on the same day, and on two separate 
occasions. Life-stage was controlled by selection of L4-stage worms on the previous 
day, to ensure all worms analysed were at the same life-stage. 
6.4.3 The YxxCC motif is non-essential in both Gpa-UNC-38.1 and Cel-UNC-38 to 
basal thrashing function of the reconstituted receptor 
Work in Chapter 5 indicated that gpa-unc-38.1 is able to rescue the basal thrashing 
rate of C. elegans unc-38(x20) mutants to wild-type levels, despite lacking the YxxCC 
motif involved in formation of the acetylcholine binding site. One possible explanation 
for this result is that gpa-unc-38.1 is only required to perform a structural role in 
assembly of the receptor and does not directly take part in acetylcholine binding.  
To test if removal of an agonist binding site could still lead to full rescue of basal 
thrashing a construct was made which removed the YxxCC motif from Cel-UNC-38 
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(Cel-unc-38-N234_I242delinsHFFASKNGI). This allowed the function of a receptor with 
only two non-consecutive agonist binding sites to be investigated. A reciprocal 
construct reintroduced the YxxCC motif from the C. elegans gene into Gpa-UNC-38.1 
(Gpa-unc-38.1-H236_I234delinsNYPSCCPGSA) to produce a receptor with three agonist 
binding sites (Figure 6-24a). 
Cel-unc-38-N234_I242delinsHFFASKNGI rescued basal thrashing to the same level as 
the wild-type strain and the line rescued with cel-unc-38. This supports the hypothesis 
that only two non-consecutive agonist binding sites are required for receptor function. 
The observed rescue of basal thrashing was therefore likely due to a structural 
requirement for an UNC-38-like subunit to reform the pentameric receptor structure, 
although acetylcholine binding occurs at agonist binding sites between other subunits. 
This seems to be analogous to the mechanism by which Gpa-unc-38.1 rescues basal 
thrashing. 
Similarly, no difference in basal thrashing was observed between lines rescued with 
Gpa-unc-38.1-H236_I234delinsNYPSCCPGSA and the native Gpa-unc-38.1. Here, three 
agonist binding sites are theoretically formed as the YxxCC motif has been introduced 
into the sequence of Gpa-UNC-38.1. However it is not known if this new agonist 
binding site is actually binding acetylcholine or if only two agonist binding sites are 
being used (Figure 6-24b). If the former is the case, then clearly the presence of an 
extra site is not affecting this aspect of receptor function. 
No change in levamisole sensitivity compared with lines rescued by the unaltered 
counterparts was conferred by either Cel-unc-38-N234_I242delinsHFFASKNGI or 
Gpa-unc-38.1-H236_I234delinsNYPSCCPGSA. However the YxxCC motif is not predicted 
to be involved in levamisole binding.  
6.4.4 The glutamate residue in loop B of Cel-UNC-38 may not be involved in 
levamisole sensitivity  
Cel-UNC-38 has a glutamate residue in loop B of the extracellular domain. In a study 
conducted by Rayes et al. (2004), replacement of a glycine residue with a glutamate 
residue in a similar position in loop B of mouse α-subunits increased channel opening 
by levamisole. Mutation of other residues in loop B did not affect levamisole 
sensitivity. It was reasoned that the absence of a glutamate residue in this position in 
Gpa-UNC-38.1 may be responsible for its inability to fully restore levamisole sensitivity 
in the rescue experiments described in 5.3.7. Thus chimeric genes were created to test 
this hypothesis. The glutamate residue was removed from Loop B of Cel-UNC-38 by 
swapping in the Gpa-UNC-38.1 Loop B sequence creating the chimeric gene 
Cel-unc-38-F174_N177delinsYPSG. Accordingly the glutamate residue was introduced 
into Loop B of Gpa-UNC-38.1 creating Gpa-unc-38.1-Y175_G178delinsFSEN.  
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The construct Gpa-unc-38.1-Y175_G178delinsFSEN rescued basal thrashing activity of 
the unc-38(x20) mutant, indicating that it assembled normally to form the L-nAChR in 
C. elegans. However, no increase in levamisole sensitivity was observed and the 
thrashing rates of the two chimeric transgene lines remained higher than that of the 
N2 worms in response to 50 and 100 µM levamisole. This indicates that the absence of 
the glutamate residue in loop B of Gpa-UNC-38.1 does not account for the reduced 
levamisole sensitivity. In loop B of other α-subunits a tyrosine and glycine residue are 
also involved in forming the acetylcholine binding pocket. Both Cel-UNC-38 and 
Gpa-UNC-38.1 lack these residues. The change effected in loop B of 
Gpa-unc-38.1-Y175_G178delinsFSEN also does not seem to affect acetylcholine 
binding as basal thrashing is unaffected. 
Unfortunately, due to technical issues a full analysis of 
Cel-unc-38-F174_N177delinsYPSG could not be undertaken as only a single transgenic 
line was generated for this construct. The slow-growth of the lines can most likely be 
attributed to the toxic nature of the pmyo-2::GFP marker gene at high concentrations 
rather than expression of the chimeric gene (Fleenor et al.). Transmission of the 
marker gene to the next generation was low, but within the parameters expected for 
microinjection.  
Some cautious conclusions can nevertheless be drawn from the preliminary data 
generated for Cel-unc-38-F174_N177delinsYPSG 50 µM and 100 µM levamisole. The 
data suggest that the basal thrashing rate of this line is fully rescued and that 
levamisole sensitivity is the same in the chimeric transgene line and wild-type worms. 
If the presence of a glutamate residue in loop B was responsible for levamisole 
sensitivity in nematode muscle, it would be expected that its removal would increase 
levamisole resistance. 
Although Rayes et al. (2004) addresses the mutation of a mammalian α-subunit to 
include a glutamate in loop B and the subsequent increase in opening of the receptor 
in response to levamisole, the reciprocal mutation of removing the glutamate from 
loop B of Cel-UNC-38 and analysing channel opening response was not undertaken. 
Here, the removal of the glutamate residue from loop B of Cel-UNC-38 did not increase 
levamisole resistance and nor did addition of a glutamate residue into loop B of 
Gpa-UNC-38.1. The glutamate in loop B may not play such an important role in 
levamisole sensitivity as previously stated however fundamental differences in the 
experiments carried out should be considered. Rayes et al. (2004) expressed the 
mutagenised mammalian α-subunits in HEK293 cells (along with β, δ, and ε subunits 
that comprise a mammalian-type receptor) and receptor opening currents in response 
to perfusion with agonists were measured using patch clamp techniques. This does not 
report on the effect of increased channel opening on the muscle and whether or not 
this increase would be physiologically relevant. Equally, the experiments described 
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here do not report on the changes in channel opening properties of the receptor 
caused by these chimeric genes. It may be that channel opening properties have 
changed, but are not translated to a phenotype which can be assessed by thrashing 
assays. Expression of the chimeric subunits in Xenopus oocytes and measurement of 
changes in channel opening rates in response to levamisole and acetylcholine would 
be beneficial to confirm these observations.  
6.4.5 Amino acid changes in transmembrane domain 2 affect channel opening 
properties in response to agonist binding 
The second transmembrane domain of each subunit of cys-loop ligand-gated ion 
channels contributes towards forming the lining of the central channel pore (Figure 
6-25a). A combination of pore diameter and the characteristics of the amino acids 
orientated towards the lining of the channel pore affect what can pass through. 
Typically negatively charged amino acids are present at the intracellular mouth of 
cation selective channels (Keramidas et al. 2004).  
Mutations at position 13 in transmembrane domain 2 of nAChRs of C. elegans (Treinin 
and Chalfie 1995; Jospin et al. 2009) produce receptors with irregular functions. 
Mutations in this position in human-type nAChRs have also been linked to the disease 
myasthenia gravis. In Gpa-UNC-38.1, a methionine is present at position 13 on 
transmembrane domain 2 whereas the equivalent residue in Cel-UNC-38 is an 
isoleucine. A mutation from a valine to a methionine residue in this position in 
Cel-ACR-2 produced a gain-of-function mutant termed acr-2(n2420gf) (Figure 6-25b). 
These worms convulse, are uncoordinated and are more sensitive to aldicarb and 
levamisole in paralysis assays (Jospin et al. 2009 (Fig 2C)). Gpa-UNC-38.1 does not have 
an increased sensitivity phenotype compared to Cel-UNC-38 and therefore chimeric 
genes were created to test the importance of this residue in receptor function. 
The chimeric gene Gpa-unc-38.1-M302I was unable to rescue basal thrashing, although 
thrashing rate was significantly higher than the unc-38(x20) background indicating that 
some rescue of basal thrashing had occurred, although not to wild-type levels. 
Resistance to levamisole also remained higher than wild-type in these lines. In 
contrast, the chimeric gene Cel-unc-38-I301M conferred both increased sensitivity to 
levamisole and increased basal thrashing rate. This increased levamisole sensitivity was 
particularly pronounced at 10 µM levamisole. This observation is similar to that 
observed by Jospin et al. (2009), with a valine to methionine change at this position in 
transmembrane domain 2 in the acr-2(n2420gf). When Cel-ACR-2(V13’M)R was 
expressed in Xenopus oocytes with the remaining subunits of the C. elegans neuronal 
receptor, sensitivity to DMPP was increased greatly and sensititivity to levamisole and 
choline increased slightly compared to the wild-type receptor (Jospin et al. 2009 (Fig 7 
A and B)). The phenotype of this line was hypothesised to be due to increased 
excitability of the neurons expressing acr-2(n2420gf) and increased calcium influx. 
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However, unlike acr-2(n2420gf), no convulsive phenotype was observed for 
Cel-unc-38-I301M. As acr-2 is expressed in the VA, VB, DB and DA neurons (Figure 1-4), 
which are involved in regulating the balance between the excitation and inhibition that 
drives locomotion in C. elegans, the increase in activity caused by acr-2(n2420gf) may 
disrupt this balance (Jospin et al. 2009). Cel-unc-38-I301M, under the myo-3 promoter, 
would only be expressed in the body wall muscle and not the interconnecting neurons 
and thus would not play a role in balancing excitation and relaxation. The faster rate of 
basal thrashing may be due to increased activation of the L-nAChR expressed in the 
body wall, leading to increased calcium influx and increased muscle contraction. As the 
worms of this line thrash normally, albeit faster, it is not known how the balance of 
relaxation is maintained. The increased thrashing rate of Cel-unc-38-I301M is likely due 
to a hyperactive response to acetylcholine, as observed for the acr-2(n242gf) mutant 
(Jospin et al. 2009 (Fig 5a)).  
The increased sensitivity of Cel-unc-38-I301M may be due to similar mechanisms. 
Although binding of levamisole to the receptor is likely to remain unchanged, the 
channel could remain open for longer leading to increased calcium influx and increased 
muscle contraction. It follows that levamisole affects paralysis by the same mechanism 
(unbalanced activation of L-nAChR in the body-wall muscle), but as the receptor is 
more highly excitable, paralysis occurs at a lower dose. It is unclear why a methionine 
residue in this position affects conductance. Both a valine to methionine change (as in 
acr-2(n2420gf)) and an isoleucine to methionine change (as in Cel-unc-38-I301M) are 
substitutions of one hydrophobic amino acid for another hydrophobic amino acid. 
However, it seems clear that the presence of a methionine in this position alters the 
pore domain in a way which increases receptor activity. 
It has been demonstrated that a methionine in this position in acr-2 (Jospin et al. 2009) 
and in Cel-unc-38-I301M increases the sensitivity of the C. elegans mutant to 
levamisole probably due to increased excitability of the receptor. It follows that 
Gpa-UNC-38.1 should also show some evidence of increased receptor excitability due 
to the methionine in TM2. Removal of a methionine from Gpa-Unc-38.1 impairs the 
ability of Gpa-unc-38.1-M302I to rescue basal thrashing, which suggests it has a more 
fundamental role in this subunit.  
6.4.6 The basis of levamisole resistance for Gpa-UNC-38.1 has not been established 
Gpa-UNC-38.1-transformed unc-38(x20)-worms have higher levamisole resistance than 
wild-type C. elegans. As unc-38(x20) transformed with Cel-UNC-38 displayed wild-type 
levamisole sensitivity¸ it is unlikely that this increased resistance is a side-effect of the 
microinjection technique. In this chapter, the molecular basis of the increased 
resistance was explored by focusing on candidate amino acid residues identified from 
the literature (Jospin et al. 2009; Rayes et al. 2004). The consequence of Gpa-UNC-38.1 
lacking the characteristics of an α-subunit was also investigated. 
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None of the changes made to Gpa-UNC-38.1 restored levamisole sensitivity to this 
subunit, and no changes increased the resistance to levamisole of Cel-UNC-38. One of 
the analysed chimeric constructs (Cel-unc-38-I301M) conferred increased sensitivity, 
which has raised more questions about the levamisole resistance of Gpa-UNC-38.1. 
There is currently an apparent discrepancy between the data obtained for expression 
of Gpa-UNC-38.1 in Xenopus oocytes (which does not seem to indicate an increase in 
levamisole resistance associated with this subunit) and the result obtained by 
thrashing analysis of transgenic mutant lines carrying Gpa-UNC-38.1 and the chimeric 
transgene Gpa-UNC-38.1 constructs (which consistently show increased levamisole 
resistance). Further work is required to rationalise this data from two different 
experimental techniques, which may be due to the difference between expression in a 
heterologous and endogenous system. The expression of the chimeric transgenes in 
described in this chapter in Xenopus oocytes may be beneficial in this regard.  
6.4.6.1 Cel-UNC-38 has been defined as an α-subunit, but may not be directly 
involved in agonist binding 
Cel-UNC-38 is defined as an α-subunit due to the presence of the vicinal cysteines in 
loop C of the extracellular domain. Loop B however lacks some residues associated 
with acetylcholine binding, although it is unclear how stringently required these 
residues are for formation of the acetylcholine binding pocket.  
An interesting result from this work is that removal of the YxxCC motif from 
Cel-UNC-38 does not have an overall effect on the ability of the receptor to bind 
acetylcholine as basal thrashing is rescued to wild-type levels. This has two possible 
explanations: Multiple agonist binding sites, including one formed by Cel-UNC-38, may 
be present on the receptor and removal of one still leaves sufficient agonist binding 
sites for acetylcholine binding and receptor function. Alternatively, Cel-UNC-38 may 
not normally form a functional agonist binding site at all (due to differences in residues 
of Loop B) and therefore the removal of the YxxCC motif does not affect basal 
thrashing as it never formed a binding site. 
Although recordings from receptors were generated by expression of only cel-lev-1, 
cel-unc-29 and cel-unc-38 in Xenopus oocytes (Fleming et al. 1997), the currents 
elicited by acetylcholine were very low. However, as cel-unc-38 is the only α-type 
subunit in that mix, it must be able to contribute towards the binding of acetylcholine 
to some extent, albeit inefficiently. Equally, the low currents generated with this 
combination of subunits in Xenopus oocytes may also be due to the fact that several 
required subunits (lev-8 and unc-63) were absent (Boulin et al. 2008). If this were the 
case, Cel-UNC-38 may also be fulfilling a merely structural role in the receptor rather 
than having a direct role in acetylcholine binding. It may also explain the loss of the 
YxxCC motifs from the plant-parasitic nematode UNC-38s. If Cel-UNC-38 does not 
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provide an acetylcholine binding site, and nor does the UNC-38 of the common 
ancestor between C. elegans and plant-parasitic nematodes, the selection pressure to 
keep the residues may be removed. 
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Figure 6-24: Schematic of potential effects of addition or removal of the YxxCC motif from 
gpa-unc-38.1 or cel-unc-38  
a) Removal of the YxxCC motif from Cel-UNC-38 should remove an agonist binding site, leaving 
only two in the receptor containing chimeric Cel-UNC-38. b) Addition of a YxxCC motif to 
Gpa-UNC-38.1 could possibly form a third agonist binding site in the receptor containing the 
chimeric gene. Potential agonist binding sites are represented by the red circles, α-subunits are 
coloured in blue and non-α subunits are coloured in grey. 
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Figure 6-25: Schematics of the transmembrane 2 (TM2) region of nAChR subunits 
a) Orientation of TM2 towards the inside of the pore in the pentameric receptor. b) Adapted 
from Jospin et al. (2009). Alignment of TM2 region of Gpa-UNC-38, Cel-UNC-38 and Cel-ACR-2. 
Residues coloured in red are orientated towards the pore. If position 13 is mutated to a 
methionine residue in Cel-ACR-2 or Cel-UNC-38 locomotion and levamisole sensitivity 
phenotypes are observed.  
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Summary 
 
• Gpa-UNC-38.1 rescues basal thrashing by structural reformation of the receptor 
rather than direct binding of acetylcholine 
 
• Glutamate residue in Loop B has no impact on levamisole sensitivity 
 
• Alterations in transmembrane domain 2 affect levamisole sensitivity of 
Cel-UNC-38 
 
• Basis of levamisole resistance of Gpa-UNC-38.1 not identified 
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7. GENERAL DISCUSSION 
 Host-seeking is a common and essential behaviour for 7.1
plant-parasitic nematodes 
All plant-parasitic nematodes must be able to locate and move towards their host in 
the soil. Host invasion also requires co-ordinated movement and migration through 
host-root tissue to reach a suitable position in which to induce a feeding site. 
Disruption of these processes has been demonstrated to impair the ability of the 
nematode to infect their host. Expression in planta of a synthetic peptide which 
disrupts chemoreception has been demonstrated to reduce the ability of G. pallida to 
infect by 50% (Liu et al. 2005). This technology has been successfully used to generate 
transgenic plantain with a level of resistance in the field against Radopholus similis and 
Helicotylenchus multicinctus (Tripathi et al. 2015). Other methods used to disrupt 
chemosensation and locomotion include the targeting of flp-genes. Downregulation of 
flp-18 induced by RNAi reduced the ability of M. incognita to infect tomato roots by 
reducing the number of J2s which reached the root (Dong et al. 2013). 
J2s, once hatched from the egg, are reliant on reaching host roots in order to complete 
the life cycle. As J2s do not feed during the infective stage, locomotion and 
host-invasion rely on limited, stored lipid reserves. The utilisation of this lipid reserve is 
slow - an estimated 50% of total lipids is used 36 days after hatching (Storey 
1984) - but hatched J2s are more vulnerable to other abiotic effects such as 
desiccation. The induction of paralysis or disruption of chemoreception therefore 
affects J2s by increasing the use of lipid reserves and the time spent in the soil where 
they are vulnerable to abiotic factors.  
The neuromuscular system is essential for coordinated movement and drugs targeting 
this system can induce paralysis and inhibit invasion behaviours. Targeting of this 
system would also affect males of amphimictic species, such as cyst nematodes. In 
these species the male must be able to locate the female on the root in order for 
fertilisation to occur (Riga et al. 1996).  
 Differences in complement of cys-loop receptors indicate that        7.2
G. pallida and G. rostochiensis may have distinct pharmacological 
neuromuscular targets 
The key aspects of neurotransmission, such as the neurotransmitters used, are likely to 
be the same in C. elegans, G. pallida and G. rostochiensis. This is supported by the 
identification of genes involved in neurotransmitter synthesis in G. pallida and                        
G. rostochiensis as well as previous published work exploring the response of J2s to 
exogenously applied neurotransmitters (see 3.4.2). 
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Differences in the complement of cys-loop receptors present in G. pallida and                    
G. rostochiensis were identified for the glutamate-gated chloride channel family and 
the nicotinic acetylcholine receptor subunit family. The differing composition of 
receptors due to the different complement of cys-loop receptor subunits may affect 
their pharmacology, and sensitivity to the anthelmintics that are known to target these 
receptors. In C. elegans, cel-glc-1, cel-avr-14 and cel-avr-15 have been linked to 
ivermectin sensitivity (Dent et al. 2000). In G. pallida and G. rostochiensis, orthologues 
for cel-glc-1 and cel-avr-15 have not been identified. Two orthologues of cel-avr-14 
were identified, although it is not known whether or not both confer sensitivity to 
ivermectin in the plant-parasitic nematodes. The gene hco-glc-5 has been shown to be 
involved in the ivermectin sensitivity of H. contortus (Glendinning et al. 2011), 
demonstrating that glutamate-gated chloride channel subunits not present in                  
C. elegans may also be involved in ivermectin sensitivity.  
For nAChR subunits, G. pallida and G. rostochiensis have fewer members than                 
C. elegans with 20 nAChRs identified in the plant-parasitic nematodes and 28 in                 
C. elegans. In addition to these 28 genes in C. elegans, there are three more predicted 
nAChRs the function of which has not yet been analysed (Rand 2006). In particular, the 
ACR-16 group of G. pallida and G. rostochiensis is smaller than that of C. elegans with 
orthologues identified for only four out of the ten members. Although orthologues of 
most members of the UNC-38, UNC-29 and ACR-8 groups were identified in G. pallida 
and G. rostochiensis, orthologues of all genes known to comprise the 
levamisole-sensitive nicotinic acetylcholine receptor of C. elegans were not found. This 
receptor comprises Cel-UNC-38, Cel-UNC-63, Cel-UNC-29, Cel-LEV-1 and Cel-LEV-8 
(Boulin et al. 2008; Lewis et al. 1980) in C. elegans, but orthologues for cel-lev-1 and 
cel-lev-8 were not identified in G. pallida and G. rostochiensis. Two orthologues were 
also identified for cel-unc-38 and cel-unc-29 in both plant-parasitic nematode species. 
In other parasitic nematode species where the levamisole-sensitive nicotinic 
acetylcholine receptor has been investigated, similar losses and duplications have 
taken place. H. contortus lacks an orthologue of cel-lev-8, and although an orthologue 
of cel-lev-1 can be found it lacks a signal peptide. Four orthologues of cel-unc-29 have 
also been found in H. contortus. A. suum lacks orthologues for both cel-lev-1 and 
cel-lev-8 and a single orthologue has been identified for each of cel-unc-38, cel-unc-29 
and cel-unc-63 (Williamson et al. 2009). Receptors comprising differing complements 
of these subunits, were found to have different pharmacological properties, affecting 
sensitivity to levamisole amongst other receptor agonists (Boulin et al. 2011; 
Williamson et al. 2009; Buxton et al. 2014). In the H. contortus receptor, Hco-ACR-8 
was found to play an essential role in levamisole sensitivity (Boulin et al. 2011). 
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 Bioassays and functional experimentation supported a difference 7.3
in resistance to levamisole and linked it to Gpa-unc-38.1 
Both G. pallida and G. rostochiensis were found to be more resistant to levamisole 
than C. elegans. A comparison of EC50 values suggested that the two plant-parasitic 
nematode species were 500-2000 fold more resistant than C. elegans (Qian et al. 
2008). As the L-nAChR of G. pallida and G. rostochiensis must differ from that of            
C. elegans, and as the composition of the receptor had been shown to affect sensitivity 
to agonists in the literature, it was hypothesised that this increased resistance to 
levamisole found in G. pallida was due to differences in the composition of the native 
receptor. 
As the loop B region of cel-unc-38 had been identified as particularly important in the 
levamisole sensitivity of C. elegans (Rayes et al. 2004), the amino acid sequences of 
Gpa-unc-38.1 and gpa-unc-38.2 were investigated. The glutamate residue linked to 
levamisole sensitivity (Rayes et al. 2004) was found to be absent in loop B of both 
gpa-unc-38.1 and gpa-unc-38.2. Additionally, the absence of residues in loop C 
essential for acetylcholine binding, particularly the lack of the vicinal cysteines (Kao et 
al. 1984), was also found in both genes. This was predicted to affect function of the 
subunit. Gpa-unc-38.1 was tested for its ability to rescue the phenotype of unc-38(x20) 
mutants, which are uncoordinated and levamisole resistant (Lewis et al. 1987; Fleming 
et al. 1997). Gpa-unc-38.1 was able to rescue basal thrashing activity of the receptor, 
suggesting reconstitution of the L-nAChR by replacing cel-unc-38, but not levamisole 
sensitivity. However, when Gpa-unc-38.1 was expressed alongside cel-unc-29, 
cel-unc-63, cel-lev-1 and cel-lev-8 in Xenopus oocytes, the sensitivity to levamisole was 
not found to differ from the native C. elegans receptor. 
 Motif swaps between Cel-unc-38 and Gpa-unc-38.1 did not 7.4
elucidate the basis of levamisole resistance of G. pallida 
Gpa-unc-38.1 was able to rescue thrashing rate of unc-38(x20) mutants, but not full 
levamisole sensitivity. Chimeric genes have been used to investigate insect-nicotinic 
acetylcholine receptors, where regions hypothesised to be responsible for imidacloprid 
sensitivity were substituted into the chicken α4-subunit to investigate if imidacloprid 
sensitivity could be conferred (Shimomura et al. 2005). A similar approach was used to 
investigate key motifs of Gpa-unc-38.1. Addition of the YxxCC motif to gpa-unc-38.1 
and removal of the motif from cel-unc-38 did not affect the rescue of basal thrashing, 
indicating that acetylcholine was binding between different subunits on the 
reconstituted receptor. This suggested that gpa-unc-38.1 played a structural role in 
rescuing basal thrashing and receptor function. Addition of the Loop B glutamate 
reported to be involved in levamisole sensitivity (Rayes et al. 2004) to gpa-unc-38.1 did 
not increase levamisole sensitivity, and the removal of the Loop B glutamate from 
cel-unc-38 did not increase levamisole resistance. This suggested that the role of the 
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loop B glutamate may not be critical to levamisole resistance. Levamisole sensitivity 
was increased by substitution of a methionine into transmembrane domain 2 of 
cel-unc-38. A similar hyperactivity of the receptor has been observed by a valine to 
methionine change in the same position of transmembrane domain 2 in cel-acr-2 
(Jospin et al. 2009). Removal of the methionine residue for an isoleucine residue in 
gpa-unc-38.1 did not affect levamisole sensitivity, but affected the ability of the 
construct to rescue basal thrashing. This highlighted the importance of 
transmembrane domain 2 in its ability to affect sensitivity of the receptor, as this 
region lines the channel pore and affects channel opening properties (Keramidas et al. 
2004). 
 The levamisole resistance of G. pallida 7.5
The molecular basis for the increased levamisole resistance found in 
Gpa-unc-38.1-rescued lines was not identified by the experiments conducted. This may 
be due to other residues within the Gpa-UNC-38.1 sequence which were not explored 
in this work, or the increased resistance may be due to changes in conformation of the 
other four subunits which led to levamisole binding less efficiently. Although it has 
been observed consistently that transgenic lines carrying gpa-unc-38.1 or any of the 
chimeric variations increased levamisole resistance compared to wild-type and 
cel-unc-38-rescued lines, the data obtained when gpa-unc-38.1 was expressed in 
Xenopus oocytes with the remaining C. elegans subunits did not identify a significant 
difference between channel activities elicited by levamisole compared to the native 
C. elegans receptors.  
7.5.1 The whole native G. pallida receptor must be considered 
The reconstitution of the whole native G. pallida receptor in Xenopus oocytes will 
allow the basis of levamisole resistance to be resolved as it would allow the 
pharmacology of the whole receptor to be characterised. However, many nAChR 
subunits (at least 20) are present in G. pallida and identifying which of these are likely 
to make up the native G. pallida L-nAChR requires consideration. This work may be 
guided by evidence provided from work on other parasitic nematodes such as                
H. contortus (Boulin et al. 2011), A. suum (Williamson et al. 2009) and O. dentatum 
(Buxton et al. 2014). However, these nematodes are more closely related to C. elegans 
and there may have been more divergence in the composition of this receptor over the 
evolutionary distance between C. elegans and plant-parasitic nematodes. 
Due to the possibility that the roles of nAChR subunits may be very different in 
plant-parasitic nematodes, a cautious approach may include the use of G. pallida 
promoter sequences to drive GFP expression to identify where these candidate genes 
are expressed. As no transformation technique exists for G. pallida, C. elegans would 
have to be used as a heterologous system for this work. Some success for using             
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G. pallida promoter regions of nAChRs to drive GFP expression has already been 
achieved indicating that this may be a good approach. However, differences in the 
promoter regions between the species and how they interact with transcription factors 
may lead to differences in the patterns of expression.  
The simple expression of candidate subunits in Xenopus oocytes without establishing 
whether or not they are likely to be expressed in the same place may be problematic 
as some subunits can be represented in multiple pentameric receptors. For example, 
Cel-UNC-38 in C. elegans is part of the L-nAChR and the neuronal nAChR (Jospin et al. 
2009) and Cel-ACR-12 is part of the neuronal receptor, but has also been identified as a 
member of a separate receptor present in GABAnergic neurons (Petrash et al. 2013).  
The possibility that a range of receptors consisting of different combinations and ratios 
of nAChR subunits may be present in the body-wall muscle of G. pallida, as is found in 
O. dentatum (Robertson, Bjorn and Martin 1999) cannot be excluded. 
7.5.2 Other genes that are not nAChRs have also been associated with levamisole 
resistance 
Other genes have been associated with levamisole resistance in C. elegans, but have 
not been considered in this work. Some proteins modulate levamisole sensitivity by 
affecting the efficiency of receptor assembly, or by affecting downstream signalling 
events. 
UNC-50, RIC-3 and UNC-74 are accessory proteins, involved in the correct assembly of 
the receptor. These are also the ancillary factors that are essential for expression of 
the receptor in Xenopus oocytes (Boulin et al. 2008). RIC-3 is a chaperone protein, 
located in the endoplasmic reticulum and is involved in folding and processing (Millar 
2008). UNC-74 is a thioredoxin and assists in the correct folding of proteins by 
promoting disulphide bond formation. UNC-50 is present in the Golgi apparatus, and is 
required for correct trafficking of nAChR subunits. The absence of any of these affects 
levamisole sensitivity by altering the number of functional L-nAChRs that are 
expressed. NRA-2 and NRA-4 are present in the endoplasmic reticulum and affect 
subunit composition (Almedom et al. 2009). 
Other proteins that have been shown to interact with the L-nAChR are TAX-6, a 
calcineurin, which negatively regulates receptor function; NRA-1, a copine, which 
controls expression levels of synaptic levamisole receptors and SOC-1, an adaptor 
protein, which is also involved In receptor expression (Gottschalk et al. 2005). The 
OIG-4, LEV-9 and LEV-10 proteins function as a complex and its presence facilitates 
clustering of L-nAChRs at the neuromuscular junction (Rapti, Richmond and Bessereau 
2011; Gally et al. 2004). MOLO-1, a single-pass transmembrane protein associates with 
L-NAChRs and acts as an auxiliary protein (Boulin et al. 2012). TPA-1 is predicted to be 
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involved in phosphorylation and the adaptation response of the receptor (Waggoner et 
al. 2000). 
UNC-68, UNC-22 and UNC-11 are involved in the contraction of the body wall muscle. 
UNC-68 is a ryanodine receptor, which amplifies the calcium signal caused by opening 
of the L-nAChR by releasing stored calcium ions to generate sufficient levels of calcium 
for muscle contraction (Maryon, Coronado and Anderson 1996). UNC-22 and LEV-11 
encode muscle proteins which are essential for muscle contraction. Mutations of these 
confer levamisole resistance by reducing response to the drug (Martin et al. 2012; 
Williams and Waterston 1994; Moerman et al. 1988). 
A search for orthologues of these genes in the genome sequence of G. rostochiensis 
shows that orthologues for all of these genes with the exception of SOC-1 are present. 
As most of these genes are associated with the clustering of nAChRs or the mediation 
of muscle contraction downstream of the receptor, it may be expected that impaired 
locomotion would be observed if they were involved in levamisole resistance. 
However, as the J2s of most species move in a coordinated manner, these genes are 
likely to function normally.  
7.5.3 Mechanisms of levamisole resistance in animal-parasitic nematodes 
Resistance to levamisole in animal-infecting nematodes has attracted particular 
attention in the literature (Kaplan 2004). The molecular mechanisms behind the 
levamisole resistance of some parasitic nematodes have been identified, and to date 
all are linked to subunits of the L-nAChR.  
In O. dentatum, levamisole resistance has been linked to the loss of a specific receptor 
in body wall muscle (Robertson, Bjorn and Martin 1999), which has been shown to 
correlate to a receptor consisting of the subunits Ode-UNC-29, Ode-UNC-63, 
Ode-UNC-38 and Ode-ACR-8 (Buxton et al. 2014). Comparison between transcriptomes 
of resistant and sensitive isolates of O. dentatum identified the downregulation of 
Ode-unc-63 and the upregulation of Ode-acr-21 and Ode-acr-25 in the resistant 
isolates. This suggested that loss of one acetylcholine receptor type could be 
compensated for by upregulation of another to allow continued activation of the body 
wall muscle (Romine, Martin and Beetham 2014). 
The expression of truncated transcripts of nAChR subunits, often produced by 
alternate splicing, has also been associated with levamisole resistance. Truncated 
transcripts of Hco-acr-8b, generated by a splice variant of the gene, have been linked 
to levamisole resistance in H. contortus (Fauvin et al. 2010). Reduced transcription of 
Hco-unc-63a and Hco-unc-29 has also been linked to levamisole resistance of                    
H. contortus (Sarai et al. 2013). Truncated transcripts of unc-63 were also found in 
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levamisole resistant isolates of H. contortus, T. circumcincta and T. colubriformis 
(Neveu et al. 2010; Boulin et al. 2011). 
These observations highlight that changes to the L-nAChR subunit composition is 
sufficient to alter levamisole sensitivity. 
 Cys-loop receptors are a diverse class and are the target of many 7.6
anthelmintics and antiparasitics 
Cys-loop receptors are the targets of many drugs used to control nematodes of both 
veterinary and human importance, as well as the target of drugs used to control insect 
pests. Different drugs target different classes of cys-loop receptors. The three widely 
used antiparasitics ivermectin, levamisole and fipronil target glutamate-gated chloride 
channels, nicotinic acetylcholine receptors and GABA-gated chloride channels 
respectively.  
Recent use of genomics has revealed that different species have different 
complements of cys-loop receptors. The glutamate-gated chloride channels are unique 
to invertebrates making these a potential target for drugs that do not affect vertebrate 
hosts. However, among invertebrates differences in the complement of cys-loop 
receptors also exist, leading to different compounds having a greater effect on some 
species than others. A list of drugs that target cys-loop receptors is provided in Table 9. 
The nAChRs in particular have been used as a target for drugs designed against 
nematode infection, as well as other pests. The diversity of nAChR subunits present 
between different species has made them a useful target. In mammals, 16 genes 
encode nicotinic acetylcholine receptors (Millar and Gotti 2009), in insects 10-12 
nAChR genes have been found (Jones and Sattelle 2010) and in nematodes the range 
seems to be particularly variable with only 8 nAChR-encoding genes having been 
identified in T. spiralis so far (Williamson, Walsh and Wolstenholme 2007) and over 30 
identified in C. elegans (Jones et al. 2007). For example, levamisole and imidacloprid 
both target nAChRs, but levamisole is typically used to treat nematode infections while 
imidacloprid is used to treat biting insects such as fleas (Raymond and Sattelle 2002). 
As G. pallida and G. rostochiensis have been shown to have a distinct complement of 
cys-loop receptors, even in comparison to other nematodes, it may be that novel drug 
targets can be identified to control plant-parasitic nematode infection. Further work 
on the nAChRs and glutamate-gated chloride channels would be beneficial, as well as 
examination of other plant-parasitic nematodes in the order Tylenchida in order to 
identify targets unique to this order.  
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 Alternate splicing and RNA editing further increase diversity of 7.7
nAChRs  
Although fewer genes encoding nAChRs have been found in insects than in nematodes, 
the diversity of subunits is increased by alteration of the transcripts from the genomic 
sequence. 
7.7.1 RNA editing  
RNA editing is the modification of adenosine residues to inosine (A to I editing) in 
pre-mRNA transcripts by adenosine deaminases (Seeburg 2002). The presence of an 
inosine residue is read as a guanosine residue, and thus RNA editing can change which 
amino acid residue is present in the translated protein.  
RNA editing has been observed to occur in one nAChR gene of the honey bee Apis 
mellifera (Jones et al. 2006) and in five nAChR genes of the fruit fly Drosophila 
melanogaster (Jones and Sattelle 2010). Some of these sites of RNA editing are 
conserved across the different insect species, while in some species these same sites 
lacked RNA editing, but were genomically encoded as guanosine residues. Examples 
are also found of RNA editing events which are species-specific (Jin et al. 2007). Some 
of these RNA editing sites occur in places which are strongly related to receptor 
function, such as around Loop E of the acetylcholine binding site (Grauso et al. 2002).  
While RNA editing is known to occur in C. elegans and its presence is essential for 
normal behaviour (Tonkin et al. 2002), no sites associated with RNA editing have been 
found for any of the nAChR genes of C. elegans or any other nematode. As RNA editing 
events may increase the amount of diversity of nAChRs within and between nematode 
species, exploration of RNA editing events may be interesting. The actions of RNA 
editing may be pertinent for nAChR genes identified from genomic sequences as this 
may not reflect the amino acid sequence of the mature protein. 
7.7.2 Alternate splicing 
Alternate splicing is the differential inclusion or exclusion of exons from the same gene 
leading to different mRNA and different mature proteins (isoforms). Different isoforms 
can alter properties of the mature protein. Cel-avr-14, which encodes a 
glutamate-gated chloride channel, is differentially spliced to give rise to two isoforms: 
Cel-AVR-14A and Cel-AVR-14B. There is evidence to suggest that Cel-AVR-14B binds 
ivermectin more effectively than Cel-AVR-14A (Dent et al. 2000). 
There are limited confirmed examples of nAChR genes of C. elegans which are 
alternately spliced, although cel-acr-19, cel-acr-24, cel-lev-1, cel-acr-17, cel-acr-20 and 
cel-des-2 have predicted splice variants on Wormbase. In insect nAChRs, examples of 
alternate splicing are widespread. The Drosophila nAChR subunits (Dα4 and Dα6) are 
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alternately spliced to produce five splice variants for both Dα4 (Lansdell and Millar 
2000) and Dα6 (Grauso et al. 2002). Similar splice variants have also been found in the 
orthologues of these genes in other insect species (Jin et al. 2007). Some of these 
splice variants had severe impacts on the receptor function and assembly. A splice 
variant of Dα4 in which exon 2 is missing seemed to impair the ability of the receptor 
to assemble (Lansdell and Millar 2000), and some splice variants of Dα6 result in 
proteins with differing amino acids for the Loop D and second transmembrane region 
(Jin et al. 2007).  
This level of alternate splicing in nAChRs has not been observed in nematodes. 
However, there are examples of alternate splicing events which introduce premature 
stop codons and lead to truncated proteins. In H. contortus alternative splicing has 
been identified in hco-unc-63 (Neveu et al. 2010) and hco-acr-8 (Fauvin et al. 2010) 
leading to truncated versions of these proteins and is associated with levamisole 
resistant populations.  
The possibility that nAChRs identified from G. pallida and G. rostochiensis can be 
altered by either RNA editing or alternate splicing has not been investigated by this 
work. If these events took place, it would expand the diversity of the subunits found in 
these species and may allow more novel targets to be identified.  
 Specificity is key in drug design 7.8
The diversity observed in the nAChRs makes them a prospective target for new drug 
design which is specific to their target organisms. The current controversy regarding 
the use of neonicotinoids demonstrates that off-target effects must be considered 
carefully as they can become damaging to the ecosystem (Whitehorn et al. 2012; 
Godfray et al. 2014).  
Studies into the nAChR family, and other cys-loop receptors, of nematodes have 
revealed that different species of nematodes have different complements of nAChR 
subunits, which may allow for targeting of specific nematode families such as the 
plant-parasitic nematodes of the order Tylenchida and avoid targeting the beneficial 
nematodes of the soil environment.  
The use of Xenopus oocytes as a heterologous expression system would be useful to 
determine sensitivity of receptors to different drugs. Potential novel targets could be 
expressed in this system, and the responsiveness of the channel probed and compared 
to those from off-target organisms. Although this system has proved problematic for 
the expression of nAChRs from insects, which require the expression of vertebrate 
β-subunits alongside the insect subunit to investigate the pharmacology (Thany et al. 
2007; Bertrand et al. 1994), Xenopus oocytes have been used successfully to express 
receptors from a range of different nematodes (Boulin et al. 2011; Boulin et al. 2008; 
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Williamson et al. 2009; Buxton et al. 2014). Furthermore, the expression of Cel-acr-23 
in Xenopus oocytes has been used to demonstrate that this subunit, novel to 
nematodes, is the target of the novel anthelmintic monepantel (Rufener et al. 2013). 
3D modelling of drug interactions may also be of use to predict drug sensitivity. 
Homology modelling of subunits based on templates produced from X-ray crystal 
structures can generate predictions for how various drugs will interact with the 
receptor by running simulations in silico.  
 C. elegans as a model for plant-parasitic nematodes 7.9
C. elegans has been used as a model for many nematode parasites, including 
veterinary parasites. As discussed in the introduction, there are many reasons why          
C. elegans is used as a model organism. 
Results obtained in this work indicate that, despite the evolutionary distance between 
C. elegans and plant-parasitic nematodes of the order Tylenchida, it is useful as a 
heterologous system to investigate plant-parasitic nematode genes. It has been shown 
that the promoter regions of nAChR genes from G. pallida can function to drive GFP 
expression in C. elegans. It was also shown that Gpa-unc-38.1 can partially functionally 
complement the unc-38(x20) strain of C. elegans.  
However, in some respects relying too much on C. elegans can be problematic. Some 
cys-loop receptors seem to have a different composition in C. elegans than in parasitic 
nematodes. For example, functional orthologues of cel-lev-1 and cel-lev-8 are not 
found in most parasitic nematode species. As these comprise the L-nAChR of                  
C. elegans, receptors of a different composition are clearly present in parasitic 
nematodes. However, due to the resources available for C. elegans and the ease with 
which it can be genetically manipulated, it still remains a beneficial model organism.  
 Duplications and deletions of cys-loop receptor subunits is 7.10
common throughout the phylum Nematoda, and leads to the diversity of 
subunits found 
A phylogenetic tree is shown in Figure 7-1, incorporating subunits associated with 
anthelmintic sensitivity (ivermectin, levamisole and monepantel), and other members 
of their groups, from C. elegans and from the parasitic nematode species H. contortus, 
O. dentatum, A. suum, B. malayi and G. pallida. This information is also summarised in 
Table 10. 
The positioning of orthologues in relation to each other reflects the evolutionary 
distance between species. According to the clades described by van Megen et al. 
(2009), C. elegans, H. contortus and O. dentatum are within clade 9, with C. elegans in 
the order Rhabditida and H. contortus and O. dentatum both in the order Strongylida. 
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A. suum and B. malayi are in clade 8, the former in the order Ascaridida and the latter 
in the order Spirurida, while G. pallida is in Clade 12 in the order Tylenchida. In the 
phylogenetic tree (Figure 7-1), the orthologues of H. contortus and O. dentatum are 
typically clustered together, with the C. elegans orthologues as the next closest 
related. The orthologues from B. malayi and A. suum are likewise closely related to 
each other, but are in sister groups to the orthologues of C. elegans, H. contortus and 
A. suum and share a common ancestor. The G. pallida orthologue is predicted to have 
split from a common ancestor basal to all other orthologues identified here, as a result 
of the position of G. pallida in Clade 12. This description is particularly well 
represented by the GLC-2 orthologues. The orthologues cluster together within their 
orthologous groups and further cluster within their groups (e.g. Orthologues of 
members of the UNC-38 group, ACR-6, UNC-38 and UNC-63). 
Some deletion and duplication events are highlighted, as well as the identification of 
novel subunits. For LEV-8, a full-length sequence has only been identified in                    
C. elegans. It is absent in H. contortus (Laing et al. 2013), but a partial sequence related 
to LEV-8 was identified in O. dentatum (Romine, Martin and Beetham 2013). The 
authors of this paper postulated that the identification of a partial sequence for LEV-8 
in O. dentatum may be evidence that the loss of this gene is a recent deletion. The 
duplications of UNC-29 in G. pallida (where two orthologues are found) and in                     
H. contortus (four paralogues) seem to be entirely separate events. Both 
Gpa-UNC-29.1 and Gpa-UNC-29.2 are predicted to have arisen from an ancestor basal 
to all of the Hco-UNC-29 paralogues and these paralogues arisen from a common 
ancestor related to Cel-UNC-29. For UNC-38 this duplication only takes place in                 
G. pallida (and, as discussed in 4.4.2.6, G. rostochiensis), but it is not clear whether or 
not this duplication extends into other plant-parasitic nematodes due to lack of 
complete genome data. 
Two novel genes were identified in H. contortus belonging to the glutamate-gated 
chloride channel family, which were named Hco-glc-5 and Hco-glc-6 (Laing et al. 2013). 
The orthologue identified from NCBI and listed in Romine, Martin and Beetham (2013) 
for AVR-15 for O. dentatum clusters with Hco-glc-6 leading to the conclusion that the 
orthologue identified as Od-avr-15 is in fact likely to be Od-glc-6. Similarly, the 
orthologue obtained from NCBI for AVR-14 for O. dentatum (Od-AVR-14) associates 
with Hco-GLC-5, suggesting misidentification of this orthologue. This may also have 
implications for the two orthologues of Cel-AVR-14 identified for G. pallida, as 
Gpa-AVR-14.1 associates with Cel-AVR-14 isoform a, but Gpa-AVR-14.2 is predicted to 
share a common ancestor with Hco-GLC-5 and Od-AVR-14 which may indicate that 
Gpa-AVR-14.2 is a novel gene similar to Hco-GLC-5.  
Other absences from this phylogenetic tree are harder to draw conclusions from, as 
absence of identification from bioinformatic data does not necessarily mean absence 
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from the genome. As a case in point, in Laing et al. (2013), a phylogenetic tree is shown 
which includes Hco-ACR-3 and Hco-ACR-12. Sequences for these were not included in 
this phylogenetic tree as they could not be identified in the H. contortus database 
available on NCBI. For this reason, it cannot be stated with certainty that the absences 
of orthologues for particular genes (e.g. absence of Bma-GLC-3 and absence of 
Bma-GLC-4 and AsuGLC-4) are representative of a true deletion, or a by-product of 
data availability of genome assembly. While absences of orthologues in G. pallida can 
be presumed with more confidence due to factors such as full access to genome and 
transcriptome data, and the availability of a closely related species G. rostochiensis as a 
comparison, the same is not true for the other parasitic nematodes. There are also 
gaps in data due to lack of research focus. Much attention has been given to the 
subunits known to be involved in sensitivity to anthelmintic drugs, but other members 
of some groups are less well characterised (e.g. the ACR-16 group and the other 
members of the DEG-3 group) and were not included for this reason.  
It does seem to be clear, however, that duplications of subunits are common in the 
phylum Nematoda and probably deletions as well. The issue of when a duplication 
results in evolution of a new gene, and when to assign a new name rather than 
numbering, is harder to determine.  
 Further directions 7.11
7.11.1 Further work on nAChRs 
The role of nAChRs of G. pallida and other plant-parasitic nematodes will be the 
subject of much future work. Although orthologues of all members of the UNC-38, 
ACR-8 and UNC-29 group have been investigated, and if present, cloned from                  
G. pallida, functional studies have only been conducted on one gene (gpa-unc-38.1). 
Functional studies on the remaining members are yet to be conducted. 
Furthermore, although members of the DEG-3 and ACR-16 groups have been identified 
in G. pallida and G. rostochiensis, no members of these groups have been cloned. The 
number of members of the ACR-16 group is particularly reduced compared to              
C. elegans. As all members of this group have been found in other parasitic nematodes 
(e.g. H. contortus (Laing et al. 2013)), this reduction in the ACR-16 group in both                 
G. pallida and G. rostochiensis may be common to all plant-parasitic nematodes and 
may be worth exploring further. Characterisation of gpa-acr-16, for which the                    
C. elegans orthologue forms a homomeric pentameric receptor in body-wall muscle, 
may be of particular interest. Further rescue studies using mutant C. elegans could be 
beneficial in this respect, to see if the G. pallida orthologue is able to rescue the 
mutant phenotype. If suitable C. elegans mutants are available for other subunits (i.e. 
with a visible phenotype), a mutant-rescue strategy can be applied to many of these 
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genes. Some examples of mutant strains which could be used are unc-63(b404) and 
unc-29 (e193) (both uncoordinated and levamisole resistant). 
The use of Xenopus oocytes as a heterologous expression system, will allow the 
identification of those subunits which may associate to form receptors, and their 
pharmacology to be determined. Unlike mutant-rescue experiments, this would not 
rely on the presence of suitable C. elegans mutants to work with. This system could be 
used to investigate the likely composition of receptors using those which have been 
identified in C. elegans as a template. This not only includes the identification of the 
composition of the G. pallida L-nAChR present in body wall muscle, but could also be 
used to investigate the orthologues of components of the neuronal receptor (cel-acr-2, 
cel-acr-3, cel-unc-38, cel-acr-12 and cel-unc-63 (Jospin et al. 2009) the cel-deg-2 
cel-deg-3 receptor (Treinin et al. 1998) and the homomeric receptor comprised of 
cel-acr-16 (Touroutine et al. 2005). 
Further work investigating the expression patterns of G. pallida nAChRs by use of their 
promoter regions to drive GFP expression in C. elegans would also be beneficial as it 
would allow their location to be identified. This would allow confirmation that subunits 
which can associate in a heterologous system (Xenopus oocytes) could also associate in 
vivo.  
7.11.2 Further work on other cys-loop receptor members and neurotransmitter 
synthesis genes 
Other members of the cys-loop receptor family have been identified, which could also 
be investigated in similar experiments. Two orthologues of cel-avr-14 were identified 
in both G. pallida and G. rostochiensis, and their role in binding ivermectin could be 
investigated by use in mutant-rescue experiments. As G. pallida and G. rostochiensis 
lack orthologues for the other two genes associated with ivermectin sensitivity 
(cel-avr-15 and cel-glc-1), it could be that these two orthologues of cel-avr-14 are the 
sole determinant of ivermectin sensitivity in G. pallida. A highly ivermectin resistant 
strain of C. elegans could be used (e.g. DA1316) to determine if rescue with either 
orthologue (gpa-avr-14.1 or gpa-avr-14.2) is sufficient to restore ivermectin sensitivity. 
A similar approach was used to highlight the role of hco-glc-6 in ivermectin sensitivity 
of H. contortus (Glendinning et al. 2011).  
Some work with other orthologues identified in Chapter 3 is already being conducted 
by collaborating labs. These include the investigation of genes encoding the serotonin 
receptor gpa-ser-7, the tryptophan hydroxylase gpa-tph-1 (serotonin biosynthesis) and 
the glutamate transporter gpa-eat-4. Functional characterisation of these has been 
conducted by mutant-rescue experiments and the functional study of behaviours. In a 
similar way, the other components identified could be investigated such as gpa-unc-25 
(involved in GABA biosynthesis) and gpa-cha-1 (acetylcholine synthesis). Both of these 
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genes have mutant phenotypes for which mutant rescue could be quantified such as 
aldicarb and levamisole hypersensitivity for cel-unc-25 (Vashlishan et al. 2008). 
7.11.3 Further aspects of gene regulation to be considered 
The cys-loop receptor genes identified may also be regulated and organised in 
different ways, such as by alternate splicing, RNA editing and gene organisation. 
Further exploration of operon conservation between the species would be useful, 
particularly for the acr-2 acr-3 operon discussed in 4.4.54.3.3.1. The majority of 
operons in         C. elegans are SL2-type, formed by trans-splicing using a SL2 small 
nuclear ribonucleoprotein particle which joins 3’ end to 5’ end of a downstream 
mRNA. The presence of SL2 elements in the C. elegans genome has been linked to 
genes that are likely to be part of an operon (Blumenthal et al. 2002). Such an 
approach could be used to identify operons in G. pallida, by identifying genes that 
produce SL2-containing mRNAs and then checking the gene structure to identify if they 
are likely to be within operons (i.e. in close proximity to an upstream gene).  
This approach may identify potential new operons formed in G. pallida or                           
G. rostochiensis, such as that described in 4.4.5 which may consist of gpa-acr-2 
gpa-acr-3 gpa-unc-29.1. The rate of operon formation in nematodes is 3.3 times 
greater than that of operon loss, suggested that new operons may be found (Qian and 
Zhang 2008). The role of alternate splicing and RNA editing in G. pallida gene 
regulation has not yet been explored. This may have implications for the diversity of 
cys-loop receptors identified. 
 The cys-loop ligand-gated ion channel gene family is a source of 7.12
potential targets for anthelmintic design  
The diversity of cys-loop receptors between species provides a wealth of potential 
targets for drug design. Although cys-loop receptors are common all animals, 
species-specific variations allow the targeted control of particular pests without 
damaging off-target species. Anthelmintics commonly target cys-loop receptors, and it 
has been shown that the presence or absence of particular subunits or the 
composition of receptors can affect the pharmacology of the receptor and thus the 
efficacy of the anthelmintic. 
This provides a mechanism to target all plant-parasitic nematodes of the order 
Tylenchida, and a novel method of control for the most damaging plant-parasitic 
nematodes of essential crops. 
  
243 
 
 
  
Drug Target Main use References 
Macrocylic lactones 
e.g. ivermectin 
Glutamate-gated 
chloride channels 
Human and veterinary 
applications 
(Geary 2005) 
Piperazine derivatives 
e.g. diethylcarbamazine 
GABA receptor agonist Human  (Bockarie and Deb 2010) 
Tetrahydropyrimidine 
derivatives  
e.g. pyrantel and 
oxantel 
nAChRs Human and veterinary 
applications 
(Kopp et al. 2008) 
Amino-acetonitrile 
derivatives  
e.g. Monepantel 
nAChRs Veterinary applications (Sager et al. 2009) 
Tribendimidine L-nAChRs Human applications (Hu, Xiao and Aroian 
2009) 
Spiroindoles 
e.g. Derquentel 
nAChRs Veterinary applications (Little et al. 2011) 
Table 9: Examples of drugs targeting cys-loop receptors 
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C. elegans G. pallida H. contortus A. suum B. malayi O. dentatum 
Cel-lev-1 - Y (no SP) - - Y 
Cel-lev-8 - - - - Y (partial) 
Cel-unc-29 2 x 4 x Y Y Y 
Cel-unc-38 2 x Y Y Y Y 
Cel-unc-63 Y (no SP) Y Y Y Y 
Cel-acr-8 Y Y - Y Y 
Cel-acr-23 - - - - - 
- - Hco-mptl-1 - - - 
Cel-deg-3 Y Y Y Y - 
Cel-des-2 y Y Y Y - 
Cel-glc-1 - - - - - 
Cel-glc-2 Y Y Y y Y 
Cel-glc-3 Y Y - - Y 
Cel-glc-4 Y y - - Y 
-  Hco-glc-5  - Y 
-  Hco-glc-6  - - 
Cel-avr-14 2 x Y Y Y Y 
Cel-avr-15 - Y - - Y 
Table 10: Complement of genes encoding members of nAChR subunits and glutamate-gated 
chloride channel subunits in different nematode species 
Data collated from NCBI databases, (Williamson, Walsh and Wolstenholme 2007; Romine, 
Martin and Beetham 2013). Y indicates an orthologue is present, no SP indicates that a signal 
peptide is not predicted. – indicates that an orthologue is not present. Numbers x indicates the 
number of orthologues for the C. elegans gene found in that species. Novel genes in species 
are also listed. 
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Figure 7-1: Maximum Likelihood tree of nAChRs and Glutamate-gated chloride channels 
associated with anthelmintic sensitivity from C. elegans, H. contortus, O. dentatum, A. suum, 
B. malayi and G. pallida.  
The phylogenetic tree using predicted protein alignments (generated by Clustal Omega 
(Sievers et al. 2011)). Sequences were obtained from NCBI and Wormbase, with reference to 
published data (Laing et al. 2013; Williamson, Walsh and Wolstenholme 2007; Romine, Martin 
and Beetham 2013). Bootstrap values for 100 iterations are labelled on nodes. Scale bar 
represents average number of substitutions per site. MEGA6 was used to compute the ML tree 
(Tamura et al. 2013). Orthologues cluster first by orthologous group, and then in relation to 
the evolutionary distance between species. 
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